Manipulating the Properties of Hydrogels to Promote Ependymal Cell Behaviour for Spinal Cord Repair by Colquhoun, Catherine Sarah
Manipulating the Properties of Hydrogels to Promote 
Ependymal Cell Behaviour for Spinal Cord Repair 
 
Catherine Sarah Colquhoun 
 
 
Submitted in accordance with the requirements for the degree of 
Doctor of Philosophy 
 
The University of Leeds 






The candidate confirms that the work submitted is her own and that appropriate credit 
has been given where reference has been made to the work of others. 
 
This copy has been supplied on the understanding that it is copyright material and that 
no quotation from the thesis may be published without proper acknowledgement. 
 
The right of Catherine Sarah Colquhoun to be identified as Author of this work has 





Firstly, an enormous thank you to my supervisor Jim Deuchars, for not only giving me 
the opportunity to undertake a PhD in his group but also for all of his support and 
guidance over the last five or so years. I would also like to express great thanks to my 
co-supervisor Sue for all of her invaluable advice and personal support, along with her 
magical ability to rein Jim in. 
I would also like to thank everyone in the Deuchars lab – for teaching me numerous 
fiddly experimental techniques, fuelling my coffee addiction, and getting me through the 
long days spent in the lab. Special thanks to Lauryn, Katie, Christian, Emily, Norah, 
and Nurha who have kept me sane along the way. 
To my amazing friends and family who manage to make me smile every day, even if it 
is at something disgusting; I’m so lucky to have so many incredible people in my life. 
Thank you to my Mum, Dad, Rob, Jon, Amanda, and my best friend and twin Sarah – I 
couldn’t ask for a better support network. Last but not least, I wouldn’t have made it 
through this PhD without the love and endless support from Laurence and my three 
little munchkins. Thank you for dragging me out of bed in the morning and dealing with 







Spinal cord injury (SCI) occurs when the spinal cord is physically crushed, impinged, 
severed, or otherwise damaged; resulting in irreversible disruption to the neuronal 
pathways responsible for motor and sensory function. The main obstacles to spinal 
cord repair include neuronal damage, loss of oligodendrocytes (leading to axonal 
demyelination), and scar formation with glial and fibrotic components. Despite the 
prevalence of SCI and its costly impact on society, treatment remains limited. 
Ependymal cells (ECs) lining the central canal show promise as a pool of endogenous 
stem cells within the spinal cord. These cells are found to proliferate, differentiate, and 
migrate in response to injury, however at present, little is known about this neurogenic 
niche and how the local microenvironment influences cellular behaviour. This project 
aims to investigate whether endogenous EC behaviour can be altered by manipulating 
the properties of the surrounding matrix. 
Nestin is a type VI intermediate filament protein and a marker of neural stem and 
progenitor cells in the central nervous system. Characterisation of transgenic mice 
expressing green fluorescent protein (GFP) under the control of nestin was carried out 
within this thesis; identifying these cells as ECs and pericytes in the spinal cord. 
(Nestin) GFP-positive ECs colocalised with a number of stem cell markers including: 
CD24, Sox2, and foxJ1.  
ECs were also shown to express chemokine receptor type 4 (CXCR4), the main 
receptor to stromal cell-derived factor-1 (SDF-1); both of which are involved in the 
directed migration of neural cells through chemotaxis. The results of spinal cord slice 
cultures and intraspinal injections presented in this thesis suggest that EC behaviour 
can be manipulated using hydrogels and SDF-1α; towards repair of SCI.   
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Chapter 1 – General Introduction 
 
1.1 The spinal cord 
The spinal cord is part of the central nervous system (CNS) and spans the length of the 
spine; extending caudally from the medulla oblongata (part of the brain stem), enclosed 
within the foramen magnum and the vertebral column. Three concentric layers of 
membrane, the meninges, envelop the spinal cord and provide further protection. 
These layers include the dura mater, arachnoid mater, and the innermost pia mater. 
The spinal cord is organised along the rostro-caudal axis into four regions: cervical, 
thoracic, lumbar, and sacral (Figure 1.1 A). The spinal cord can be divided further into 
the white and grey matter, with the former being comprised of myelinated and 
unmyelinated axons making up the ascending (sensory) and descending (motor) nerve 
fibres. These are present in the form of tracts, which allow for the processing of 
sensory inputs and initiate movement of the body via afferent and efferent neuronal 
projections. Sensory afferent nerve fibres enter the spinal cord via the dorsal roots 
whereas the motor and preganglionic efferent nerve fibres exit via the ventral roots 
(Figure 1.1 B). 
The grey matter forms the distinct butterfly shaped area, central to the spinal cord and 
this is comprised of dendrites and axons as well as glial cells and neuronal cell bodies 
organised into a series of 10 laminae in the transverse plane (Rexed, 1954). The dorsal 
horn contains laminae I-VI, the intermediate zone contains lamina VII, and the ventral 
horn contains laminae VIII-IX. At the centre of the cord is lamina X and the central 
canal (Figure 1.1 B). This thesis focuses on the central canal, and so the organisation 





Figure 1.1 Schematic diagram of the spinal cord organisation 
(A) Spinal cord segment organisation along the rostro-caudal axis including: cervical, 
thoracic, lumbar, and sacral regions. (B) Transverse section of the spinal cord and 
basic anatomical features and laminae (I – X). Drawn using BioRender.   
 
1.1.1 Central canal region cellular organisation 
The central canal region resembles a duct as it is surrounded by a heterogeneous cell 
population, through which the cerebrospinal fluid (CSF) flows. CSF is secreted by 
ependymal cells lining the choroid plexus and flows caudally from the lateral ventricles 
down through the spinal cord central canal. The CSF contains a number of ions (Na+, 
Cl-, HCO3-, K+, Mg2+, and Ca2+), vitamins (e.g. folate, ascorbic acid), hormones, and 
peptides and proteins actively transferred from the blood (e.g. leptin) or synthesised in 
the choroid plexus (e.g. insulin-like growth factor and brain-derived neurotrophic 
factor). 
The ependymal cells (ECs) are the most abundant cell surrounding the central canal 




















































analysis of these cells using transmission electron microscopy identified three EC 
subtypes: biciliated cuboidal ECs, radial ECs, and tanycytes (Figure 1.2). Typical 
biciliated cuboidal ECs are the most common subtype and these cells possess motile 
cilia responsible for CSF propulsion (Alfaro-Cervello et al., 2012a). Radial ECs are 
found at the ventral and dorsal poles with long basal processes extending along the 
dorsoventral axis (Alfaro-Cervello et al., 2012a). Lastly, tanycytes are characterised by 
their single cilium and a long basal process terminating on blood vessels (Hugnot, 
2011).  
 
Figure 1.2 Central canal cellular organisation 
Schematic of the murine spinal cord central canal, depicting the organisation of: radial 
ependymal cells (EC), biciliated cuboidal ECs, tanycytes, blood vessels, cerebrospinal 
fluid contacting cells (CSFcC), glial fibrillary acidic protein+ve (GFAP+) cells, neuronal 
nuclei+ve (NeuN+) cells, and oligodendrocyte transcription factor+ve (Olig2+) cells. 





Cerebrospinal fluid contacting cells (CSFcCs) are located in the ependymal and 
subependymal layers within the central canal region and have “bulb-like protrusions” 
that extend into the CSF (Figure 1.2). In the spinal cord of lamprey and zebrafish these 
CSFcCs are sensitive to mechanical stimulation and changes in CSF pH (Jalalvand et 
al., 2016; Orts-Del’Immagine and Wyart, 2017). 
Additional cells within the subependymal layer include: astrocytes (glial fibrillary acidic 
protein - GFAP+ve cells), oligodendrocyte progenitor cells (olig2+ve cells), and 
neurons (NeuN+ve cells). 
 
1.2 Spinal cord injury 
Spinal cord injury (SCI) occurs when the spinal cord is physically damaged due to 
contusion, laceration, or compression and although complete transection of the spinal 
cord is a rare occurrence in humans, axonal destruction is often observed, resulting in 
sensory and motor deficits. Each year in the UK alone, around 2,500 people sustain an 
SCI, leading to a cost of approximately £500 million per annum in immediate treatment 
costs resulting in a great social burden (backuptrust.org.uk, 2019). 
SCI is typically classified according to its neurological level using the International 
Standards for Neurological Classification of Spinal Cord Injury. This tests the motor and 
sensory function of the patient. The level of SCI damage is defined as the most caudal 
level at which function remains intact (Lee and Thumbikat, 2015). Severity of such an 
injury is then graded (A-E) according to the American Spinal Cord Association 
Impairment Scale (NICE, 2016), and grouped according to the cause of damage, with 
patients presenting contusion or cavity injuries accounting for 49% of cases (Kim and 
Lee, 2014; Silva et al., 2014). 
Despite the prevalence of SCI and its costly impact on society, treatment remains 
limited, with current therapies focussing on reducing pain and paralysis rather than 




treatment for SCI consists of stabilisation and decompression of the spinal cord, 
followed by a high dose of the anti-inflammatory steroid methylprednisolone along with 
immune modulators (Silva et al., 2014). However, there is considerable debate around 
the efficacy of this pharmacological intervention (reviewed (Silva et al., 2014)) and so 
research into alternative strategies for repair still remains crucial. 
1.2.1.1 SCI pathophysiology 
To effectively design a treatment for SCI, firstly the pathophysiological processes that 
occur following injury must be understood. In all cases of SCI, the pathological 
progression can be subdivided into primary, secondary, and chronic phases. 
The primary injury phase occurs through the initial insult to the spinal cord and can be 
grouped according to the morphological type: impact with persistent compression of the 
cord, impact with transient compression, distraction (separation of adjacent vertebrae), 
and laceration/transection. This initial insult leads to instantaneous cell death and 
damage, primarily affecting the softer central grey matter (Freund et al., 2013). 
Mechanical damage to the spinal cord also leads to haemorrhaging of the vasculature 
which disrupts blood flow, resulting in local infarction and additional damage due to 
ischemia (Dumont et al., 2001). 
Furthermore, progressive post-traumatic damage also results in loss of motor and 
sensory function. Secondary acute (0 - 72 h) events include ionic changes, the 
formation of free radicals, glutamate excitotoxicity, apoptosis, and inflammation brought 
about by resident cells and invading immune cells when the blood-spinal cord-barrier 
(BSCB) is damaged (reviewed in more detail by (Silver and Miller, 2004; Oyinbo, 2011; 
Silva et al., 2014). Damaged cells also release adenosine triphosphate (ATP), thereby 
mediating chemotaxis of microglia towards the injury (Wu et al., 2007) and reactivity of 
astrocytes, oligodendrocytes, and oligodendrocyte progenitor cells via the activation of 




Mechanical shearing of myelinated axons results in the disruption of the myelin sheath 
which in turn leads to the accumulation of myelin inhibitors (Nogo-A, Myelin Associated 
Protein and Oligodendrocyte Myelin Glycoprotein) that hinder axon regeneration via 
binding to Nogo-66 receptor protein (Wang et al., 2006). Additionally, apoptosis of 
resident oligodendrocytes leads to further denudation of intact axons, impairing 
conduction and limiting functional recovery (Grossman et al., 2001; Hulsebosch, 2002). 
In the chronic stage of SCI, a fibrous scar is formed at the damaged site in order to 
prevent further damage and promote repair. The fibrotic component of the scar formed 
following SCI is located at the centre of the lesion site, and this contains EC-derived 
astrocytes, stromal cells derived from Glast+ve cells deemed to be type-A pericytes, 
along with invading meningeal fibroblasts where the BSCB is compromised (Göritz et 
al., 2011).  
The astrocytic response to spinal cord injury is typically referred to as reactive gliosis or 
astrogliosis. This is characterised by cellular hypertrophy, increased proliferation, 
process extension, and the production of intermediate filament proteins: GFAP, nestin, 
and vimentin, in and around the lesion site (Yang et al., 1994). While fibrotic scar 
formation results in a protective barrier around the site of injury; misalignment of 
reactive astrocytes occurs during the formation of the glial component at the injury 
border, followed by deposition of inhibitory chondroitin sulphate proteoglycans 
(CSPGs) and other extracellular matrix (ECM) proteins, thus creating a chemical and 
physical barrier to axonal regeneration and limited repair (Rolls et al., 2009; Yuan and 
He, 2013; Bradbury and Burnside, 2019). 
When confronted with the glial scar, the growth cones of regenerating axons undergo 
dramatic morphological changes and halt elongation (Davies et al., 1999) reportedly via 
binding of sulphated proteoglycans to the LAR (leukocyte common antigen related 
gene) family of transmembrane protein tyrosine phosphatases (PTPσ and PTPδ) (Shen 




(Dickendesher et al., 2012). Degradation of CSPGs via cleavage of glycosaminoglycan 
(GAG) chains using the bacterial enzyme chondroitinase ABC (ChABC) has previously 
been investigated to overcome this issue, resulting in the promotion of functional 
recovery in vivo following a bilateral lesion to the dorsal columns (C4 level) in rats 
(Bradbury et al., 2002). In this study ChABC was administered using a silastic tube 
inserted intrathecally, rostral to the lesion and recovery was assessed using 
immunohistochemistry, axon-tract tracing, electrophysiology and behavioural 
assessment. CSPG formation has also been inhibited in vivo using hepatocyte growth 
factor (HGF) from human mesenchymal stem cells (hMSCs) following a C4 “right over 
hemisection” injury in rats (Jeong et al., 2012). Transplantation of HGF-hMSCs resulted 
not only in significantly decreased GAG deposition, but also increased axonal growth 
beyond the glial scar and functional recovery of the forepaw. Glial scar formation has 
also been attenuated following experimental SCI using the natural anti-inflammatory 
agent curcumin, reducing astrogliosis and the presence of inflammatory cells, 
ultimately leading to improved functional repair (Wang et al., 2014; Jin et al., 2014). 
This scar tissue does however, form a protective barrier and these astrocytes reduce 
secondary degeneration and regulate the injury site by scavenging excess ions (Cui et 
al., 2001) and protecting neurons from nitric oxide (Chen et al., 2001). Careful 
consideration must be taken of the scar’s dual and conflicting roles when designing 
repair strategies (reviewed by (Bradbury and Burnside, 2019)). 
 
1.3 Manipulating neurogenesis post SCI 
The production of new neurons as well as astrocytes and oligodendrocytes is typically 
referred to as neurogenesis. In the adult mammalian brain, postnatal neurogenesis 
occurs in two neurogenic niches: the dentate gyrus (DG) of the subgranular zone 
(SGZ) within the hippocampus (Toni et al., 2008), and the subventricular zone (SVZ) 




Under physiological conditions, neuroblasts/type A cells are generated from radial glia-
like stem cells within the SVZ and these then migrate along the rostral migratory 
stream (RMS) towards the olfactory bulb (OB) where they differentiate into 
interneurons (Lois and Alvarez-Buylla, 1994; Carleton et al., 2003). In the DG of the 
SGZ, radial glia-like stem cells proliferate and generate neuroblasts that migrate along 
the SGZ where they differentiate into neuronal and glial cells in the granular layer of the 
DG. 
ECs in the spinal cord share a number of markers associated with the stem cells of the 
brain, including: sox2, a transcription factor involved in the maintenance of cell 
pluripotency (Zhang, 2014; Feng and Wen, 2015); nestin, an intermediate filament 
protein found in precursor cells of the developing and adult CNS (Hockfield and McKay, 
1985; Gritti et al., 1996); and vimentin, an intermediate filament expressed in the radial 
glia of the developing DG (Sancho‐Tello et al., 1995; Hamilton et al., 2009). 
Nestin+ve cells isolated from the postnatal brain of transgenic mice using fluorescence-
activated cell sorting (FACs) formed neurospheres and differentiated into neurons, 
astrocytes, and oligodendrocytes in vitro (Mignone et al., 2004). In the spinal cord of 
adult mice, nestin is expressed predominantly in dorsal and ventral ECs (Alfaro-
Cervello et al., 2012b). Additionally, vimentin is expressed in the cytoplasm and some 
of the radial processes of ECs at the central canal of adult mice (Alfaro-Cervello et al., 
2012b). CD133 (Prominin-1) is also expressed in human and murine embryonic stem 
cells (Uchida et al., 2000; Kania et al., 2005), and labels ependymal cells in the adult 
mouse SVZ and central canal (Lee et al., 2005; Coskun et al., 2008; Pfenninger et al., 
2011). In vitro, ECs were tracked using tamoxifen-induced recombination in cells 
derived from foxJ1- and nestin-CreER mice; giving rise to inducible and permeant 
genetic labelling using β-galactosidase (β-gal) and GFP expression. These ECs were 
shown to form neurospheres that could be serially passaged (> 8 times), and were 





1.3.1 Neurogenesis following SCI 
In the intact spinal cord, proliferation of ECs is restricted to self-renewal (Johansson et 
al., 1999; Meletis et al., 2008). However, in lower vertebrates ECs contribute 
significantly to neuronal regeneration and repair, and more recently, stem cell-like 
activity has been observed in mammals in response to injury (Johansson et al., 1999; 
Ogai et al., 2014a). ECs are thought to possess “latent neural stem cell potential”; 
proliferating and undergoing multilineage differentiation following SCI (Namiki and 
Tator, 1999; Takahashi et al., 2003; Lacroix et al., 2014), producing  astrocytes 
responsible for scar formation 4 months post-injury (Barnabé-Heider et al., 2010; 
Stenudd et al., 2015).  
In addition to this, ECs also generate myelinating oligodendrocytes and neurons in vitro 
(Meletis et al., 2008) crucial for the repair of SCI (Qin et al., 2015). 4 weeks following a 
dorsal funiculus incision in transgenic mice, analysis of the cellular fate of EC progeny 
using molecular markers and electron microscopy identified β-gal+ve ECs (recombined 
cells of FoxJ1-CreER mice) expressed Olig2 (oligodendrocyte marker) and these cells 
were scattered throughout the injury site, indicating EC multipotency in vivo (Meletis et 
al., 2008).  
Following compressive injury in the adult rat, ECs proliferate and differentiate at the site 
of the lesion into reactive astrocytes, with differences observed following injuries of 
varying severity (Mothe and Tator, 2005a). Delivery of exogenous injury-reactive ECs 
and oligodendrocyte precursor cells has been investigated in a rat model of severe 
spinal cord contusion injury. Here the transplanted cells migrated to the lesion site and 
this resulted in significant motor function recovery (Moreno-Manzano et al., 2009). 
 




Postnatal human neurogenesis has been widely debated (e.g. (Spalding et al., 2013; 
Sorrells et al., 2018) and conflicting conclusions have raised questions regarding 
methodological factors and study design (reviewed in (Bergmann et al., 2015; 
Kempermann et al., 2018; Snyder, 2019). In a recent study by (Moreno-Jiménez et al., 
2019) the post-mortem delay (time between death and tissue fixation) and method of 
tissue fixation greatly influenced the detection of postnatal neurogenesis in the DG of 
human tissue. In tissue samples with a post-mortem delay of 24 h and minimal tissue 
processing (no freezing or paraffin inclusion), the authors identified neurons at a range 
of maturation stages in the brain as identified by immunofluorescence cell labelling 
(Moreno-Jiménez et al., 2019). Here, colocalisation of doublecortin (DCX)+ve neurons 
was seen with both calretinin and calbindin; thereby identifying these cells as immature 
and more differentiated neurons respectively and indicating the presence of postnatal 
neurogenesis in the DG of neurologically healthy humans.  
Studies have also shown that adult humans have central canal ECs (Mothe et al., 
2011; Cawsey et al., 2015). ECs isolated from the human spinal cord immediately 
following death from stroke or trauma  formed neurospheres expressing sox2 and 
nestin and differentiated into glial cells and neurons in vitro (Dromard et al., 2008; 
Mothe et al., 2011). Additionally, following trauma to the CNS, nestin immunoreactivity 
at the central canal increases (Cawsey et al., 2015). However, adult human spinal cord 
ECs aren’t thought to proliferate in vivo following injury (Cawsey et al., 2015; Paniagua-
Torija et al., 2018) suggesting these cells may need manipulating to promote 
endogenous repair. 
1.3.3 Directing stem cell behaviour 
Previous research has focussed on the use of stem cell transplants as a means of 
replacing the cells lost following spinal cord injury, however these are limited due to the 
safety and ethical issues, as well as the timely nature of stem cell procurement 




although transplantation of naïve neural stem cells improved motor function recovery 
within a rat model, allodynia-like hypersensitivity was caused in unaffected forepaws 
(Hofstetter et al., 2005). Additional problems associated with exogenous administration 
of neural progenitors include the risk of teratoma formation (Li et al., 2008) and issues 
related to cell fate when administered without differentiation cues (Panayiotou and 
Malas, 2013). Additional to this, implanted cell viability has been shown to be as low as 
3% for human embryonic stem cell-derived cells in the injured CNS, leading to poor 
functional outcomes (Kawasaki et al., 2000; Li et al., 2008). Following focal ischemia in 
rat cerebral cortex, stem cell graft placement was also shown to be a determinant of 
cell survival, with human CNS-derived neurospheres having a greater survival rate in 
non-ischemic tissue rather than at the lesion site; highlighting the issue of the oxygen 
depleted environment into which these cells would be implanted (Kelly et al., 2004). 
Therefore, a potentially safer and novel approach to spinal cord repair would involve 
the manipulation of neurogenesis by endogenous stem cells in situ. 
In the SVZ neurogenic niche, inflammatory signals and the regulation of Wnt activity 
contribute to adult stem cell quiescence, and therefore regulate the regenerative 
potential of these cells in the aging brain (Kalamakis et al., 2019). These mechanisms 
may therefore hold the key to manipulating adult spinal cord neurogenesis for injury 
repair. Antibody inhibition of the inflammatory cytokine, CXCL10 resulted in the 
activation of quiescent OB NSCs, and a significant increase in the number of newly 
born neuroblasts in vivo in mice (Kalamakis et al., 2019) (Figure 1.3). Whether spinal 
cord ECs are retained in a quiescent state by similar mechanisms is currently 
unknown, however, this study shows the potential for re-activation of stem cells in adult 
tissue. 
The exercise-induced increase in circulating growth factors (Vascular Endothelial 
Growth Factor - VEGF (Leiter et al., 2019) and Insulin-like growth factor-I (IGF-I) (Carro 
et al., 2000; Nieto-Estévez et al., 2016)) positively modulates NPC proliferation and the 




downregulation, via Neural Growth Factor (NGF) or Neurotrophin-3 (NT-3) application, 
is required for the differentiation of neuronal progenitor cells to neurons (Angelastro et 
al., 2003) (Figure 1.3). This neurogenic response been enhanced using retinoic acid 
(RA); whereby RA increased the differentiation of NSCs, and significantly increased the 
response of stem cells to NT-3 in order to promote the generation of mature neurons 
(Takahashi et al., 1999). 
IGF-I also promotes the proliferation and differentiation of oligodendrocyte-committed 
progenitor cells (McMorris and Dubois‐Dalcq, 1988) and induces oligodendrogenesis 
from adult NSCs potentially via the blocking of BMP signalling (therefore blocking 
astrocyte generation – see Figure 1.3) (Hsieh et al., 2004). A number of additional 
growth factors also direct differentiation of NSCs into myelinating oligodendrocytes in 
the brain. Experimentally increasing Fibroblast Growth Factor receptor-3 (FGFR) 
activation, via ligand-independent activation of FGFR in transgenic adult mice, resulted 
in increased myelin repair following acute focal demyelination of the corpus callosum 
(induced by lysophosphatidylcholine (LPC) injection) as well as chronic global 
demyelination (induced by cuprizone diet) (Kang et al., 2019). Additionally, activation of 
the Epidermal Growth Factor receptor (EGFR) also directs NSC differentiation for the 
generation of OPCs and myelinating oligodendrocytes in vitro and in vivo.  
In vivo administration of ChABC in combination with EGF, basic Fibroblast Growth 
Factor (bFGF), and Platelet derived growth factor-AA increased the proliferation of 
ependymal cells following SCI, promoted oligodendrogenesis, and reduced the 
differentiation of ECs into astrocytes (Karimi-Abdolrezaee et al., 2012). However, 
whether these oligodendrocytes were generated from ECs is not clear. Laminin also 
regulates oligodendrogenesis by increasing OPC survival in the SVZ indicating that the 
ECM is important in driving beneficial NSC differentiation and survival (Relucio et al., 





Figure 1.3 Directing stem cell behaviour 
Simplified schematic depicting examples of the pathways to neuron, oligodendrocyte, 
and astrocyte cell differentiation. Examples of the factors regulating differenatiation and 
migration are detailed. Cell repellants are detailed in red, * indicates a dual action. 




Differentiation of NSCs down an astrocytic lineage is directed by activation of the Janus 
kinase-signal transducer and activator of transcription (JAK-STAT) pathway. This 
signalling pathway can be stimulated in NSCs by a number of cytokines from the 
interleukin-6 (IL-6) family, including: ciliary neurotrophic factor (CTNF) and 
cardiotrophin-1 (CT-1) (Johe, 1996; Rajan and McKay, 1998). Along with the JAK-
STAT pathway, bone morphogenic proteins (BMP) also promote the preferential 
differentiation of NSCs into astrocytes during the gliogenic phase of development 
(Gomes et al., 2003; Miller and Gauthier, 2007).  
Therefore, targeting growth factor receptors and signalling axes may provide a 
therapeutic mechanism for directing stem cell fate. Whether the cells within the spinal 
cord are controlled in a similar fashion is yet to be determined.  
In order to manipulate endogenous ECs following injury into differentiating into 
preferential lineages, first we must attract these cells to the injury site via implantation 
or injection of molecules that direct cell migration – referred to as chemoattractants.  
Directed migration of neural cells towards or away from endogenous and exogenously 
applied stimuli has been investigated (see examples in Figure 1.3). Interestingly, 
microglia and astrocytes have been implicated in the inflammatory reactions of a 
number of pathologies; releasing cytokines for attracting both immune cells along with 
stem and progenitor cells (Zuena et al., 2019), and these may play a critical role in 
manipulating the behaviour of ECs following SCI.  
Chemokine ligand 2, CCL2, is expressed by microglia and astrocytes following a lesion 
to the brain and during multiple sclerosis (MS). CCL2 expression is thought to induce 
leukocyte migration and infiltration into the CNS (Babcock et al., 2003); thus mediating 
the immune response. CCL2 and Hepatocyte Growth Factor (HGF) also play a role in 
the migration of adult NSCs in an animal model of MS (Widera et al., 2004; Cohen et 
al., 2014). Here, the remyelination required for functional improvement following 




initiated via the recruitment of OPCs to the de-myelinated region, followed by 
differentiation of these cells into myelin-forming oligodendrocytes. Chemotactic 
migration of OPCs is triggered via HGF secretion by reactive microglia (Lalive et al., 
2005; Li et al., 2012).  
Most notable across the neural cell types, is the regulation of directed migration via 
Stromal derived factor-1α (SDF-1α ) signalling (Figure 1.3). SDF-1α activates CXCR4 
and CXCR7; two G-protein-coupled receptors expressed in the developing and 
postnatal CNS (Banisadr et al., 2002; Stumm et al., 2003; Tissir et al., 2004; Cui et al., 
2013). Binding of SDF-1α to these receptors is thought to result in the activation of a 
number of signal transduction pathways leading to calcium flux (Princen et al., 2003) 
and phosphorylation of focal adhesion components (Ganju et al., 1998; Kucia et al., 
2004). Interestingly, CXCR4 is expressed by ependymal cells (Stumm et al., 2002) and 
therefore, SDF-1α /CXCR4 signalling could be a potential target for the manipulation of 
endogenous stem cells following spinal cord injury (see Chapter 6 for more detail). 
Hydrogels have been identified as potential candidates for delivering chemokines for 
spinal cord repair. This is due to their physical and mechanical properties closely 
mimicking the spinal cord, along with the ability of their chemical composition to be 
adapted and functionalised. How the cells interact with their environment can influence 
their behaviour dramatically. There is therefore a need to consider EC response to 










1.4 Hydrogels for spinal cord repair 
In order to manipulate endogenous stem cells and provide a growth-permissive 
environment at the site of injury, a tissue engineering approach could be utilised, 
encompassing both neuroprotection and regeneration. Biomaterials used for neural 
tissue engineering should meet a number of requirements in order to efficiently achieve 
this goal. They should be biocompatible, degrade at an appropriate rate in vivo, have a 
suitable mechanical strength, and should be porous in order to permit the flow of 
nutrients and migration of cells. 
Among the various biomaterials available, hydrogels have been identified as promising 
candidates for spinal cord repair. This is due to their physical and mechanical 
properties closely mimicking the spinal cord, along with the ability of their chemical 
composition to be adapted and functionalised. Additionally, a number of hydrogels 
show promise for SCI repair as they can be delivered to the spinal cord via injection, 
due to their shear thinning properties and/or in situ gelation (Guvendiren et al., 2012; 
Yang et al., 2014). Previous research has included the release of growth factors, 
encapsulation of cells, and functionalisation using bioactive motifs to promote specific 
cell behaviour. The use of hydrogels for the repair of CNS injuries has been widely 
investigated, and these studies can be grouped according to hydrogel composition. 
1.4.1 Synthetic hydrogels 
Synthetic hydrogels have the advantage of being relatively simple to manipulate in 
order to adjust chemical and mechanical properties. While these are typically 
biocompatible, additional motifs are often required in order to achieve sufficient cell 
attachment (Table 1.1).  
Polyethylene glycol (PEG) hydrogels have been shown to be biocompatible and 
neuroprotective within the CNS, with chemical modifications allowing for control over 
degradation rates (Mahoney and Anseth, 2006). Incorporation of peptide motifs such 




arginine (YIGSR), and isoleucine-lysine-valine-alanine-valine (IKVAV) has been 
achieved in 3D, with cellular extension being greatest on gels with RGDS (Gunn et al., 
2005). Additional components such as collagen, poly-l-lysine (PLL) and the signalling 
molecules basic fibroblast growth factor (FGF-2) and ciliary neurotrophic factor (CNTF) 
have also been investigated using PEG hydrogels (Mahoney and Anseth, 2006; 
Burdick et al., 2006; Royce Hynes et al., 2007; Freudenberg et al., 2009). Sustained 
Neurotrophin-3 release was achieved using a degradable PEG-PLA (polylactic acid) 
hydrogel for the repair of spinal cord hemisection in rats, resulting in increased 
functional recovery and regeneration of axons (Piantino et al., 2006). 
Poly-hydroxyethylmethacrylate (PHEMA) and poly-hydroxypropylmethacrylate (PHPMA 
NeuroGelTM) hydrogels have recently been investigated for SCI repair. In an 
experimental model of SCI, both hydrogel physical properties and functionalisation 
were found to have a significant impact on axonal and blood vessel ingrowth (Hejčl et 
al., 2013) which has been shown to be important for oligodendrocyte development in 
the brain (Dejana and Betsholtz, 2016). PHPMA implantation into a 3 mm cat spinal 
cord transection resulted in regeneration of the descending supraspinal axons of the 
ventral funiculus as well as the afferent fibres of the dorsal column across the hydrogel 
implanted lesion site as identified by axonal labelling (BDA and WGA-HRP) and 
staining for neurofilaments and myelin basic protein (Woerly et al., 2001).  
The peptide RADA16 developed by (Zhang et al., 1993) has been shown to self-
assemble under physiological conditions into a hydrogel comprised of nanofiber 
networks displaying the laminin epitope IKVAV (Tysseling-mattiace et al., 2009). FGL, 
the neural cell adhesion molecule motif has been recently incorporated into such gels 
and assessed in vitro using a spinal cord-derived neural stem cell (SC-NSC) culture 
(Wang et al., 2015). A significant increase in cellular adhesion and proliferation was 
found for the functionalised gels compared to RADA16 gels alone. Furthermore, 
migration was increased for FGL functionalised gels, indicating a beneficial effect of 




Table 1.1 Synthetic hydrogels investigated for spinal cord injury repair 
 
Abbreviations: HS: heterophase separation, NSC: neural stem cell, PEG: polyethyleneglycol, PHEMA: polyhydrocyethylmethacrylate[2-
(methacryloyloxy)ethyl] trimethylammonium chloride, PHPMA: poly[N-(2-hydrocypropyl) methacrylamide, SP: solid porogen.   
 
Hydrogel Modification Assessment  Outcomes Reference 
PEG 
PEG-diacrylate, RGDS, 
YIGSR, & IKVAV 
PC12 cell culture 
Extension of cells was greatest on RGDS functionalised 
gels.  
(Gunn et al., 
2005) 
PLA tri-block copolymer 
Postmitotic neuron cell 
culture 
Higher metabolic activity and proliferation with increasing 
percentage of PLA (degradable component - lactic acid) 






HEMA - MOETACL 
(positive surface charge), 
HPMA-SP, PMA-SP-
RGD, HPMA-HS-RGD 
Rat T8 hemisection 
Porous HPMA-SP hydrogels promoted a statistically 
significant greater ingrowth of axons and less connective 
tissue elements into the implant.  
HPMA & RGD promote the ingrowth of blood vessels. 
(Hejčl et al., 
2013) 
 
PHPMA - Cat T6-T7 transection 
Axon re-growth, regeneration of descending supraspinal 
axons of the ventral funiculus and afferent fibres of the 







Spinal cord derived 
NSC cultures 
PGL promoted NSC proliferation and migration into the 
scaffold. 
(Wang et al., 
2015) 
K2(QL)6K2 (QL6) 
Rat T6-T7 clip 
compression model  
Reduced glial scar formation. 
Promoted axonal preservation/regeneration.  
Significant functional improvement of axons. 
Significant neurobehavioral recovery.  





K2(QL)6K2 (QL6), another self-assembling peptide has also been investigated in vivo 
using a clip compression model of SCI in the spinal cord of rats (Liu et al., 2013). It was 
found that not only did this hydrogel significantly reduce astrogliosis and inflammation 
following injury (as shown by GFAP and Iba1 staining); QL6 injection also resulted in 
promoted axonal preservation (BDA anterograde and Fluorogold retrograde tracing) 
along with significantly enhanced functional improvement of axons as measured by 
electrophysiology. Injection of QL6 resulted in increased conduction velocity, reduced 
refractoriness and increased high-frequency conduction and significant 
behavioural/functional recovery occurred for rats receiving this treatment. 
1.4.2 Natural hydrogels  
A range of hydrogels derived from naturally occurring proteins, peptides, 
polysaccharides and GAGs have been utilised within the area of CNS repair (Table 
1.2). These benefit from their inherent biocompatibility and degradability under 
physiologically relevant conditions as well as their biological activity. 
Agarose is a linear polymer comprised of repeating agarobiose disaccharide subunits 
derived from algae and forms a hydrogel in the temperature range of 17– 40 oC. 
Laminin functionalised agarose hydrogels have been shown to promote dorsal root 
ganglion (DRG) cell migration and orientated neurite extension when cultured in 3D 
(Bellamkonda et al., 1995). Additionally, RGDS peptides (found in fibronectin) have 
been used to create modified channels, leading to orientated axon growth following 
DRG cell culture (Luo and Shoichet, 2004). More recently, a study by Caron et al. used 
an arginine-glycine-aspartic acid (RGD) cell adhesion sequence modified 
agarose/carbomer-based hydrogel for enhanced hMSC attachment, viability, and the 
delivery of paracrine factors in vivo (Caron et al., 2016). hMSCs were grown and these 
cells deposited ECM over 14 days prior to lyophilisation and re-seeding of the scaffolds 
for implantation; ultimately modulating the pro-inflammatory environment in a mouse 




Agarose gels can be loaded with lipid microtubules containing the neurotrophin brain-
derived neurotrophic factor (BDNF), encouraging neurite growth into the hydrogels in a 
dorsal over-hemisection model in vivo (Jain et al., 2006).Templated agarose hydrogels 
have also been investigated in a rat model of SCI for the release of syngeneic marrow 
stromal cells expressing either BDNF or green fluorescent protein. (Gao et al., 2013) 
found that these gels organised regenerating axons into fascicles, and BDNF 
significantly enhanced neurite growth in a directional manner.  
Local, sustained release of ChABC (Lee et al., 2010) and Rho GTPases (Cdc42 and 
Rac1) (Jain et al., 2011) has been achieved using agarose based hydrogels and lipid 
microtubes, resulting in a beneficial reduction in the inhibitory CSPGs and GFAP+ 
astrocytes, leading to an improvement in locomotor function when delivered in 
combination with neurotrophin-3 (in the case of ChABC) in vivo. 
Also derived from algae is alginate; a linear polysaccharide formed by repeating units 
of (1–4)-linked β-D-mannuronate and α-L-guluronate. Alginate has a negative charge 
that forms a hydrogel upon ionic crosslinking with divalent counter-ions (D’Ayala et al., 
2008) and can also gel via the stabilisation of a physical network by additional 
intermolecular hydrophobic interactions.  
Alginate has been utilised in vivo for the delivery of glial cell line-derived neurotrophic 
factor (GDNF) using microspheres and normal (free) loading (Ansorena et al., 2013). 
Controlled release was achieved with both methods; however the release kinetics of 
the microsphere loaded GDNF resulted in hindered diffusion and reduced repair of the 
hemisected rats. Free GDNF delivered by this alginate hydrogel resulted in increased 
neurites surrounding the lesion as well as reduced number of astrocytes and improved 
functional recovery compared to the control group. 
Alginate hydrogels have also been modified using microspheres loaded with alginate 




resulted in a significant increase in the rate of neural progenitor cell (NPC) expansion 
when cultured in vitro compared to the non-degradable control (Ashton et al., 2007). 
Directed axonal regeneration has been achieved in vitro and in vivo using highly 
anisotropic capillary hydrogels composed of alginate (Prang et al., 2006). Using an 
entorhino-hippocapal slice culture model these gels were shown to elicit orientated 
regrowth, resulting in target re-innervation. Following implantation into an acute cervical 
lesion in an adult rat model, regenerating axons grew into the gels in a longitudinal 
manner, with aligned axonal and GFAP+ processes. 
The use of cellulose hydrogels in spinal cord repair has been limited despite the 
promising neuronal differentiation of hMSCs in vitro (Gu et al., 2010). Methylcellulose, 
a compound derived from cellulose has been modified via attachment of laminin, giving 
rise to increased neural stem cell (NSC) survival, neurite outgrowth and differentiation 
into neuronal and oligodendrocyte lineages (Stabenfeldt et al., 2010). 
Chitosan is a biodegradable, cationic polysaccharide produced by deacetylation of 
chitin found within crustaceans and forms a hydrogel via hydrogen bonding and 
hydrophobic interactions. Due to receptor-mediated binding of N-acetylglucosamine, 
chitosan gels stimulate a significant immune response in the brain and so their use is 
limited (Crompton et al., 2006). In order to mitigate the effects of such a response, 
modifications have been made to the chemical structure for use in spinal cord repair.  
Further modifications include pH adjustment and poly-d-lysine (PDL) functionalisation, 
resulting in increased cell viability (up to 0.05 % PDL) in 3D cultures compared to 
unfunctionalised controls (Crompton et al., 2007). 
Fibrin is a fibrous protein involved in the clotting of blood. This has been used in 
conjunction with the glycoprotein fibronectin to create injectable hydrogels for the repair 
of SCI. Following a knife-cut cavity in the rat spinal cord, hydrogels were injected into 
the lesion cavity and it was found that at 4 weeks axonal growth was the greatest for 




reduced survival of neurons in the adjacent intact spinal cord, supported by additional 
evidence indicating a slight inhibitory effect of fibronectin on neurite extension (Deister 
et al., 2007). Fibrin gels have been investigated for the release of ChABC in the 
lesioned spinal cord, showing a marked reduction in inhibitory GAGs (reduced by 37 
%) compared to injection alone (Hyatt et al., 2010). 
Hyaluronic acid (HA) is another naturally derived material used within tissue 
engineering. This is a non-sulphated GAG found naturally within neural tissue, 
consisting of repeating D-glucuronic acid and N-acetylglucosamine disaccharide units. 
The majority of HA present in the CNS is produced by astrocytes, and surrounds the 
myelinated axons and neuronal cell bodies found within the white and grey matter of 
the spinal cord (as seen using immunofluorescence in the rat spinal cord) (Bignami et 
al., 1992). 
The biological effects of HA are molecular weight (MW) dependent, with high MW 
forms of HA being beneficial within the inured spinal cord; reducing epidural scar 
formation and maintaining astrocytes in an unreactive state (Akeson et al., 2005). High 
MW HA has also has a suppressive effect on inflammatory cells that may cross the 
compromised BSCB (Schimizzi et al., 2006; Bollyky et al., 2007). High MW HA 
however, is degraded into low molecular weight HA following injury (mediated by a 
family of hyaluronidases), triggering increased proliferation of astrocytes and the 
formation of a glial scar (Struve et al., 2005). 
Both MW variants of HA are capable of binding to the receptor CD44 expressed on the 
surface of astrocytes (amongst other cells) (Underhill, 1992; Haegel et al., 1993).  
HA/CD44 binding stimulates Rac1-PKNƔ kinase activity; upregulating cortactin 
phosphorylation, thus attenuating F-actin crosslinking, cytoskeleton activation and 
astrocyte migration (Bourguignon et al., 2007). RHAMM (receptor for HA-mediated 




microglia (Turley et al., 1994) and a number of in vitro studies suggest the involvement 
of RHAMM in neurite outgrowth (Nagy et al., 1995; Nagy et al., 1998). 
Previously, hydrogels created from pure HA were demonstrated to enhance neural 
regeneration and reduce glial scar formation in the CNS following experimental SCI 
(Lin et al., 2009), however, cell attachment remains an issue with such materials. 
Recently a hyaluronic acid-based hydrogel was found to improve neuronal survival in 
spinal cord slice cultures, highlighting the potential benefits for the use of this material 
following SCI (Schizas et al., 2014). 
Modification of HA hydrogels using various ECM components including laminin, RGD, 
IKVAV, PDL and PLL has been achieved. Gels modified with laminin and implanted 
into brain lesions of rats were shown to improve repair of tissue; reducing the number 
of reactive astrocytes around the injured area (Hou et al., 2005). Similarly, RGD, PDL, 
PLL and IKVAV modified HA hydrogels have also been investigated within traumatic 
brain injury models, resulting in increased cell migration (Tian et al., 2005; Cui et al., 
2006; Wei et al., 2007) demonstrating their potential use for the treatment of additional 
CNS injuries. 
HA hydrogels have also been investigated for the release of neurotrophic factors and 
bioactive agents in the CNS. Anti-NgRs (Nogo receptor antibodies) have been released 
from HA gels in a pH dependent manner, in vitro (Hou et al., 2006) and in vivo (Wei et 
al., 2010). These studies show the beneficial effect the slow release of anti-NgRs has 
on neurite outgrowth (chick DRG) and axonal ingrowth within an SCI model. 
Furthermore, sustained release of BDNF has also been achieved using HA based 
hydrogels in a rat model of SCI (Park et al., 2010). Compared to hydrogels alone and 
the direct delivery of BDNF, BDNF-containing hydrogels resulted in the greatest 
improvement of functional recovery as assessed by locomotive testing (Basso-Beattie-




Table 1.2 Naturally-derived hydrogels investigated for spinal cord injury repair 





DRG (E9 chick) & PC12 
cell culture 
Promotion of neurite extension varied according to 
peptide sequence. 
(Bellamkonda et al., 





DRG cell culture Orientated axonal growth. 
(Luo and Shoichet, 
2004) 
RGDS &  hMSC 
delivery 
Mouse T12 clip 
compression 
Increased M2 macrophage population. (Caron et al., 2016) 
BDNF delivery 
Rat T10 dorsal over-
hemisection 
Increased neurite growth into hydrogel, reduced 
astrocytes and CSPGs 
(Jain et al., 2006) 
BDNF & Rho 
GTPase delivery 
Rat  T8-10 dorsal over-
hemisection 
Higher percentage of axons from the corticospinal tract 
spanning the CSPG-rich regions located proximal to the 
lesion site. 
(Jain et al., 2011) 
ChABC & NT-3 
delivery 
Rat  T10 dorsal over-
hemisection 
Improvement in locomotor function when delivered 
together. 
(Lee et al., 2010) 
Alginate 
GDNF delivery 
Rat T9-10 lateral 
hemisection 
Free GDNF delivery resulted in increased number of 
neurites, reduced number of astrocytes & improved 
functional recovery. 






Longitudinal axonal growth. 
(Prang et al., 2006) 
Rat C3 transection 
Axonal profiles grew into gels longitudinally, aligned 
along GFAP+ processes. 




Abbreviations: BBB: Basso-Beattie-Bresnahan, BDNF: Brain Derived Neurotrophic Factor: ChABC: Chondroitinase ABC enzyme, CSPG: chondroitin 
sulphate proteoglycan, DRG: dorsal root ganglion, GDNF: Glial Cell Line-Derived Neurotrophic Factor, GFAP+: Glial Fibrillary Acidic Protein positive, 
hMSC: human mesenchymal stem cell, hEnSC: Human endometrial-derived stromal cells, NSC: neural stem cell, NSPC: neural stem/progenitor cell, 
PDL: poly-d-lysine, PLL: poly-l-lysine.   




NSC neurospheres from 
transgenic mice E14.5 
Reduced apoptosis, increased neurite extension and 
greater neuronal and oligodendrocyte differentiation for 
laminin functionalised gels. 
(Stabenfeldt et al., 
2010) 
Chitosan  PDL  Cortical cell culture Neuron survival improved with PDL. (Crompton et al., 2006) 
Fibrin ChABC delivery Rat C4 incision  
Reduction in sulphated GAGs compared to control and 
injected ChABC groups.  




fibronectin gels & 
mix of the two 
Rat T7-9 transection 
Gel mixture integrated with the host tissue and 
supported growth of axons. 
(King et al., 2010) 
Hyaluronic 
acid 
- Spinal cord slice cultures 
Improved neuronal survival and limited microglial 
activation. 
(Schizas et al., 2014) 
 
Anti-NgR release DRG (chick) culture 
Improved neural cell attachment and survival and 
increased neurite outgrowth. 
(Hou et al., 2006) 
Anti-NgR & PLL Rat T8-9 hemisection 
Significant increase in axon extension into gel at 8 
weeks. Increase in cell number and myelinated axons 
compared to control. Supported angiogenesis and 
inhibited glial scar formation. 
(Wei et al., 2010) 
BDNF release (& 
IKVAV) 
Rat T10 clip 
compression 




1.4.3 Measuring substrate stiffness 
Stem cells sense the extent to which a substrate or ECM deforms in response to an 
applied traction force; essentially measuring the substrate’s stiffness and responding 
accordingly. The stiffness of a material can be measured using a number of 
methodologies. As hydrogels are viscoelastic, with a combination of solid and fluid 
phases, these properties are typically assessed using rheology. Rheometers allow the 
precise measurement of a material’s response to applied force (stress) or deformation 
(strain). In most cases a dynamic (oscillating) shearing force is applied to the material 
using a frequency or strain sweep (using either a cone or a plate), giving rise to outputs 
such as complex shear modulus (G*), storage modulus (G’) and loss modulus (G’’) 
(described in more detail in Chapter 3.2.3).  
The mechanical properties of hydrogels can also be assessed using compressive 
methods. One popular technique involves compressing the material between parallel 
plates using a continuous stress or strain. The Young’s (compressive elastic) modulus 
(Ey) is then calculated as the gradient of the stress-strain curve in the linear (elastic) 
region and is a direct indication of the material’s stiffness. Additionally, Ey can be 
determined using atomic force microscopy (AFM) by quantifying the deflection of a 
cantilever tip upon indentation at the hydrogel surface, or by using microbead 
displacement calculations. Additional techniques for CNS tissue are reviewed by 
(Budday et al., 2019). 
1.5 Mechanotransduction in the CNS 
Transmembrane proteins, such as integrins, enable cells to bind to the surrounding 
ECM or substrate, mechanically anchoring the cytoskeleton to the ECM and allowing 
the transmission of contractile forces required for movement and “sensing” of 
mechanical stiffness referred to as mechanotransduction (Tsai and Kam, 2009; Moore 
et al., 2010). The traction forces exerted by cells via these cell surface integrins 




cascades, and gene expression; ultimately directing cell fate (Paszek et al., 2005; 
Huebsch et al., 2010; Lee et al., 2013). Additionally, cell-cell junction adhesion via 
cadherin-catenin complexes allows cells to communicate forces between the F-actin 
cytoskeletons of neighbouring cells, further amplifying cellular responses (Figure 1.4) 
(Buckley et al., 2014). The activity of the ion channel, Piezo1, directs neural stem cell 
differentiation. Piezo1 opens in response to cell tension mediated by external 
mechanical stimuli (tensile/shear forces) and changes in traction forces a cell transmits 
due to ECM stiffness (Pathak et al., 2014).  
 
 
Figure 1.4 Stem cell mechanosensitivity 
Stem cells apply traction forces to their surroundings via cell-ECM adhesion ligand 
(blue matrix) binding to integrin receptors on cells (green). They can also transfer these 
forces to neighbouring cells via cell-cell junctions, e.g. cadherins (yellow). These 
internal forces are shown as red arrows. Additionally, cells can sense the external 
forces applied to them (compression/tension and shear – shown as black arrows), 
using mechanically-gated ion-channels (blue) and changes to the cell’s cytoskeleton. 







1.5.1 Neural tissue biomechanics 
The mechanical properties of biological samples are inherently difficult to characterise 
and compare due to the heterogeneous nature of tissue, variations in tissue origin 
between studies, and the differing testing methods employed. CNS tissue has a high 
water content and is thought to exhibit nonlinear viscoelastic properties, and as such 
the tissue is strain-stiffening and measurements are influenced by length and time 
scales of loading (reviewed in detail in (Budday et al., 2019)). Due to the experimental 
variations and testing inaccuracies, the reported elastic modulus of CNS tissue varies 
widely, with values ranging from 40 Pa to 20 kPa for the brain (Franze et al., 2013) and 
a recent study giving a shear modulus of 0.4–1.4 kPa for the human brain (Budday et 
al., 2017). Despite these limitations, it is widely accepted that CNS tissue is “ultrasoft” 
and therefore highly susceptible to damage. 
Interestingly, in contrast to scars formed elsewhere in the body, the glial scar formed 
following SCI is significantly softer than uninjured tissue (Franze et al., 2013; 
Moeendarbary et al., 2017). In a study by (Moeendarbary et al., 2017), the stiffness of 
uninjured cortical tissue ranged from 50 to 500 Pa, and following a unilateral stab injury 
to the neocortex of the brain, the tissue either side of the injury was ~15% softer than 
the contralateral tissue control 9 days post-injury (PI). Uninjured rat spinal cord tissue 
stiffness was determined to be 420 Pa for grey matter and 177 Pa for white matter. 
Following a spinal cord crush injury, the stiffness of the lesion site tissue reduced 
significantly, with the greatest reduction seen in the grey matter (~ 40% reduction in 
elastic modulus at 3 weeks PI to around 200 Pa). This phenomenon is thought to be 
due to extensive production of highly hydrated CSPGs at the injury site. Additionally, in 
contrast to other scar tissue, crosslinked collagen I is absent from the glial scar (Stichel 
and Müller, 1998) and instead, collagen IV, vimentin, and GFAP are upregulated 





1.5.2 Manipulating neural stem cell behaviour using substrate 
stiffness 
A number of studies have demonstrated the sensitivity of neural stem cells to substrate 
elasticity, with soft matrices comparable to native CNS tissue increasing cell 
proliferation (Saha et al., 2008a; Banerjee et al., 2009a; Leipzig and Shoichet, 2009a) 
and inducing neurogenesis (Engler et al., 2006; Seidlits et al., 2010) reviewed by (Lin 
et al., 2016; Vining and Mooney, 2017).  
1.5.2.1 Proliferation and migration 
The stiffness of the surrounding substrate also influences stem cell proliferation and 
migration (Pelham and Wang, 1997). Cell movement requires the generation and 
transmission of protrusive and contractile forces for lamellipodial extension and 
uropodal retraction respectively (Thomas and DiMilla, 2000). This occurs via dynamic 
adhesion and detachment of specific, reversible transmembrane glycoproteins with 
ECM proteins in the surrounding scaffold.  
Human glioblastoma cell migration extent and speed decreases with increasing matrix 
compliance (Thomas and DiMilla, 2000) and adult rat SEZ NSPCs only migrated from 
neurospheres when cultured on soft hydrogels with a stiffness of 0.8 kPa (Hynes et al., 
2009; Leipzig and Shoichet, 2009b). Additionally, increased NSC/NSPC proliferation 
occurs on soft hydrogels (< 800 Pa) (Banerjee et al., 2009b)(Leipzig and Shoichet, 
2009b). (Saha et al., 2008b) did however, show that adult NSC spreading, self-
renewal, and differentiation is inhibited when cultured on hydrogels with a stiffness of 
10 Pa, indicating these cells also have a lower stiffness threshold. 
1.5.2.2 Differentiation 
Neural stem and progenitor cells from embryonic and adult rats and mice have been 
investigated for their response to substrate modulus. Greatest neuronal differentiation 




cases to occur on soft gels with moduli under 3 kPa. Glial differentiation was varied 
across different substrates (Table 1.3).  
NSCs from the hippocampus of adult rats differentiated preferentially into neurons 
when cultured on poly acrylamide (PA) hydrogels with moduli of 100-500 Pa, whereas 
on stiff gels with moduli of 1-10 kPa, glial differentiation was enhanced (Saha et al., 
2008b) (Table 1.3). Neuronal differentiation was greatest when cultured on soft 
chitosan hydrogels (<1 kPa), and differentiation into astrocytes occurred on hydrogels 
with stiffnesses ranging from 0.8-3.5 kPa. (Leipzig and Shoichet, 2009b). Here they 
cultured NSPCs from the sub ependymal zone of adult rats and found that they 
differentiated mainly into oligodendrocytes, which was increased on hydrogels with an 
elastic modulus of 7 kPa. Little to no differentiation into neurons or astrocytes was 
observed when cultured on hydrogels with a stiffness of 7 kPa.  
NSCs from embryonic rat (E15.5) cerebral cortices showed an increase in astrocytic 
differentiation with decreasing stiffness of PDMS hydrogel (Teixeira et al., 2009). 
Additionally, on all hydrogels, there was a greater number of neurons compared to 
culture plate controls, (elastic modulus of ~109 Pa (Teixeira et al., 2009)), however 
differentiation into neurons and oligodendrocytes was found to be independent of 
PDMS stiffness.  
Additional studies have investigated the behaviour of stem cells cultured within 3D 
hydrogels, more reminiscent of the in vivo environment. (Banerjee et al., 2009b) found 
that the greatest enhancement in neuronal differentiation of adult NSCs from the 
hippocampus of rats was observed when cells were cultured within soft alginate 
hydrogels with an elastic modulus comparable to that of CNS tissue (180 Pa – Table 
1.3). NPCs from the ventral midbrain of embryonic mice (E13.5) differentiated into 
neurons when co-cultured within soft HA gels, and increased glial differentiation was 




Increased glial differentiation of NPCs from the brain of embryonic rats (E15) was also 
seen when cultured on PEG/HA hydrogels with increasing stiffness (up to ~15 kPa) 
(Aurand et al., 2014). However, neuronal differentiation was only observed when these 
cells were cultured within hydrogels with compressive moduli of ~5 kPa. In the same 
study, the fate of adult NPCs was investigated. Neuronal differentiation was observed 
in hydrogels with a stiffness of up to ~20 kPa, and once again, increased differentiation 
into neurons was seen for cells cultured within soft hydrogels (~5 kPa) (Aurand et al., 
2014). Differentiation of adult NPCs into astrocytes was only observed when cultured 
within hydrogels with compressive moduli of ~5 kPa, opposite to the trend seen for 




Table 1.3 Studies investigating the effect of increasing hydrogel stiffness on the fate of neural stem cells 
Hydrogel Stiffness (Pa) Tuning of 
stiffness Porosity 
Cell type, source, 
location 2D/3D Neuron Astrocyte Olig. Reference 
  
Chitosan 




NSPCs, adult rat, SEZ of 
the lateral ventricles 2D 
  
    (Leipzig and 
Shoichet, 2009b) 




N/A NSCs, adult rat, 
hippocampus 2D 
  
        - 
(Saha et al., 
2008b) 
PDMS 12 - 750 kPa (Ey*) 
Crosslinker 
concentration N/A 
NSC, rat embryo E15.5, 
cerebral cortices 2D 
  
      
(Teixeira et al., 
2009) 
Alginate 180 – 20,000 
(G’) 




N/A NSCs, adult rat, 
hippocampus 3D   - - 
(Banerjee et al., 
2009b) 
HA 





NPCs, embryonic mouse 
E13.5, ventral midbrain  
& primary spinal cord 
astrocytes 
3D   
    - 
(Seidlits et al., 
2010) 
PEG 120 – 31,300 (Ey) PEG/HA ratio N/A 
NPCs, embryonic rat 
E15, brain  
NPCs, adult rat, 









(Aurand et al., 
2015) 
Key:     = decrease,       = significant decrease,    = increase,        = significant increase,        = no change  - = not assessed 
Abbreviations: Ey: Young’s modulus, Ey*: bead displacement method, G’: storage modulus, G*: complex modulus, HA: hyaluronic acid, kPa: kilo 
Pascal, NSC: neural stem cell, NPC: neural progenitor cell, NSPC: neural stem/progenitor cell, Pa: Pascal, PA: polyacrylamide, PEG: polyethylene 




These studies do however present a number of methodological limitations. As can be 
seen in the examples presented in Table 1.3, numerous methods have been used to 
tune and characterise the stiffness of the hydrogels and a variety of cell sources have 
been used; therefore limiting comparison. Additionally, the porosity is rarely 
characterised (see Table 1.3), and could contribute to the change in cell behaviour 
observed. Use of 2D culture techniques may also impact on the cellular response to 
hydrogel stiffness due to the artificial polarity created between the surfaces of the cell 
investigated (Cukierman et al., 2001). In addition to this, in most cases the impact of 
stiffness modulation (i.e. crosslinking density) on the physical properties of the resulting 
hydrogel (porosity, fibre diameter etc.) has not been addressed and so causal 
relationships cannot be established conclusively. Similarly, CNS tissue stiffness has 
also been characterised using various techniques, thus adding further confusion when 
attempting to accurately match hydrogel properties to native tissue due to a lack of 
standardisation (Aurand et al., 2012). 
From the overall trends seen in the literature, it could be theorised that ependymal cells 
may exhibit increased proliferation and differentiate preferentially into neurons when 












1.6 Hypothesis  
It is hypothesised that the mechanical properties of hydrogels can be modulated 
independently of porosity, and that these can be used to deliver SDF-1α to the spinal 
cord in order to alter the proliferation, differentiation, and migration of spinal cord 
ependymal cells. 
1.6.1 Aims 
This project aimed to determine the potential of manipulating endogenous ependymal 
cells using hydrogels, towards repair for SCI. This included: determining the feasibility 
of producing a library of collagen hydrogels with varied mechanical properties and 
constant porosity; characterising a transgenic line for the labelling of spinal cord 
ependymal cells; developing organotypic spinal cord slice cultures for the assessment 
of biomaterials; and an investigation into the effects of hydrogels and a chemokine on 
ependymal cell behaviour in vitro and in vivo (see Figure 1.5). 
1.6.2 Objectives 
1. To investigate the potential of synthesising hydrogels with tuneable stiffness within 
the range of native central nervous system tissue, whilst maintaining porosity 
2. To characterise the expression of (nestin) GFP in transgenic mice  
3. To optimise a protocol for the detection of EdU incorporated into the dividing cells 
of fluorescently labelled cells and spinal cord slice culture methods 
4. To investigate the effects of hydrogel composition on ependymal cell proliferation 
and distribution 
5. To determine if ependymal cell migration can be manipulated using SDF-1α in vitro 










Figure 1.5 Overview of the objectives of this thesis 
The development work carried out in chapters 3 to 5 enabled the interrogation of the 












Chapter 2 - General Methods 
 
2.1 Materials 
The following materials were used throughout this thesis. The chemicals and drugs are 
detailed in Table 2.1, consumables and glassware are detailed in Table 2.2, and the 
equipment used are detailed in Table 2.3. 
 
Table 2.1 Chemicals and drugs used within this thesis 




A10807 Alfa Aesar. Heysham, UK 
2,4,6-Trinitrobenzene Sulfonic Acid 
(TNBS) 
P2297 Sigma-Aldrich. Poole, UK 
5-ethynyl-2’-deoxyuridine (EdU) N/A Carbosynth, Compton, UK 
Acetic Acid  537020 Sigma-Aldrich. Missouri, 
USA 
Agar  A7002 Sigma-Aldrich. Poole, UK 
Alexa Fluor secondary antibodies See chapter 4,  
Table 4.4 
Invitrogen or Life 
Technologies 
AMD3100  ab120718 Abcam, Cambridge, UK 
Atipamezole hydrochloride N/A Antisedan, Vetoquinol & 
Orion pharma. 
Northamptonshire, UK 
B27 supplement 17504044 Gibco. NY, USA. 
Biotin azide E3730 Lumiprobe 
Biotin picolyl azide 92186 Biotium 
Biotin-conjugated secondary 
antibodies 






Chemical/Drug (abbreviation)  Cat. number Supplier 
Buprenorphine hydrochloride N/A Vetergesic, Ceva animal 
health Ltd. 
Buckinghamshire, UK. 
β-mercaptoethanol (βME) M6250 Sigma-Aldrich. Poole, UK 





p-Phenylenediacetic Acid (4Ph) 
 
1,3-Phenylenediacetic Acid (13Ph) 
 














Dimethyl Sulfoxide (DMSO) D5879 Sigma-Aldrich 
Disodium Hydrogen Phosphate 
(Na2HPO4) 
S374-500 Thermofisher.  
Leicestershire, UK. 
Dulbecco’s modified eagle’s medium 
(DMEM) 
D6546 Sigma-Aldrich. Poole, 
UK 
Ethanol  16368  Sigma-Aldrich. Poole, UK 
Fluoroshield F6182 Sigma-Aldrich. Poole, 
UK 
Fluoroshield with DAPI F6057 Sigma-Aldrich. Poole, 
UK 
Foetal bovine serum (FBS) A3912 Sigma-Aldrich. Poole, 
UK 
Gelatin, porcine skin 04055-500G Sigma-Aldrich. Poole, 
UK 
Glutaraldehyde 36218 Gurr 
Hydroxystilbamidine (FG - 
FluoroGold) 












Chemical/Drug (abbreviation)  Cat. number Supplier 
Ketamine  N/A Ketavet, Zoetis UK Ltd. 
London, UK 
L-Glutamine  G7513 Sigma-Aldrich. Poole, 
UK 
Magnesium sulphate heptahydrate 
(MgSO4.7H2O) 
M/1050/53 Fisher Chem. Leics., UK 
Medetomidine hydrochloride N/A Domitor, Vetoquinol & 
Orion pharma., UK 
Monosodium phosphate monobasic 
monohydrate (NaH2PO4.H2O) 
095388 Fluorochem Ltd. Hadfield, 
UK 
Mouse on Mouse Kit BMK 2202 Vector laboratories, UK 
Neurobasal-A medium 10888022 Gilbco, ThermoFisher 
Scientific,  
N-Hydroxysuccinimide (NHS) 804518 Merck. Schuchardt. 
Hohenbrunn, Germany 
Paraformaldehyde (PFA) 15812-7 Sigma-Aldrich. Poole, 
UK 
Penicillin/streptomycin P44580 Sigma-Aldrich. Poole, 
UK 
Phosphate buffer (PB) sterile D8537-500 Sigma-Aldrich. Poole, 
UK 
Phosphate-buffered saline (PBS) 
tablets 
BR0014G Oxoid Ltd., Hampshire, 
UK 
Potassium chloride (KCl)  31248 Sigma-Aldrich. Poole, 
UK 
Recombinant Murine SDF-1α 
(CXCL12) 
250-20A Peprotech, NJ, USA 
Sodium Bicarbonate (NaHCO3) S6014 Honeywell, Fluka. USA 
Sodium Chloride (NaCl,) S/3120/66 Fisher Chem. Leics., UK 
Sodium pentobarbital N/A Euthatal, Merial Pentoject, 
Animalcare, UK 
Streptavidin Alexa Fluor488 S32354 Life Technologies 
Streptavidin Alexa Fluor555 S32355 
 
Life Technologies 




Chemical/Drug (abbreviation)  Cat. number Supplier 
Triton X-100  X100 Sigma-Aldrich. Poole, 
UK 
Trizma base  T1503 Sigma-Aldrich. Poole, 
UK 
Trizma hydrochloride  T3253 Sigma-Aldrich. Poole, 
UK 
Tween20  P9416  Sigma-Aldrich. Poole, 
UK 
Virkon (Rely+On) 148-0201 Day Impex, VWR, UK  
Vitrogel®3D TWG001 TheWell Bioscience, NJ, 
USA 
 
Table 2.2 Consumables and glassware used within this thesis 
Consumable Cat. Number Supplier 
Absorbable sutures W9015 Ethicon, New Jersey, USA. 
Culture inserts PICM0RG50  Millicell, Merck Millipore, 
Germany. 
Curved needle 16mm, W2502 Ethicon, New Jersey, USA. 
6 & 48 well plates  140675 & 150687 Thermo Fisher Scientific 
Eye lubricant Lacri-Lube Allergan, Dublin, Ireland 
Non-dissolvable sutures W2502 Ethicon, New Jersey, USA. 
Blades (sterile) #10 Swann Morton. Sheffield, UK 
Blades (non-sterile) INS4610 VWR, UK. 




7550-1-C Campden instruments, Leics., 
UK. 
Coverslips (various) 43210.KJ VWR, UK. 
Microscope slides N/A143 Academy Science Ltd., UK.  
Eppendorf tubes Various Thermo Fisher Scientific UK. 
Leics., UK 
Falcon tubes (15mL, 
50mL) 
339650, 339652 Thermo Fisher Scientific UK. 
Leics., UK 




Consumable Cat. Number Supplier 
Serological pipettes 
(sterile) 
ARLAPS10 Sigma-Aldrich. Poole, UK. 
Pasteur pipettes  Various SLS, UK. 
Separating funnel 527-1222 VWR, UK. 
 
Table 2.3 Equipment used within this thesis 
Equipment Model  Make 
Blunt forceps & spring 
scissors 
654558 World Precision 
Instruments 
CD spectrometer J-715 spectropolarimeter Jasco 
Class II Safety Cabinet Herasafe, Heraseus. Germany. 
Confocal microscope LSM880 Zeiss 
Culture incubator N/A Labtech inc., 
Massachusetts, USA 
Dissection microscope SMZ-2B Nikon 
Electrode puller P-97 Flaming/Brown Sutter Instrument Co. CA, 
USA 
Fine forceps Dumont tweezers, #55 World Precision 
Instruments 
Fluorescence microscope E600  Nikon 
Fluorescence microscope M7000 EVOS 
Freeze drier Alpha 2-4 LD plus SciQuip, UK. 
Laminar flow hood N/A Astec Microflow. 
Hampshire, UK 
Platinum Sputter Coater 208HR Cressington 




 Quanta FEG 
Stereotactic frame 51730U Stoelting Co., Illinois, USA 









Equipment Model  Make 
Vibratome VT1000S Leica. Germany. 
 
2.1.1 Common buffers, solutions, and culture medium 
The composition, diluent, and pH (where appropriate) of each buffer, solution, drug, 
and culture medium used throughout this thesis are detailed in Tables 2-4 to 2-7. The 
pH meter was calibrated before each use at 20°C using pH 4 and 7 calibration 
solutions. 
Table 2.4 General buffers used within this thesis 
   Composition Diluent 
Phosphate-buffered 
saline 
PBS pH 7.4 10 mM Na2HPO4, 1.8 mM 
KH2PO4, 137 mM NaCl, 
4 mM KCl 
diH2O 




TBS 0.1 M 
pH 7.6 
Trizma base, Trizma 
hydrochloride  
diH2O 
PBS Triton X-100 PBST 0.1% & 0.2% 
(v/v) 
0.1% & 0.2% (v/v) Triton 
X-100 
PBS 
PBS Tween20 T20 0.1% (v/v) 0.1% (v/v) Tween 20 PBS 
Sodium phosphate 
buffer 
SPB 0.1 M, pH 7.4 NaH2PO4.H2O & Na2HPO4 H2O 
 
Table 2.5 General solutions used within this thesis 
 Abbreviation Composition Diluent 
Acetic acid N/A 17.4 mM, pH 7.4 diH2O 
Agar N/A 3% (w/v) – heated to near 
boiling, bubbles poured off, 





 Abbreviation Composition Diluent 
Artificial cerebrospinal 
fluid 
aCSF Sodium chloride 124 mM, 
NaHCO3 26 mM, KCl 3 mM, 
MgSO4.7H2O 2 mM, NaH2PO4 
2.5 mM, Glucose 10 mM, 
CaCl2 2 mM 
diH2O 
Ethanol N/A 70% (v/v) diH2O 
Gelatin N/A 10% (w/v) – heated to near 
boiling, bubbles poured off, 
then left to cool  
diH2O 
Glutamine N/A 2.5 w/v  PB 
NaHCO3 N/A 4 wt.%, pH 8.5 diH2O 
Osmium tetroxide N/A 1 % w/v PB 
Paraformaldehyde  PFA 4% (w/v) 0.1 M PB 
PFA with glutaraldehyde  N/A 0.25% (w/v) 4% PFA 
Sucrose artificial 
cerebrospinal fluid 
SaCSF Sucrose 217 mM, NaHCO3 26 
mM, KCl 3 mM, MgSO4.7H2O 
2 mM, NaH2PO4 2.5 mM, 





TNBS 0.5 wt.%  diH2O 
Virkon N/A 1% (w/v) diH2O 
 
Table 2.6 Drug solutions used within this thesis 
 Abbreviation Concentration  Diluent 
Administered I.P – given as: mass of drug/mass of animal 
Atipamezole  N/A 1 mg/kg final Sterile saline 




 Abbreviation Concentration  Diluent 
Hydroxystilbamidine 
(Fluorogold)  
FG 1% (w/v) 50 mg/kg final Sterile saline 
Ketamine N/A 75 mg/kg final Sterile saline 
Medetomidine  N/A 1.0 mg/kg final Sterile saline 
Sodium pentobarbital  N/A 60 mg/kg final diH2O 
 
Table 2.7 Culture media solutions 
Medium name Composition 
Dissection medium Dulbecco’s modified eagles medium (DMEM), 1% 
(v/v) penicillin/streptomycin. 
Serum-containing medium Neurobasal A medium; 1% (v/v) L-Glutamine, 1% 
(v/v) penicillin/streptomycin, and 10% (v/v) fetal 
bovine serum. 
Serum-free medium Neurobasal A medium; 1% (v/v) L-Glutamine, 1% 
(v/v) penicillin/streptomycin, and 2% (v/v) B27 
supplement. 
 
2.2 Data analysis 
Data were collated in Microsoft Excel and analysed using IBM SPSS statistics 21. 
Average values were calculated and presented as mean ±SE (unless stated 
otherwise). Shapiro-Wilk and Levine’s tests were applied for distribution and equality of 
variance analysis respectively. A decision tree was used to determine the appropriate 





Figure 2.1 Decision tree used to determine the appropriate statistical test depending on the homogeneity of distribution and variance. 




Chapter 3 – Investigating the potential manipulation of hydrogel 
mechanical properties 
 
3.1  Introduction  
Despite the pressing clinical need for improved spinal cord injury repair, clinical 
treatment options remain limited. Tissue engineering advancements in the past decade 
have resulted in a vast library of biomaterials; however, the physical and mechanical 
factors affecting ependymal cells (ECs) within the spinal cord have not been 
investigated. 
Collagen is the primary component of extracellular matrices and type I collagen has 
been found to support the growth and differentiation of neurons when used as a 
hydrogel scaffold in vitro (see Table 3.1) (O’Connor et al., 2001; Ma et al., 2004; Huang 
et al., 2013). Soluble collagen I inhibits glial proliferation in the peripheral nervous 
system (Eccleston et al., 1989)(as measured by [3H]thymidine incorporation) and so 
may decrease scarring following SCI (Klapka and Müller, 2006; Macaya and Spector, 
2012). Additionally, collagen IV promotes neurite outgrowth in sympathetic neurons of 
the peripheral nervous system following short term culture (24 hours) as compared to 
poly-lysine coated coverslips (Lein et al., 1991). In this study collagen IV selectively 
enhanced only axonal growth whereas dendritic growth was not affected. Furthermore, 
this activity was found to be associated with the non-collagenous (NC1) domain on 
collagen, mediated primarily by the transmembrane α1β1 integrin found on these cells.  
Collagen hydrogels have been functionalised with hyaluronic acid (HA) and laminin and 
investigated in vitro. Neural stem/progenitor cells (NSPCs) cultured on HA-
functionalised hydrogels exhibited greater neuronal differentiation compared to 2D 




printing of various ECM proteins (aggrecan, fibrinogen, fibronectin, and laminin) 
resulted in the alignment of astrocyte layers according to protein patterning, ultimately 
leading to reduced CSPG expression compared to un-patterned gel controls (Hsiao et 
al., 2015). 
 
Table 3.1 Selection of studies investigating collagen hydrogels for CNS repair 
Hydrogel  Culture Outcomes Reference 
Collagen 3D culture, NSPCs, 
cerebral cortex or 
subcortical region, E13 
rat 
Cells expanded, differentiated 
into neurons, and formed 
synapses. 
(Ma et al., 
2004) 
Collagen 3D culture, cortical 
neurons, E18 rat 
Cells exhibited normal 
neuronal polarity with long 
neurites (> 500 μm), >50% 
survival compared to 0% for 
agarose gel. 
(O’Connor 
et al., 2001) 
Collagen 3D culture, NSCs, 
cerebral cortex, E14 rat 
Significant increase in 
process outgrowth from 
NSCs cultured in gels 
compared to control. 







3D culture, NSPCs, 
cerebral cortex, 
embryonic; SVZ, P6 & 
adult mice 
Increased neuronal 
differentiation of embryonic 
progenitors compared to 2D 
culture 
Postnatal progenitors 
produced mainly mature 
neurons 
(Brännvall 





2D culture, astrocytes, 
cerebral cortex, P2 rats 
Alignment of astrocytes with 
protein pattern.  
Reduced CSPG expression 





E= embryonic age, P=postnatal age (days) 
Although some of the collagen scaffolds detailed above have been investigated as 
substrates for the promotion of CNS repair, little is known about the response of ECs to 




hydrogels; the migration, proliferation, and differentiation of endogenous ECs could be 
manipulated, ultimately helping repair damaged spinal cord tissue. 
In order to investigate the behaviour of ependymal cells in response to hydrogel 
mechanical properties, I first aimed to develop and characterise a number of collagen 
hydrogels, to then use in chapter 6 to investigate the effects of hydrogel composition on 
ependymal cell behaviour (see Figure 3.1). 
 
3.1.1 Aims and Objectives 
This chapter aimed to investigate the feasibility of manipulating the elastic modulus of 
collagen hydrogels, without changing the hydrogel physical properties. This was 
achieved by investigating the following objectives: 
1. To determine the effect of changing the collagen concentration, crosslinker 
concentration, and the crosslinker structure (see Table 3.2 for rationale) on the 
following hydrogel properties: 
 Mechanical  
-  Rheology to determine the elastic modulus (stiffness) 
 Physical   
- TNBS assay to infer the degree of crosslinking/functionalisation 
- Pore spacing assessment using SEM imaging & NMR  
2. Determine the effects of post-processing hydrogels (i.e. ethanol disinfectant washes) 
and whether the methods used for culturing hydrogels (incubation in culture medium at 















Increasing the collagen concentration should increase the hydrogel 
stiffness due to the additional collagen fibrils present. This should 
also reduce the porosity of the hydrogel. Crosslinking should remain 
constant (Head et al., 2016).  
Crosslinker 
molar ratio 
Increasing the crosslinker molar ratio (compared to collagen lysine 
groups) should increase the degree of functionalisation and increase 
the hydrogel stiffness due to the additional crosslinks formed. It may 




Changing the crosslinker structure may result in a change to the 
hydrogel mechanical properties due to a change in the crosslinking 
bond lengths. It is unknown whether the porosity or the degree of 






3.2 Methods  
3.2.1 Isolation of type I collagen 
Type I collagen was isolated via acidic treatment of rat tail tendons according to a 
method used previously (Tronci et al., 2013). Frozen rat tails (obtained from Central 
Biomedical Services, University of Leeds) were thawed in 70% ethanol (v/v) for 30 
minutes to disinfect the skin and transferred into a class II safety cabinet. The skin was 
removed using a scalpel and locking clamp forceps and tails were then dried for 1 hour 
at RT. Individual tendons were removed from the tendon sheath, placed in acetic acid 
(17.4 mM) and stirred for 4 days at 4°C to dissolve (50 mL per tail). The mixture was 
then centrifuged (38,400 RCF, 4°C) for 40 minutes and the tissue pellets were 
discarded. The remaining mixture was transferred to a round bottomed flask, frozen 
overnight at -80°C and then freeze-dried for 7 days to obtain dry collagen. 
3.2.1.1 Circular dichroism spectroscopy 
Circular dichroism (CD) spectroscopy measures the difference between the absorption 
of left and right circularly polarised light over a range of wavelengths and is used to 
study the secondary structure of polypeptides and proteins. CD was carried out on the 
acid-extracted products to confirm the dichroic properties and assess whether there 
was any conformational change following extraction.  
Extracted collagen and a gelatin (negative) control were dissolved in acetic acid (17.4 
mM) at a concentration of 0.002 g/mL. Sample solutions were collected in quartz cells 
of 10.0 mm path length and CD spectra were obtained with a 2.5 nm bandwidth. 
Gelatin was used as a control as this is denatured collagen and so should not show 
any typical peaks associated with triple helices. Acetic acid (17.4 mM) was used as a 
reference and this solvent spectrum was subtracted from each sample spectrum along 




Ellipticity, θ (millidegrees (mdeg)), was converted into mean residue ellipticity [θ]MRW 
(deg.cm2.dmol-1) using equation 1(147). 
[𝜃]𝑀𝑅𝑊 = (𝑀𝑅𝑊 ×  𝜃)/(10 × 𝑑 × 𝑐) Equation 1 
Where MRW is the mean residue weight for the peptide bond (94.5 Da for collagen  
and 91 Da for gelatin (Lopes et al., 2014)), c is the concentration of the sample (g/mL) 
and d is the path length (1 cm).  
3.2.2 Hydrogel synthesis 
Collagen hydrogels were created according to the method published by (Tronci et al., 
2013; Head et al., 2016), whereby the collagen lysine groups (lys) were directly 
functionalised using a number of bi-functional monomers and thus, crosslinked. These 
crosslinkers include: 4-phenylenediacetic acid (4Ph), 1,3-phenylenediacetic acid 
(13Ph), and adipic acid (Ad) (Figure 3.22). 
 
 
4-Phenylenediacetic acid  (4Ph) 1,3-Phenylenediacetic acid (13Ph) 
 
Adipic acid (Ad) 
Figure 3.2 Crosslinker molecular structures used for collagen gelation 
Chemical structures of the di-acid crosslinkers used in this chapter: 4-





Carboxylic acid groups (COOH) of 4Ph, 13Ph, or Ad (1 Figure 3.3) were activated 
using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (2) (EDC, 1:6 
molar ratio carboxylic acid:EDC) and N-hydroxysuccinimide (4) (NHS, 1:1 molar ratio 
carboxylic acid:NHS) at 0°C for 1 hour in sodium phosphate buffer (SPB) (Figure 3.3).  
The o-acylisourea active ester intermediate (3) formed initially is rapidly hydrolysed in 
aqueous solutions to form a carboxylate and a urea derivative (8 & 9 – side reactions), 
and readily undergoes electron displacement giving rise to an unreactive N-acylurea 
(10).  NHS is added to stabilise the reactive intermediate via conversion to an amine-
reactive ester (5). This therefore increases the reaction efficiency as this ester is 
reactive towards amine groups and more stable against hydrolysis (Grabarek and 
Gergely, 1990).  
Following activation any remaining unreacted EDC was quenched using 2-
mercaptoethanol (βME) for 10 minutes to stop any unwanted side reactions. The NHS-
activated crosslinker was then added to a collagen solution (in acetic acid, 17.4 mM), 
cast into well plates, and allowed to crosslink overnight at room temperature (RT) 
(Figure 3.3, iii). Hydrogels were then washed in 0.1 M PB (3 times) to remove any 






Figure 3.3 Synthetic route adapted for the creation of chemically crosslinked 
collagen 
Collagen hydrogel synthesis involved (i) initial activation of bifunctional carboxylic acid 
groups of the crosslinker (1) using EDC (2) - forming o-acylisourea active ester 
intermediate (3). (ii) Reaction with NHS (4) – forming the stable amine-reactive NHS 
ester (5), followed by (iii) addition of the collagen solution and nucleophilic 
addition/elimination reaction of collagen lysine amines (6) to the activated diacid. R1 = 
bifunctional crosslinker backbone (two reactions per mole of crosslinker), R2 = collagen 
backbone. 
Side reactions of the o-acylisourea active ester intermediate (iv) Hydrolysis of o-
acylisourea active ester (3), yielding a carboxylate and urea derivative (8 & 9) and (v) 
rearrangement producing N-acylurea (10).  
 
 
Side reactions of (3) 
 







Manipulating hydrogel mechanical and physical properties 
A number of crosslinking variables were investigated, including: collagen concentration, 
crosslinker COOH: collagen lys molar ratio, and the crosslinker structure (Table 3.3).  
For hydrogels formed with final collagen concentrations of 0.4, 0.6, and 0.8 wt. % the 
crosslinker 4Ph was used and the crosslinker carboxylic acid to collagen lysine molar 
ratio was maintained at 1:1 (Table 3.3, row 1). For hydrogels where the crosslinker 
COOH:collagen lys molar ratio was varied from 0:5, 1:1 and 1.5:1 the final 
concentration of collagen was maintained at 0.8 wt.% and the crosslinker used was 
4Ph (Table 3.3, row 2). Finally, hydrogels were formed using 4Ph, 13Ph, and Ad 
crosslinkers. Here, the final collagen concentration was maintained at 0.8 wt. % and 
the crosslinker COOH:collagen Lys molar ratio was maintained at 1:1 (Table 3.3, 
experiment 3).  





collagen Lys molar ratio 
Crosslinker 
structure 
1 0.4, 0.6, & 0.8 1:1 4Ph 
2 0.8 0.5:1, 1:1, & 1.5:1 4Ph 
3 0.8 1:1 4Ph, 13Ph, & Ad 
Conditions trialled in bold, and control variables. Collagen concentration was varied in 
experiment 1, crosslinker carboxylic acid: collagen lysine group molar ratio was varied 
in experiment 2, and the crosslinker structure was varied in experiment 3.  
 
Effect of the culture process on hydrogel stiffness 
Hydrogels were first washed in PB (3 x 10 minutes) to remove any unreacted 
chemicals, then disinfected using an ethanol concentration gradient with 15 minute 
washes in 10, 20, 30, 50, and 70% ethanol solutions. To determine whether the culture 
process has an impact on hydrogel mechanical properties, rheological characterisation 
using rheometry was then carried out immediately or hydrogels were stored at 4 °C for 
21 days prior to testing. These hydrogels were compared to control samples, where 




culture medium and incubating them at 37 °C was investigated. Here, hydrogels were 
washed in PB and disinfected (as described previously) then washed in culture medium 
with no serum (3 x 10 minutes) and either tested immediately (medium d0), or 
incubated at 37 °C in a 5% CO2 enriched environment for 7 days prior to testing 
(medium d7). 
3.2.3 Assessment of mechanical properties using rheology 
Hydrogel mechanical properties were assessed using a rheometer. All rheological 
measurements were performed using a Kinexus Pro rheometer with a parallel plate 
system. A 20 mm plate with a gap of 3.5 mm were used for all tests. Hydrogels were 
formed in 24 well plates and cut to size using a 20 mm cylindrical punch. All 
experiments were performed at 25 oC unless stated otherwise. Strain amplitude 
sweeps were carried out at a frequency of 1 Hz from 0.1% to 1000% strain. The linear 
viscoelastic region (LVER) was identified for each gel as 0.5% strain, where the 
storage modulus (G’) and loss modulus (G”) are independent of strain amplitude. G’ 
and G’’ are each measures of the solid (elastic) and fluid (viscous) phases of the 
material respectively. For a self-supporting hydrogel, G’ is usually an order of 
magnitude greater than G’’ and so G’ is typically quoted alone as an indication of 
material stiffness (greater G’ = increased stiffness) (Borzacchiello and Ambrosio, 
2009). Frequency sweeps were then performed on fresh hydrogel samples within this 
LVER from 0.5 Hz to 5 Hz at 0.5% strain. Storage modulus, G’ is quoted at 1 Hz. 
3.2.4 Assessment of physical properties 
Degree of functionalisation - TNBS assay  
A 2,4,6-trinitrobenzenesulfonic acid (TNBS) colorimetric assay was used to determine 
the number of free primary amino groups following reaction with NHS-activated di-
acids, and the consequent degree of collagen functionalisation (grafting) or 




quantification of free (unreacted) amino groups at 346 nm via the formation of an 
orange coloured derivative (Figure 3.4).  
Dehydrated hydrogels (0.011 g) were added to a solution of 1 mL sodium hydrogen 
carbonate (NaHCO3; 4 wt.%, pH 8.5) and 1 mL TNBS solution (0.5 wt.%), covered in 
foil and reacted at 40 °C under mild agitation for 4 hours. 3 mL hydrochloric acid (HCl, 
6 M) was added and heated to 60 °C for 1 hour to hydrolyse and dissolve additional 
insoluble components. 
 
Figure 3.4 Colourimetric 2,4,6-trinitrobenzenesulfonic acid assay schematic 
Reaction of trinitrobenzenesulphonic acid (TNBS) with an amine, producing an orange 
derivative and a sulphite ion. R = collagen backbone. 
 
Solutions were cooled to RT, diluted with 5 mL diH2O and extracted three times using a 
separating funnel with 20 mL anhydrous diethylether in order to remove any unreacted 
TNBS. An aliquot of the aqueous phase (5 mL) was heated at 40 °C to remove excess 
ether and diluted further using 15 mL diH2O. Solutions were read against a blank 
(control) sample, whereby HCl was added prior to the addition of TNBS in order to 
prevent any protein reaction occurring. 
The number of moles of free amino groups per gram of collagen in crosslinked samples 









2 × 𝐴𝑏𝑠(346 𝑛𝑚) × 𝑉
𝜀 × 𝑙 × 𝑥
 Equation 2 
Where: Abs(346 nm) is the absorbance value of the sample at 346 nm, V is the volume 
of sample solution (0.02 L), ε is the molar absorption coefficient for 2,4,6-trinitrophenyl 
lysine (1.46 x 104 L mol-1 cm-1), l is the cell path length (1 cm), x is the sample mass 
(0.011 g).  
From this, the degree of functionalisation/crosslinking (% functionalisation) was 
calculated as in Equation 3: 
% 𝑓𝑢𝑛𝑐𝑡𝑖𝑜𝑛𝑎𝑙𝑖𝑠𝑎𝑡𝑖𝑜𝑛 = (1 −  
𝑚𝑜𝑙𝑒𝑠(𝐿𝑦𝑠)𝐶𝑟𝑜𝑠𝑠𝑙𝑖𝑛𝑘𝑒𝑑
𝑚𝑜𝑙𝑒𝑠(𝐿𝑦𝑠)𝑁𝑎𝑡𝑖𝑣𝑒 𝐶𝑜𝑙𝑙𝑎𝑔𝑒𝑛
) × 100 Equation 3 
Moles(Lys)Collagen denotes the lysine molar content in native collagen. For rat tail 
collagen this is 3.24 x 10−4 mol/g (Tronci et al., 2013). 
Scanning Electron Microscopy (SEM) imaging  
Analysis of pore size and internal architecture was carried out using scanning electron 
microscopy (SEM) following critical point drying (CPD) by Martin Fuller (School of 
Molecular and Cellular Biology, University of Leeds). Firstly the hydrated hydrogels 
were fixed in glutaraldehyde (2.5% w/v in PB) overnight, followed by two PB washes 
and fixed further using osmium tetroxide (1% w/v in PB). Hydrogels were then 
dehydrated in increasing concentrations of acetone and critically point dried, replacing 
the solvent with liquid CO2. This method is typically used for biological specimens as it 
allows the structural integrity to be maintained (Cohen, 1979). Acetone is used as an 
intermediate fluid prior to CO2 phase conversion as this is miscible with CO2 and also 
reduces the damage caused by drying due to the reduced surface tension of the 
solvent with air compared to water. Samples were then sputter coated with platinum at 




3 SEM images (5000x magnification) per hydrogel condition were analysed using the 
BoneJ plugin developed by (Doube et al., 2010) for ImageJ (see Figure 3.5), whereby 
firstly the scale was set and the scale bars were then removed from the original image 
(Figure 3.5 A). The images were then smoothed to reduce background noise and 
converted to binary (Figure 3.5 B). The BoneJ thickness tool was used to generate the 
fibril thickness (Figure 3.5 C) and the spacing between collagen fibrils (pore spacing) 
(Figure 3.5 D) (validated for use on hydrogels by (Clarkson, 2018)).  
 
Figure 3.5 SEM image analysis using the BoneJ plugin for ImageJ 
(A) The original SEM image used for analysis, scale bar = 20 µm, and (B) the binary 
conversion. The BoneJ plugin was used to generate: (C) matrix thickness and (D) pore 
spacing. 
 
Porosity analysis via Carr-Purcell-Meiboom-Gill sequence (CPMG) 
SEM pore spacing data were also compared to NMR porosity measurements. Carr-




spin T2 relaxation times of any nucleus within a sample. This gives accurate 
quantification of the porosity of samples in a non-destructive manner, using nuclear 
magnetic resonance (NMR). Here, T2 is proportional to pore size, and therefore larger 
T2 values correspond to larger pore volumes (Coates et al., 1999). CPMG was carried 
out by Carlos Grattoni (School of Earth and Environment, University of Leeds) at 2 
MHz with a field strength of 0.047 Tesla. The software used to get the T2 distributions 
was WinDXP (Oxford Instruments). 
 
3.3 Results 
3.3.1 Collagen extraction 
CD spectroscopy confirmed the preservation of the triple helix structure of collagen in 
acid-extracted products, as indicated by the positive maximum absorption band at 210-
230 nm (Figure 3.6). A minimum absorption band was also observed around 190 nm, 
indicating the single polyproline-II helix conformation.  
 
Figure 3.6  Preservation of the collagen triple helix following acid extraction 
CD spectra of collagen (black) and gelatin (red) control mean residue ellipticity, 
indicating the preservation of the collagen triple helix (210-230 nm) and polyproline-II 





3.3.2 NMR porosity method development 
As this method is typically used for porous rocks, the effect of hydrogel solvent was first 
assessed in order to inform future measurement conditions. Hydrogels were either 
washed in PBS or H2O (3 x 10 minutes) prior to NMR porosity measurements. Solvent 
samples were used as a control and tested using the same method. From the NMR 
porosity plots, the mean T2 values were calculated for each hydrogel. These are 
proportional to the porosity of the hydrogel, with greater T2 values corresponding to 
increased pore volumes. 
There was no significant difference in mean T2 values, and therefore hydrogel porosity, 
between solvents used (n=3, P=0.733). The mean T2 value ±SD was 1393.7 ±57.12 
ms for 0.8 wt.% collagen hydrogel in PBS and 1442.0 ±64.51 ms for 0.8 wt.% collagen 
hydrogel in H2O. Therefore, future measurements were made using PBS-hydrated 
hydrogels (Figure 3.7). 
 
Figure 3.7 NMR porosity measurement using different hydrogel solvents 
(A) NMR porosity plot showing normalised signal against T2, and (B) the resulting 
mean T2 measurements taken from this graph. n=3. 
 
 
3.3.3 Formation of hydrogels 
Collagen hydrogels were formed and the mechanical properties were assessed using 




hydrogel variant (Figure 3.8 A), and so this value was used for the subsequent 
frequency sweeps (Figure 3.8 B). Additionally, as expected, the storage modulus (G’ - 
Figure 3.8 blue) was around 1 order of magnitude greater than the loss modulus (G’’ – 
Figure 3.8 red); confirming the formation of self-supporting hydrogels (see 
Supplementary data Table 8.1 for the frequency sweep data for each hydrogel repeat).  
 
 
Figure 3.8 Example of rheology data used to characterise hydrogel mechanical 
properties 
The storage moduli (G’ blue) and loss moduli (G’’ red) measured using: (A) Shear 
strain amplitude sweep at 10 rad/s from 0.1% to 1000% strain to determine the linear 
viscoelastic region (LVER). (B) Frequency sweep carried at 0.5% strain. Data taken 
from 4Ph-crosslinked hydrogel 0.8 wt.% collagen, 1:1 COOH:Lys ratio. Data presented 





3.3.4 Manipulating the properties of collagen hydrogels 
Collagen concentration, crosslinker molar ratio, and the structure of the crosslinker 
were investigated as potential routes for forming hydrogels with different mechanical 
properties, whilst maintaining constant porosity and degree of crosslinking. 
3.3.4.1 Effect of collagen concentration 
Three collagen concentrations: 0.4, 0.6, and 0.8 wt.% (final concentration) were 
investigated in order to determine if this variable caused a change in the properties of 
the resulting hydrogels. For all of these conditions the collagen lys:crosslinker COOH 
molar ratio was maintained at 1:1. 
The collagen concentration did not significantly impact the degree of functionalisation 
(determined by TNBS assay, Figure 3.9 A). This was expected as the molar ratio of 
crosslinker to collagen lysine groups was scaled accordingly, and thus remained 
consistent between groups.  
There was a significant difference between the storage modulus of hydrogels created 
using different collagen concentrations (P= 0.0083 to 0.0002; Figure 3.9 B), with 
hydrogels formed using 0.8 wt.% collagen exhibiting the greatest storage modulus 
(mean storage modulus ±SD (Pa): 0.4: 81.45 ±3.119, 0.6: 211.8 ±29.51, 0.8: 351.7 
±51.41).  
The spacing between collagen fibrils (as determined using the BoneJ plugin analysis of 
SEM images) was not significantly different between the collagen concentrations 
investigated (Figure 3.8 C and D; mean spacing ±SD (µm): 0.4: 0.661 ±0.111, 0.691 
±0.125, 0.741 ±0.112). However, NMR porosity measurements (Figure 3.9 E & F) 
showed a significant decrease in mean T2 values, and therefore reduced porosity, for 
0.8 wt.% collagen hydrogels, indicating these hydrogels had smaller pores (mean T2 








Figure 3.9 Effect of collagen concentration on the physical properties of 
hydrogels 
(A)TNBS assay % functionalisation, (B) storage modulus determined by rheology 
frequency sweeps, quoted at 10 rad/s (C) pore spacing determined using BoneJ plugin 
from SEM images (D) representative SEM images, (E) normalised NMR signals, and 
(F) mean T2 values taken from these plots. Scale bars = 30 µm, inset = 5 µm. 1:1 4Ph 









3.3.4.2 Effect of crosslinker molar ratio 
Interestingly, the molar ratio of the carboxylic acid groups of the 4Ph crosslinker used 
(as compared to collagen lys groups), did not significantly affect the degree of collagen 
functionalisation (Figure 3.10 A). The storage modulus of gels created using varying 
crosslinker molar ratios were not significantly different (Figure 3.10 B; n=3, P = 0.3039 
to 0.8793). Additionally, there was no significant difference in the mean pore spacing 
between collagen fibrils (Figure 3.10 C & D). 
 
 
Figure 3.10 Effect of 4Ph crosslinker molar ratio  
0.8 wt.% collagen crosslinked using: 0.5, 1, and 1.5 4Ph crosslinker COOH:collagen lys 
molar ratio. (A)TNBS assay % functionalisation, (B) storage modulus determined by 
rheology frequency sweeps, quoted at 10 rad/s, (C) mean pore spacing determined 
using BoneJ plugin from SEM images (D) representative SEM images. Scale bars = 30 





3.3.4.3 Effect of crosslinker chemical structure on hydrogel properties 
The degree of functionalisation remained similar for hydrogels crosslinked using 4Ph, 
13Ph, and Ad (Figure 3.11 A) with no significant differences detected. Rheological 
characterisation showed that hydrogels crosslinked using 4Ph, 13Ph, and Ad had 
storage moduli (Pa) of 351.7 ±51.42, 395.6 ±80.87, and 332.0 ±37.39 respectively and 
these were not significantly different. Furthermore, porosity analysis using SEM and 
NMR measurements also showed that these hydrogels had similar pore spacing and 
pore volume (Figure 3.11 C – F), once again with no statistically significant differences 
between the crosslinker variants (SEM pore spacing ±SD (µm): 4Ph: 0.741 ±0.112; 
13Ph: 0.774 ±0.101; Ad: 0.650 ±0.031; NMR porosity T2 ±SD (ms): 4Ph: 1416.7 
±107.6; 13Ph: 1418.4 ±55.49; Ad: 1479.6 ±16.35).  
3.3.4.4 Effect of culture conditions on hydrogel mechanical properties 
To determine the effect of the culture process on hydrogel mechanical properties, 
hydrogels were washed in PB, disinfected using an ethanol concentration gradient, and 
tested (using rheology) immediately or following storage at 4 °C for 21 days.  
As expected, the process of disinfecting hydrogels in ethanol was shown to increase 
the storage modulus of the gels significantly when tested immediately (d0: PB: 468.2 
±13.35 Pa; Ethanol: 512.0 ±0.814 Pa; n=3, P = 0.0240) and following 21 days 
incubation (Figure 3.12) (d21: PB: 420.3 ±19.69 Pa; Ethanol: 549.7 ±16.13 Pa; n=3, P 
≤ 0.0001). 
Additionally, it was found that storing hydrogels in either solution for 21 days resulted in 
a significant difference in the hydrogel storage moduli. For PB-hydrated hydrogels, 
these exhibited a decrease in stiffness over time whereas ethanol storage lead to an 
increase in stiffness (Figure 3.12). As such, hydrogels were always used/tested 





Figure 3.11 Effect of crosslinker structure on hydrogel properties 
Characterisation of hydrogels crosslinked using 4-Phenylenediacetic acid (4Ph), 1,3-
Phenylenediacetic acid (13Ph) or Adipic acid (Ad). (A)TNBS assay % functionalisation, 
(B) storage modulus determined by rheology frequency sweeps, quoted at 10 rad/s (C) 
mean pore spacing determined using BoneJ plugin from SEM images (D) 
representative SEM images. Scale bars = 30 µm, inset = 5 µm. (E) normalised NMR 
signals, and (F) mean T2 values. Mean storage moduli determined by rheology 






Figure 3.12 Effect of ethanol disinfection on hydrogel storage modulus. 
Storage modulus determined by rheology frequency sweeps, quoted at 10 rad/s for 
hydrogels washed with PB or ethanol and tested immediately (d0) or following 21 days 
incubation (d21). Data presented as mean ±SD. n=3, * P ≤0.05. 
 
To further assess whether hydrogel mechanical properties change when culturing, the 
effect of hydrating in culture medium and incubating at 37°C was investigated. 
Hydrogels were either tested immediately following ethanol disinfection and hydration 
in medium (medium d0), or heated at 37 °C for 7 days prior to testing (medium d7). The 
storage modulus of the hydrogels processed this way were compared to hydrogels 
from the same batch that were washed in PB following ethanol washes and tested 
immediately (PB). Two crosslinkers: 4Ph and Ad were used to investigate if they 
differed in response to culture conditions.  
There was no significant difference between hydrogel storage modulus for all 
conditions. There was however, a trend towards reduced storage modulus for 4Ph 
crosslinked hydrogels maintained in culture. (Figure 3.13; 4Ph PB: 649.7 ±57.01 Pa, 
medium d0: 556.2 ±40.67, medium d7: 491.6 ±134.9 Pa). 
There was a significant difference between the control PB-hydrated hydrogel 
crosslinked using different crosslinkers (4Ph PB: 649.7 ±57.01 Pa; Ad PB: 434.03 
±13.18 Pa; n=3, P= 0.0178). This trend was not seen previously when assessing the 



























mechanical properties of hydrogels formed using different crosslinkers, indicating that 
there could be batch to batch variations. 
 
Figure 3.13 Effect of hydrating in culture medium and heating at 37 °C for 7 days 
on the rheological properties of collagen hydrogels. 
Storage modulus of collagen hydrogels crosslinked with 4Ph or Ad and hydrated in 
phosphate buffer (PB) compared to hydrogels washed in culture medium with no serum 
and either tested immediately (medium d0), or heated at 37 °C for 7 days prior to 
testing (medium d7). Storage modulus determined by rheology frequency sweeps, 




3.3.5 Batch reproducibility 
It was evident when repeating rheology measurements that the mechanical properties 
of hydrogels varied between batches (see supplementary Figure 8.1). It wasn’t clear 
however, whether this was due to the collagen or the crosslinker solution batches and 
so this was investigated.  
The batch of crosslinker solution didn’t impact the resulting storage modulus of the 
hydrogels formed (Figure 3.14 A). There was however, a significant difference between 
the storage modulus of hydrogels created using different batches of collagen solution 
(same batch of extracted collagen, Figure 3.14 B, ** P < 0.01). Interestingly, there was 




formed using collagen solution batch 2 and 3. Collagen solution batch number 1 was a 




Figure 3.14 Effect of collagen and crosslinker solution batch on hydrogel storage 
modulus. 
Storage modulus determined by rheology frequency sweeps, quoted at 10 rad/s for 
hydrogels formed from different batches (denoted as 1, 2, and 3) of collagen and 4Ph 

















3.3.5.1 Hydrogel synthesis conditions 
To investigate the factors influencing the resulting hydrogel mechanical properties, the 
starting concentrations of the collagen and activated crosslinker solutions were varied 
(see Figure 3.15 A). Final concentrations (of the combined collagen and crosslinker 
mixture) remained constant in all three hydrogel conditions, with a molar ratio of 2:1 
collagen: crosslinker.   
Firstly, a control hydrogel was created using a 1.2 wt.% initial collagen solution 
crosslinked with 4Ph at a molar ratio of 1:2 (referred to as Col 1.2 4Ph; Figure 3.15 A). 
The effect of a diluted initial collagen solution was then investigated. Here, the same 
1.2 wt.% initial collagen solution was diluted to 0.96 wt.%, prior to crosslinking with 4Ph 
to form a hydrogel (referred to as Col 0.96 4Ph x2; Figure 3.15). To maintain the same 
final molar ratio of the two solutions (1 4Ph: 2 Col lys), a concentrated crosslinker 
solution was used (referred to as 4Ph x2).  
There was a significant difference between the storage modulus of hydrogels created 
using different initial collagen solution concentrations. When the initial collagen 
concentration was diluted to 0.96 wt.% (from the same batch of collagen solution) prior 
to mixing with the concentrated 4Ph crosslinker (Col 0.96 4Ph x2; Figure 3.15 A), the 
storage modulus reduced from 521.6 ±9.473 Pa to 200.0 ±6.600 Pa.  
To confirm whether this effect was due to the concentration of the collagen solution or 
the activated crosslinker solution, the concentrated activated 4Ph solution was diluted 
prior to crosslinking with same 1.2 wt.% initial collagen solution (referred to as Col 1.2 
4Ph x2 diluted). The storage modulus was found to be similar to that of the control 
hydrogel when 4Ph x2 was diluted prior to mixing (525.6 ±21.21 Pa, Figure 3.15 B), 
thereby confirming this change in stiffness was not due to the concentration of the 




These data indicate that the initial collagen concentration in the starting solution, 





Figure 3.15 Effect of initial collagen concentration on hydrogel rheological 
properties 
(A) Schematic depicting dilution method generating Col 1.2 4Ph (control); Col 0.96 4Ph 
x2 – created using diluted initial collagen solution mixed with concentrated 4Ph 
solution; and Col 1.2 4Ph x2 (diluted) – created by diluting the concentrated 4Ph x2 
solution prior to mixing with collagen. (B) Storage modulus determined by rheology 








In this chapter, the potential manipulation of hydrogel mechanical properties was 
investigated by varying the collagen concentration, the crosslinker molar ratio, and the 
structure of the crosslinker used.  
Hydrogel manipulations  
The method of varying the collagen concentration was found to significantly affect the 
storage modulus of the resulting hydrogels, however, this method is not suitable for the 
manipulation of hydrogel mechanical properties as it also leads to physical changes. 
NMR porosity measurements indicated that increasing the collagen concentration in 
hydrogels significantly reduces the pore volume within hydrogels; thereby rendering it 
an unsuitable method for independent modulation of mechanical stiffness. Additionally, 
altering collagen concentration leads to a change in the number of cell-attachment 
sites, which could potentially impact cell behaviour further. Furthermore, despite the 
degree of functionalisation remaining constant, it is not clear whether crosslinking 
occurs in the same fashion in each of these conditions. As the collagen concentration 
is increased, it is possible that increased grafting (reaction of only one carboxyl group) 
starts to take place, due to the increased competition between lysine residues.  
A previous study aimed to investigate the response of neural stem cells (from the brain 
of adult rats) to hydrogels of varying stiffnesses, created by altering the concentration 
of alginate. Here the porosity was not assessed, and as such, it is likely that the 
change in stem cell behaviour was confounded by the structural changes caused as a 
result of the change in alginate concentration (Banerjee et al., 2009a).  
Varying the crosslinker molar ratio was also investigated. Here it was found that no 
significant changes were made to the mechanical and physical properties of the 
resulting hydrogels. As one mole of crosslinker reacts with two moles of collagen lysine 




groups should theoretically lead to 100% crosslinking, however, in reality only 65.2% 
functionalisation was achieved.  
The potential manipulation of collagen hydrogel mechanical properties using 
crosslinkers with structural differences was also investigated in this chapter. The 
hydrogels formed using 4Ph, 13Ph, and Ad all had storage moduli in the region of 300-
400 Pa. These hydrogels also had similar degrees of functionalisation and porosity as 
measured by SEM imaging and NMR CPMG experiments.  
The repeated measurements made in the course of this chapter highlighted the 
inconsistencies in the hydrogel properties between batches. It was identified that the 
issues with repeatability are likely to be due to collagen batch variability, with the 
starting collagen concentration (and the resulting solution viscosity) significantly 
impacting hydrogel storage modulus. It is also likely that as collagen was extracted in-
house from a natural source, the purity and quality may not have been consistent, 
therefore impacting on hydrogel repeatability. Future studies would therefore benefit 
from a commercial source of collagen to ensure consistent quality and purity of starting 
materials.  
Impact of culture conditions on hydrogel stiffness 
This chapter also aimed to determine if the culture conditions affect the mechanical 
properties of collagen hydrogels. As expected, ethanol disinfectant washes were 
shown to lead to a significant increase in hydrogel storage modulus, however this 
remained in the range of 400 to 600 Pa (Gopinath et al., 2014). Additionally, hydrogels 
mechanical properties were not shown to significantly change upon hydrating in culture 
medium and incubating at standard culture conditions (37 oC and 5% CO2 enriched 







3.5  Conclusions 
In this chapter, characterisation of collagen hydrogels developed in-house indicated 
that the hydrogel stiffness can’t be reliably manipulated, independent of physical 
properties.  
Changing the collagen concentration lead to: 
 No significant change in the % functionalisation 
 A significant change to the storage modulus of hydrogels 
 No detectable pore spacing change when assessed using SEM measurements 
 A significant change in porosity when assessed using NMR measurements 
Changing the crosslinker molar ratio lead to: 
 No significant change in the % functionalisation 
 No significant change to the storage modulus of hydrogels 
 No significant change to the pore spacing - assessed using SEM measurements 
Changing the crosslinker structure lead to: 
 No significant change in the % functionalisation 
 No significant change to the storage modulus of hydrogels 
 No significant change to the porosity - assessed using SEM & NMR measurements 
Additionally, it was found that disinfecting collagen hydrogels using ethanol washes 
leads to a significant increase in hydrogel storage modulus, however, culturing these 
hydrogels for 7 days does not cause a change to the mechanical properties. 
Overall, this chapter highlights the issues surrounding creating a tuneable collagen 






Chapter 4 – Characterisation of GFP Expression in the Spinal 
Cord of (Nestin) GFP Transgenic Mice 
 
4.1 Introduction 
4.1.1 Transgenic reporter lines used for studying neurogenesis 
Transgenic mouse lines in which the neural stem cells of the embryonic and adult 
central nervous system express a reporter molecule, such as a fluorescent protein, are 
useful tools for studying neurogenesis in vitro and in vivo (Mignone et al., 2004; 
Encinas et al., 2011; Park et al., 2013). The reporter genes in such transgenic lines can 
either be expressed constitutively (consistently) or can be induced using an external 
trigger. 
4.1.1.1 Inducible transgenic reporter lines 
Spatial and temporal control over transgene expression can be achieved using 
inducible transgenic reporter lines. These are routinely used to study the molecular and 
cellular mechanisms involved in stem cell development and behaviour. Tetracycline-
controlled transactivator (tTA or Tet-Off) systems (Gossen and Bujard, 1992) are 
widely used for inducible gene expression, both in vitro and in vivo. In these systems 
tTA or reverse tTA (rtTA or Tet-On) is placed downstream from the tetracycline 
operator (tetO), and tetracycline (or the analogue doxycycline) is used to either block 
(in the case of tTA) or induce gene expression (in the case rtTA).  
4-hydroxytamoxifen (4HT)-regulated expression models are commonly used with Cre 
recombinase (an enzyme that targets LoxP) for the expression of promotor genes 





of the estrogen receptor is fused with Cre recombinase (CreERT), and this binds to 
heat shock protein 90 (HSP) in the cytoplasm, rendering it tamoxifen-inducible. As a 
result, the addition of 4HT or tamoxifen triggers the CreERT-HSP complex to separate, 
translocation of CreERT into the nucleus, followed by recombination. Overall, this 
results in either inactivation (and creation of knockout alleles) or activation of gene 
expression in these animals. A number of Cre/loxP lines have been utilised for studying 
the lineage of stem cells in the brain. Promoters (DNA sequences that define where 
transcription of a particular gene by RNA polymerase begins) have included: Nestin 
(Meletis et al., 2008; Burns et al., 2009; Dhaliwal and Lagace, 2011; Imayoshi et al., 
2011; Liang et al., 2012; Sun et al., 2014), Glast1 (Mori et al., 2006), Gli1 (Ahn and 
Joyner, 2005), FoxJ1 (Meletis et al., 2008; Barnabé-Heider et al., 2010), and Sox2 
(Favaro et al., 2009). 
More recently, viral gene delivery systems have been developed for the delivery of Cre 
recombinase using adeno-associated viral-, lentiviral-, and retroviral-based vectors. 
Using these methods, recombination can be controlled to target specific cell 
populations using viruses expressing Cre under the promoter of particular genes (e.g. 
the FoxJ1 gene for targeted recombination in ependymal cells (Carlén et al., 2009)).  
4.1.1.2 Constitutive transgenic reporter lines 
A number of constitutive transgenic reporter lines have also been developed using a 
range of constructs and reporters, resulting in varied gene expression (nestin 
transgenic reporter lines summarised in Table 4.1 and reviewed elsewhere (Walker et 
al., 2010; Dhaliwal and Lagace, 2011)). The animals used in this chapter were 
originally created by G. Enikolopov’s laboratory. In these mice the regulatory elements 
of the second intron of the nestin gene were used to create a reporter line expressing 
green fluorescent protein (GFP) (referred to as (nestin) GFP) (Mignone et al., 2004). 
Nestin is a type VI intermediate filament protein and a marker of neural stem and 





transgenic line, (nestin) GFP is selectively expressed in progenitor cells and pericytes 
(Birbrair et al., 2013; Licht et al., 2016), and diminishes in differentiated cells; allowing 
for the identification and isolation of neural stem cells (NSCs) (Mignone et al., 2004).  
While these GFP-expressing (GFP+ve) cells have been characterised in the brain, the 
identity of (nestin) GFP+ve cells has not been confirmed elsewhere within the CNS. In 
this chapter, known markers of ECs and a retrograde tracer for pericyte identification 
were used to investigate (nestin) GFP expression in the spinal cord.  
Since one aim of chapter 6 of this thesis is to use (nestin) GFP mice to track spinal 
cord ECs and assess their behaviour in response to hydrogels, characterising the 
fluorescently labelled cells is of great importance. Additionally, identification of cell 
markers and proteins in (nestin) GFP+ve cells may help inform tissue engineering 
strategies aimed at manipulating ependymal cell migration and differentiation. 
GAD67-GFP transgenic mice were also used in this chapter in order to assess the 
selectivity of the antibodies used. The enzyme glutamic acid decarboxylase (GAD) is 
responsible for catalysing decarboxylation of glutamate into ᵞ-aminobutyric acid 
(GABA) and is present in two isoforms: GAD65 and GAD67 (Tamamaki et al., 2003; 
Gotts et al., 2016). GAD67-GFP has been shown to label CSFcCs, which are also 
located at the central canal region in the spinal cord of mice (Corns et al., 2015; Gotts 
et al., 2016). Where possible, immunofluorescence (IF) results were also validated 
against published RNAseq data (Rosenberg et al., 2018) and Allen Brain Atlas data 





Table 4.1 – Nestin reporter mice used to study neurogenesis 
Name Construct Reporter EC labelling  Ref. 
(Nestin) GFP 5.8‐kb promoter and the 1.8‐kb second intron of nestin gene eGFP Brain 
(Mignone et al., 
2004) 
pNestin‐GFP 2.5 kb nestin promoter, 1.8 kb nestin enhancer 2nd–3rd intron eGFP Brain  
(Yamaguchi et al., 
2000) 
E/nestin:eGFP 
637-bp (1162–1798) of 2nd intron from nestin, hsp68 min 
promoter 
eGFP 
Brain and spinal 
cord 
(Kawaguchi et al., 
2001) 
NesPlacZ/3 Rat nestin gene; 5-kb upstream and 3 introns LacZ 
Brain and spinal 
cord 
(Johansson et al., 
2002) 
Nes714tk/lacZ 
714-bp of 2nd intron from human nestin, 107-bp of thymidine 
kinase promoter 
LacZ No  




5.8-kb upstream to 5.4-kb downstream of nestin gene. 




(Beech et al., 
2004) 
Nestin‐rtTA‐eGFP 5-kb‐nestin promoter, 700-bp of 2nd intron of nestin gene eGFP Dorsal neural tube (Yu et al., 2005)  
Nestin‐CFPnuc 
5.8‐kb nestin promoter, 1.8‐kb nestin enhancer 2nd–3rd 
intron 
CFP Brain 
(Encinas et al., 
2006) 
Nestin‐eGFP 2nd Intron, thymidine kinase promoter EGFPmut4 Brain 
(Walker et al., 
2010) 





4.2 Hypothesis and Aims 
It is hypothesised that GFP in (nestin) GFP transgenic mice can be used to selectively 
identify ependymal cells (ECs) in the spinal cord. 
This chapter uses immunofluorescence on perfusion-fixed spinal cord slices to: 
1. Examine the presence of specific cell markers and proteins in (nestin) GFP labelled 
cells in the spinal cord of transgenic mice 
2. Determine if there are appropriate antibodies to discriminate between ECs and 
CSFcCs at the central canal 
3. Identify if ECs express proteins with potential use for targeting in modulating 
proliferation and/or migration 
The development work carried out in this chapter will enable the hypotheses in 
chapters 5 and 6 to be interrogated, as shown in Figure 4.1. 
 
Figure 4.1 Schematic depicting the overall aim of chapter 4 in relation to the rest 







4.3.1  Animals used 
All experiments were carried out under UK Home Office Licence (P1D7A177), in 
accordance with the UK Animals (Scientific Procedures) Act 1986 and the ethical 
standards set out by the University of Leeds Ethical Review Committee. Every effort 
was made to minimise the number of animals used and their suffering.  
(Nestin) GFP and GAD67-GFP transgenic mice were bred in-house as heterozygotes, 
housed in standard conditions with a 12 hour light-dark cycle, and given ad libitum 
access to food and water. 
4.3.2 Hydroxystilbamidine Labelling of Pericytes 
Mice received an intraperitoneal (I.P.) injection of 0.05 mL hydroxystilbamidine 
(Fluorogold, FG) (50 mg/kg) 48 h prior to being perfused to fluorescently label pericytes 
by retrograde tracing from the periphery (Edwards et al., 2013). FG is directly visible 
using fluorescence microscopy. 
4.3.3 Perfusion fixation and tissue processing 
Mice were terminally anaesthetised with sodium pentobarbital (60 mg/kg) I.P. and 
perfused transcardially with 0.1 M PB to remove blood, then with 4% PFA for tissue 
fixation. The spinal cord and brain were removed and post fixed overnight at 4 °C in 4% 
PFA, before being stored in 0.1 M PB at 4 °C.  
The pia mater was removed using fine forceps and a dissection microscope, and tissue 
was sectioned at 40 μm (spinal cord) or 50 μm (brain) on a vibrating microtome. 
Sections of spinal cord or brain ~1 cm in length were cut using a flat blade, and glued 
to the vibratome chuck. The chuck was then screwed into place in the water bath 





then cut at an amplitude of 0.4 mm/s and vibrating frequency of 80 Hz and tissue 
sections were transferred into a well plate containing PBS using a paintbrush. 
4.3.4 Immunofluorescence 
Immunofluorescence (IF) optimisation was carried out to determine the 
permeabilisation solution and antibody (primary and secondary) concentrations for 
each antibody used. IF was performed on tissue sections as described in Figure 4.2. 
Briefly, cell membranes were permeabilised via slice incubation in either 0.1% (v/v) 
Tween 20 (T20) or 0.1% (v/v) Triton X-100 (PBST) for 30 minutes at RT prior to 
antibody incubation. All primary antibody incubations were performed for at least 48 h 
at 4 °C in either 0.1% PBST (Table 4.3) or PBS (for T20 treated sections, Table 4.2). 
Sections were then washed three times with PBS (10 minutes). Antibodies were 
detected by incubating sections in the appropriate Alexa Fluor conjugated secondary 
antibody (1:1000 in PBS) or biotin-conjugated secondary antibody (1:250 in PBS) at RT 
for 2 h (Table 4.4). In the case of biotinylated secondary antibodies, sections were 
washed three times with PBS (10 minutes) then incubated with streptavidin Alexa Fluor 
for 2 h at RT. Finally, sections were washed twice in PBS, followed by a wash in 0.1M 
PB, and were then mounted on microscope slides, air dried, and covered in 
Fluoroshield with DAPI (cell nuclei counter-stain) before being coverslipped. 
4.3.5 Image capture  
Sections (n>3 sections per animal of lumbar and thoracic cord, N=3 animals, Table 4.5) 
were imaged using a Zeiss LSM880 laser scanning confocal microscope equipped with 
argon (λex = 488 nm) and He‐Ne (λex = 543 nm) lasers. Images were acquired using 
Carl Zeiss ZEN software (Zeiss Microscopy) and CorelDRAW 2017 was used for image 
processing - brightness/contrast/intensity and creating figures. DAPI nuclear staining 
was used to identify each cell and only whole cells were counted. Manual cell counts of 
the number of (nestin) GFP cells, antibody-labelled cells, and co-localised cells at the 





Figure 4.2 Immunofluorescence protocol used for fixed tissue slices 
Flow chart detailing the immunofluorescence method used to label proteins within 
perfusion-fixed tissue slices. Permeabilisation was initially carried out using either 
Tween20 or Triton-X100, followed by antibody incubation and subsequent antibody 
detection steps using either a directly conjugated secondary antibody or a biotinylated 
secondary antibody and streptavidin Alexa Fluor. Slices were then washed and 
mounted on microscope slides for visualisation 
 
4.3.6 Data Analysis  
Cell counts were collated in Microsoft Excel and analysed using IBM SPSS statistics 






Table 4.2 Antibodies used – permeabilised using Tween20 
Target Raised in Dilution Antigen Evidence  





Mouse 1:100 M1/69 unknown epitope specificity ECs: adult mice (Pruszak et al., 







Rat 1:500 129/Sv mouse-derived endothelioma cell 
line tEnd.1 
Endothelial cells (Day et al., 2007) BD 
Biosciences 
550274 
Galectin-3 (Gal-3)* Goat 1:1000 
 
E. coli-derived recombinant mouse Gal-3, 
Ala2-Ile264, Accession # NP_034835 
ECs: adult rat brain (Comte et al., 






Rabbit 1:500 Synthetic non-phosphopeptide derived from 
human NKA-α1 around the phosphorylation 
site of serine16 (A-V-SP-E-H) 
ECs: adult mice  (Edwards et al., 
2013; Corns et al., 2015) 
AbD Serotec 
ab58475 
Vimentin Chicken 1:500 Recombinant vimentin ECs: adult mice (Alfaro-Cervello et 
al., 2012b) & rats (Schnitzer et al., 
1981; Mladinic et al., 2014) 
Millipore 
AB5733 
Antibodies marked with an asterisk were detected using biotin-conjugated secondary antibodies followed by streptavidin Alexa Fluor555. Specificity as 





Table 4.3 Antibodies used – permeabilised using PBST 
Target Raised in Dilution Antigen Evidence  Source  
Calbindin-D28k Rabbit 1:500 Calbindin D-28k 
ECs: rat & mouse, not human 







HEK293 human embryonic kidney cell 
line transfected with mouse CD63, 
Met1-Met238, Accession # P41731 
ECs: adult & juvenile mouse 
spinal cord (Allen Institute for 
Brain Science, n.d.) 
R&D systems  
MAB5417 
Chemokine receptor 
type 4 (CXCR4)* 
Rabbit 1:8000 
Non-phosphorylated C-terminus of 
CXCR4 (residues 341-352) 





protein J1 (FoxJ1)* 
Mouse 1:1000 Not detailed 
ECs: embryonic, juvenile & 
adult mouse (Meletis et al., 
2008; Alfaro-Cervello et al., 
2012a; Li et al., 2018; 
Franklin et al., 2018) 
eBioscience 
14-9965-80 
Glial fibrillary acidic 
protein (GFAP) 
Mouse 1:100 
Synthetic peptide amino acids 411-422 
(KTVEMRDGEVIK) of human GFAP 
Astrocytes (Gomes et al., 
1999) & radial glia (Mamber 





disease 2-like 1 
protein  (PKD2L1) 
Rabbit 1:250 
Synthetic peptide corresponding to N-
terminal residues of mouse PDK2L1 
CSFcCs (Huang et al., 2006; 
Orts-Del’Immagine et al., 
2012; Orts-Del’Immagine et 





region Y-box 2 
(Sox2) 
Goat 1:500 
Epitope mapping near the C-terminus 
of Sox-2 of human origin 
ECs: embryonic & adult rat 
(Graham et al., 2003; 
Mladinic et al., 2014) 
Santa Cruz 
SC-17320 (Y-17) 
Antibodies marked with an asterisk were detected using biotin-conjugated secondary antibodies followed by streptavidin Alexa Fluor555. Specificity as 





Table 4.4 Secondary antibodies used on tissue sections 
The antibody marked with an asterisk is part of the Mouse on Mouse immunodetection 
kit. 
Antibody Raised in Antigen 
Cat. 
number Dilution Source 
Alexa 
Fluor555 
Donkey Mouse A31570 
1:1000 Invitrogen 
Donkey Rabbit A32794 
Goat Chicken A21437 
Goat Rat A21437 
Biotinylated 
Donkey Goat A16003 
1:250 
Novex 
Donkey Rabbit A16039 










Table 4.5 Animals used in this chapter  
N.B. Tissue was taken from the same 3 (nestin) GFP animals in sections 4.5.3 and 4.4.4. n numbers represent the total number of slices 
counted/imaged from each spinal cord region, from all animals. * FG-injected.  ** Total slices per antibody (CD24, Gal-3, NKA-α1, Sox2, & Vimentin).




Sections per condition (n) Brain (OB, 
SVZ & SGZ) 






CD24 17 18 - 6-8  
4.5.3.2 Gal-3 14 16 - 6-8 
4.5.3.3 NKA-α1 17 14 - 6-8 
4.5.3.4 Sox2 14 15 - 6-8 
4.5.3.5 Vimentin 14 18 - 6-8 
4.5.4.1 CD63 9 - 6-8 
4.5.4.2 CXCR4 9 - 6-8 
4.5.4.3 FoxJ1 9 - 6-8 
4.5.4.4 Calbindin-D28k 9 - 6-8 
4.5.4.5 GFAP 9 - 6-8 
4.5.5 PKD2L1 9 - 6-8 
4.5.1 (Nestin) GFP* 2 CD31 6 12 6  
4.5.5 
GAD67-GFP 2 
PKD2L1 6 - 6-8 





4.4 Results  
4.4.1 (Nestin) GFP colocalises with markers of pericytes in the 
spinal cord and brain 
(Nestin) GFP expression was present throughout the spinal cord in the white and grey 
matter, intensifying at the central canal (Figure 4.3 A & B). FG labelling colocalised with 
(nestin) GFP in the white and grey matter of the spinal cord (Figure 4.3 B) and brain 
(Figure 4.4) identifying these cells as pericytes (Edwards et al., 2013). As expected, 
these (nestin) GFP pericytes were also found in close apposition to CD31+ve 
endothelial cells (Figure 4.3 Ai). (Nestin) GFP+ve cells were located within the 
hippocampal dentate gyrus (DG) (Figure 4.4 A), as well as the subventricular zone (not 
shown) and glomerular layer (GL) and subependymal layer (SEL) of the olfactory bulb 
(Figure 4.4 B), reflecting nestin expression patterns seen elsewhere (Mignone et al., 
2004; Encinas et al., 2011).  
FG labelling was largely absent from the subgranular zone (SGZ) of the DG, and here 
(nestin) GFP was expressed mainly in neural stem cells (Figure 4.3 A, white dashed 
region). A sub-population of (nestin) GFP+ve cells, located at the central canal of the 








Figure 4.3 (Nestin) GFP labels pericytes and ependymal cells in the spinal cord.  
Representative confocal images of (A) CD31 staining (red) and (B) FG-labelled cells 
(yellow) in the spinal cord of (nestin) GFP mice (green). Scale bars A & B = 200 µm, i = 












Figure 4.4 (Nestin) GFP labels pericytes and neural stem cells in the brain. 
Representative confocal images of (A) FG-labelled cells (yellow) in the subgranular 
zone (SGZ, dashed region) of the dentate gyrus (DG) of (nestin) GFP mice (green). (B) 
(nestin) GFP expression in the olfactory bulb (rotated, coronal plane). White arrows 
denoting the glomerular layer (GL) and subependymal layer (SEL). Scale bars A = 100 
µm, B = 200 µm.  
 
4.4.2 (Nestin) GFP colocalises with antibodies labelling ECs in the 
spinal cord  
(Nestin) GFP+ve cells at the central canal of the spinal cord were not labelled by FG or 





Antibodies used to label ECs include: CD24, galectin-3 (gal-3), NKA-α1, sox2, and 
vimentin. (Nestin) GFP expressing cells at the central canal were immunoreactive 
against all EC markers, confirming their identity as ECs. GAD67-GFP transgenic tissue 
was used to assess whether some of the antibodies labelled ECs and/or CSFcCs at 
the central canal region of the spinal cord. 
4.4.2.1 CD24 
CD24 has been identified as a neural stem cell surface marker (Pruszak et al., 2009; 
Yuan et al., 2011) and has been shown to label ependymal cells in the spinal cord 
(Pfenninger et al., 2011; Alfaro-Cervello et al., 2012b) as well as neuroblasts in the 
subependymal zone of the adult murine brain (Calaora et al., 1996; Belvindrah et al., 
2002). CD24 labelled cells lining the central canal throughout the length of the spinal 
cord (Figure 4.5 & Figure 4.6 A).  
 
Figure 4.5 CD24 labels ependymal cells along the length of the central canal.  
Representative confocal images of saggital central canal CD24 staining (red) and 




On average, cells expressing (nestin) GFP colocalised with over 95% of CD24 labelled 
cells at the central canal (thoracic= 96.6% ±3.92, lumbar= 95.1% ±1.20; N=3 , n=35) 
(Figure 4.6 B & D, white arrows with asterisk indicate non-colocalised CD24+ cell). 
Interestingly, despite being used as an EC marker, CD24 was identified in some 






Figure 4.6 CD24 colocalises with (nestin) GFP ECs and some GAD67-GFP CSFcCs at the central canal.  
Representative confocal images of CD24 labelling (red) in (A) half a spinal cord slice (central canal in dashed box), central canal of (B) (nestin) GFP 
and (C) GAD67-GFP tissue (green). (D) Graph showing the percentage of CD24+ve cells colocalised with (nestin) GFP (data presented as mean 






In the brain, galectin-3 is expressed in activated microglia (Lalancette-Hébert et al., 
2012), neurons (Yoo et al., 2017), and ependymal cells (Comte et al., 2011).  
In all spinal cord sections, 100% of (nestin) GFP+ve cells at the central canal 
colocalised with gal-3 labelling (N=3, n=30) (Figure 4.7 A, B & D). No colocalisation 
was found between gal-3 and GAD67-GFP+ve CSFcCs, indicating that at the central 
canal, this Gal-3 antibody is selective for ependymal cells (Figure 4.7 C). Gal-3 also 




Na+/K+ATPase (NKA) is a transmembrane protein present in excitable cells (Edwards 
et al., 2013; Corns et al., 2015). The catalytic α subunits of NKA (isoforms: α1-4) 
maintain ionic gradients via the exchange of Na+ and K+ ions and in the spinal cord of 
mice the α1 subunit (NKA-α1) is expressed in α-motoneurons, sympathetic 
preganglionic neurons – SPNs, and ECs (Edwards et al., 2013; Corns et al., 2015).  
NKA-α1 staining colocalised with (nestin) GFP+ve cells at the central canal and also 
labelled GFP-negative terminals in the intermediolateral nucleus (IML, Figure 4.8 A & 
Ai). Over 90% of NKA-α1 labelled cells colocalised with (nestin) GFP at the central 
canal (Figure 4.8 B & D) (thoracic= 90.30 ±1.427, lumbar= 94.10 ±1.246; N=3, n=31). A 
few NKA-α1 labelled cells were GFP-negative or had faint GFP fluorescence and so 
were not counted as colocalised (Figure 4.7 B, white arrows).  
A sub-population of CSFcCs were also immunoreactive for NKA-α1 (not shown), 






Figure 4.7 Galectin-3 colocalises with (nestin) GFP ECs and but not GAD67-GFP CSFcCs at the central canal.  
Representative confocal images of Galectin-3 labelling (red) in (A) half a spinal cord slice (central canal in dashed box), central canal of (B) (nestin) 
GFP and (C) GAD67-GFP tissue (green). (D) Graph showing the percentage of Galectin-3+ve cells colocalised with (nestin) GFP (data presented as 





Figure 4.8 NKA-α1 colocalises with (nestin) GFP ECs and some GAD67-GFP CSFcCs at the central canal.  
Representative confocal images of NKA-α1 labelling (red) in (A) half a spinal cord slice (central canal in dashed box), central canal of (B) (nestin) 
GFP and (C) GAD67-GFP tissue (green), (Ai) NKA-α1 labelling of terminal in the IML, (D) Graph showing the percentage of NKA-α1+ve cells 







Sox2 (sex determining region Y-box2) is a transcriptional regulator present in 
pluripotent stem cells (Zhang, 2014; Ogai et al., 2014b). 
Sox2 labelled cells at the central canal and throughout the white and grey matter in the 
spinal cord (Figure 4.9 A). (Nestin) GFP+ve cells at the central canal colocalised with 
over 90% of sox2+ve cells. In thoracic sections, colocalisation rose to 100% (thoracic= 
100.0 ±0.00, lumbar= 91.60 ±1.514; N=3, n=29). 
Additional sox2+ve cells that were GFP-negative were found close to the ependymal 
cell layer in lumbar sections (Figure 4.9 B & D, white arrows). These were identified as 
CSFcCs, with sox2+ve cells colocalising with GAD67-GFP+ve cells (Figure 4.9 C, 
white arrows).  
 
4.4.2.5 Vimentin  
Vimentin is a class III intermediate filament protein found in fibroblasts and blood 
vessel cells, as well as ependymal cells and astrocytes in the adult murine brain 
(Schnitzer et al., 1981).  
Approximately 100% of vimentin labelling colocalised with (nestin) GFP+ve cells at the 
central canal of the spinal cord (thoracic= 99.80± 0.1984, lumbar= 100.3 ± 0.1987; 
N=3, n=32) (Figure 4.10 A, B & D). No colocalisation was found between vimentin and 
GAD67-GFP, indicating vimentin labelling is selective to ependymal cells at the central 








Figure 4.9 Sox2 colocalises with (nestin) GFP ECs and GAD67-GFP CSFcCs at the central canal.   
Representative confocal images of Sox2 labelling (red) in (A) half a spinal cord slice (central canal in dashed box), central canal of (B) (nestin) GFP 
and (C) GAD67-GFP tissue (green). (D) Graph showing the percentage of Sox2+ve cells colocalised with (nestin) GFP (data presented as mean 





Figure 4.10 Vimentin colocalises with (nestin) GFP ECs but not GAD67-GFP CSFcCs at the central canal  
Representative confocal images of vimentin labelling (red) in (A) half a spinal cord slice (central canal in dashed box), central canal of (B) (nestin) 
GFP and (C) GAD67-GFP tissue (green). (D) Graph showing the percentage of vimentin+ve cells colocalised with (nestin) GFP (data presented as 





4.4.3 Other markers of interest 
Other cell markers investigated include: CD63, CXCR4, FoxJ1, Calbindin-D28k, and 
GFAP. CXC chemokine receptor type 4, also known as CXCR4, is expressed in ECs 
(Tysseling et al., 2011; Hugnot and Franzen, 2011) and is the main signalling receptor 
to the chemokine stromal cell-derived factor-1 (SDF-1). Additionally, forkhead box 
protein J1 (foxJ1) is a transcription factor transiently expressed in progenitor cells 
within the spinal cord, and is widely used to label ependymal cells in the spinal cord of 
mice (Jacquet et al., 2009; Li et al., 2016). (Nestin) GFP+ve cells colocalised with 
CXCR4 and foxJ1 labelling at the central canal (Figure 4.11 B and C).  
Additionally, CD63, a marker of exosomes (Kong et al., 2017), appeared to label the 
cell membrane of (nestin) GFP+ve ECs in contact with CSF (Figure 4.11 A). 
CalbindinD-28k also appeared to label ependymal (nestin) GFP+ve cells (Figure 4.12 
D) and fluorescence was most prominent in the cell membrane in dorsal ependymal 
cells. Calbindin-D28k is a calcium binding protein present in the ependymal cells of 
rodents and overexpression of this protein has been shown to promote neuronal 
differentiation and neurite outgrowth in embryonic and adult hippocampal progenitor 






Figure 4.11 (Nestin) GFP colocalises with other antibodies at the central canal. 
Representative confocal images of (A) CD63, (B) CXCR4, (C) and FoxJ1 staining (red) 









Figure 4.12 (Nestin) GFP colocalises with other antibodies at the central canal.  
Representative confocal images of (D) calbindin-D28k and (E) GFAP staining at the 









Anti-GFAP was used to identify reactive glial cells around the central canal. Glial 
fibrillary acidic protein (GFAP) is an intermediate filament found in astrocytes and other 
glial cells within the CNS (Hol and Pekny, 2015). GFAP labelled processes extended 
from/around the central canal, however, it wasn’t clear whether this staining colocalised 
with (nestin) GFP+ve cells. (Figure 4.12 E). These results are similar to those seen 
elsewhere, whereby astrocytic processes are found within the lamina-X and make 
contact with the ependymal layer (Alfaro-Cervello et al., 2012b). However, as GFAP 
does not label the cell body, it was difficult to confidently identify which cells these 
GFAP+ve processes originated from. Ependymal cells are thought to derive from radial 
glia (Doetsch and Alvarez-Buylla, 1996; Filippov et al., 2003), and published RNA seq. 
data shows expression of GFAP in ependymal cells (see Table 4.6). 
 
 
4.4.4 (Nestin) GFP does not label CSFcCs 
Anti-PKD2L1 was used as a marker of cerebrospinal fluid contacting cells (CSFcCs) 
found in the sub-ependymal layer or in close apposition with ECs. No colocalisation of 
PKD2L1 with (nestin) GFP+ve cells was observed, confirming the identity of (nestin) 
GFP+ve cells as ECs at the central canal (Figure 4.13 A). As expected, there was 
colocalisation of PKD2L1+ve cells with GAD67-GFP+ve CSFcCs (Figure 4.13 B). 
Interestingly, published RNA seq. data unexpectedly shows GAD-67 is expressed in 













Figure 4.13 (Nestin) GFP does not label CSFcCs at the central canal 
Representative confocal images of PKD2L1 staining (red) at the central canal of (A) 
















4.4.5 Allen Brain Atlas and RNA sequencing data 
The Allen Brain Atlas (ABA) is a database of gene expression (using RNA in situ 
hybridization localisation) in spinal cord and brain tissue of juvenile and adult mice 
(Allen Institute for Brain Science, n.d.). Table 4.6 presents data from the ABA for each 
gene investigated (where possible), RNA sequencing data from Rosenberg, 2018 
(Rosenberg et al., 2018) (presented as transcripts per million), along with the IF 
presented in this chapter for comparison. It can be seen that ABA and RNA seq. data 
support our IF results in most cases. There are however, a number of contradicting 






Table 4.6 Distinguishing between ECs and CSFcCs at the central canal 
Antibody/gene 
Ependymal cells Cerebrospinal fluid contacting cells 
Immuno. Allen Brain Atlas RNA seq. Immuno. Allen Brain Atlas RNA seq. 
Calbindin-28k/ CALB1 Yes Some, adult 1 N.D Unclear 36.3 
CD24 Yes Juvenile and adult 37.6 Yes Unclear 1 
CD63 Yes Juvenile and adult 22.7 N.D Unclear 1 
CXCR4  Yes N.D 1 No N.D 1 
FoxJ1 Yes N.D 52.9 No N.D 1 
Galectin-3/ LGALS3 Yes Faint 23.1 No Unclear 1 
GFAP Unclear Unclear 120.5 Unclear Unclear 1 
NKA-α1/Atp1a1 Yes Adult 207.7 Some Unclear 132.2 
PKD2L1 No No 1 Yes Juvenile and adult 2424.2 
Sox2 Yes Juvenile and adult 202.1 Yes Unclear 50.0 
Vimentin Yes N.D 97.2 No N.D 1 
Immunofluorescence conclusions from this chapter: yes = antibody colocalisation with (nestin) GFP+ve ECs or GAD67-GFP+ve CSFcCs in 
transgenic tissue. No = no colocalisation. RNA seq data from Rosenberg, 2018 (Rosenberg et al., 2018) values presented as transcripts per million. 







The results presented in this chapter demonstrate that (nestin) GFP expression within 
the SC of these transgenic mice is limited to ECs and pericytes. 
(Nestin) GFP expression in this transgenic line has been shown to be present from 
embryonic day 7, and persist in the progenitor cells of adult mice (Mignone et al., 
2004). Nestin immunoreactivity is typically observed in the cytoplasm of a sub-
population of ECs at the central canal, with nestin-labelled cellular processes extending 
dorsally (and in some cases ventrally) along the midline (Hamilton et al., 2009). In this 
transgenic mouse line, (nestin) GFP is expressed in the cell nucleus as well as the 
cytoplasm. Additionally, due to the half-life of GFP, fluorescence may be detected after 
nestin expression is terminated. This difference in nestin labelling could account for the 
variability in literature with regards to colocalisation of anti-nestin and other stem cell 
markers.  
In this chapter we show labelling of (nestin) GFP+ve ECs with a number of stem cell 
markers. Sox2 labelling in particular indicates the stemness of ECs as this is a critical 
factor for directing neural differentiation and stem cell maintenance (Ogai et al., 
2014c)(Zhang, 2014). FoxJ1 has been shown to be essential for EC development and 
transgenic mice under the regulation of the foxJ1 promoter are routinely used to label 
and track ECs (Jacquet et al., 2009; Li et al., 2016; Muthusamy et al., 2018). FoxJ1 has 
also been implicated in stem cell potential maintenance and cell fate determination (Li 
et al., 2018), further supporting the notion that ECs are stem cells.  
Additionally, CD24 is a glycosylphosphatidylinositol-anchored membrane glycoprotein 
expressed in cells of the developing mouse brain as well as in zones of secondary 
neurogenesis in adult mice (Calaora et al., 1996). CD24 has also been shown to 
regulate cell proliferation and differentiation in regions of adult neurogenesis in vitro 





shown to generate primary neurospheres, although these cells didn’t yield secondary 
spheres (Coskun et al., 2008).  
NKA-α1 aids in the maintenance of cell resting potential, and so could play a role in the 
hyperpolarisation of ECs associated with cell division (Corns et al., 2013). ECs are 
depolarised by GABA (Corns et al., 2013) and acetylcholine (Corns et al., 2015) and 
research has shown potentiation of EC proliferation by the α7 containing nicotinic 
acetylcholine receptor modulator PNU-120596 (Corns et al., 2015) indicating a 
potential route for manipulating EC behaviour. 
In addition to these stem cell markers, we show that ECs possess proteins involved in 
the regulation of the neurogenic niche more broadly. CD24 is thought to be involved in 
cell-cell and cell-matrix interactions (via P-selectin (Aigner et al., 1997; Nieoullon et al., 
2005) and L1CAM (Kleene et al., 2001) binding), and act as a neurite growth inhibitor 
(Shewan et al., 1996) and vimentin is also implicated in neurite formation and is 
expressed in neurons during axonal regeneration (Cochard and Paulin, 1984; Shea et 
al., 1993). Together, this indicates ECs may play a role in the regulation of neurite 
outgrowth, and the manipulation of ECs following injury could help regulate functional 
repair. 
4.5.1 Do ECs sense their environment? 
How ependymal cells exert their impact on the neurogenic niche is currently unknown. 
One potential avenue is via the release of molecules following an injury stimulus. For 
example, we have shown that ECs may release exosomes (due to the presence of the 
exosomal marker CD63) and exosomes from the CSF of rats following spinal cord 
injury have previously been linked to neuron proliferation (Kong et al., 2017). It is 
therefore possible that ECs “sense” changes in the spinal cord and CSF, and react by 
releasing cytokines or other molecules via exosomes to manipulate cell behaviour post 





aquaporin-4, which is involved in trans-ependymal CSF flow and reabsorption, 
supporting this hypothesis (Halsey et al., 2018).  
In addition to the role CD63 plays in membrane protein trafficking, it is also implicated 
in the regulation of leukocyte recruitment (Doyle et al., 2011), cell adhesion and 
migration (Koyama et al., 1998), and the activation of cellular signalling cascades 
(Tugues et al., 2013).  
Additionally, foxJ1 has been shown to regulate ciliogenesis during development 
(Aamar and Dawid, 2008); these cilia are involved in sonic hedgehog (Shh) signalling 
and postnatal neurogenesis in the hippocampus (Breunig et al., 2008; Spassky et al., 
2008; Han et al., 2008). Elsewhere in the body, cilia are thought to have a 
mechanosensory role (Nauli et al., 2013), however, it is unclear whether this is the 
case for neuronal and ependymal cilia within the CNS (Fuchs and Schwark, 2004). 
4.5.2 Potential targets for the manipulation of ECs 
CXCR4/SDF-1 is thought to direct the migration of ECs in the spinal cord and brain 
following injury (Itoh et al., 2009; Jaerve et al., 2011; Tysseling et al., 2011). Therefore, 
this regulatory mechanism could hold the key to successful EC manipulation following 
injury (discussed further in chapter 5). 
Gal-3 is implicated in cell migration from the SVZ to the OB (Comte et al., 2011) and it 
is thought that Gal-3 regulates neuroblast migration via cell-ECM adhesion, the 
formation of astrocytic glial tubes, and CSF-flow (as a result of ependymal cell cilia 
beating) (Sawamoto et al., 2006). In gal-3-depleted mice, EC cilia and SVZ astrocytic 
glial tubes were disrupted, and as a result, fewer newly born neurons were detected 
migrating from the SVZ to the OB (Comte et al., 2011). Interestingly, following spinal 
cord injury, gal-3-depleted mice showed improved functional recovery, tissue 
preservation, and an increase in the number of neutrophils compared to control WT 





potential manipulation of ECs using laminin-functionalised tissue engineering strategies 
for injury repair. 
4.5.3 Distinguishing between ECs, CSFcCs, and pericytes 
This chapter has also shown that at the central canal, (nestin) GFP is specific to ECs 
and does not label CSFcCs. Some antibodies (CD24, NKA-α1, and sox2) labelled both 
ECs and CSFcCs at the central canal, whereas gal-3 and vimentin labelled only ECs.  
Interestingly, some GAD67-GFP CSFcCs were immunoreactive against CD24. It is 
possible this change in staining is due to the use of T20 for cell permeabilisation as 
opposed to PBST and antigen retrieval used previously (Corns 2015); highlighting the 
need to consider fixation and permeabilisation protocols in IF for cell characterisation. 
RNA seq. data (Table 4.6) did not show CD24 expression in CSFcCs and so perhaps 
only a subset are CD24+ve, with further clarification required. 
NKA-α1 also colocalised with a subpopulation of CSFcCs and this observation was 
supported by RNA seq. data (Table 4.6). Previously, CD24 and NKA-α1 have been 
used as EC markers, implying proliferation of ECs due to colocalisation with EdU 
(Corns et al., 2015). However, this may not be the case and these cells may actually 
have been CSFcCs, emphasising the importance of this transgenic line for the 
assessment of EC behaviour, as (nestin) GFP only labels ependymal cells at the 
central canal.  
This chapter also demonstrated sox2 labelling of some CSFcCs. Typically sox2 is 
downregulated upon differentiation (Bylund et al., 2003), however colocalisation of 
sox2 and PKD2L1 has been seen previously (Petracca et al., 2016) and sox2 
expression in CSFcCs was demonstrated by (Rosenberg et al., 2018). If CSFcCs retain 






Increasing evidence has shown that pericytes are also multipotent (Dore-Duffy et al., 
2006). Following stroke, isolated pericytes have been shown to express nestin and 
sox2 (amongst other markers) and generate neural and vascular cells in vitro 
(Nakagomi et al., 2015). This chapter has demonstrated the potential of using this 
(nestin) GFP transgenic line in combination with FG for the identification of pericytes. 
Flow cytometry using (nestin) GFP with FG and/or a pericyte-specific antibody (e.g. 
PDGF-β) could be used for the isolation and exclusion of pericytes, thereby allowing 
EC isolation. This would be useful for EC implantation as it would remove the 
requirement of EC antibody labelling (and the blocking of critical cell proteins) prior to 
implantation or the assessment of EC behaviour. 
 
4.6  Conclusions  
The experiments carried out in this chapter show: 
1. (Nestin) GFP labels ECs and pericytes throughout the spinal cord and brain. 
 At the central canal, (nestin) GFP is specific to ECs and does not label CSFcCs. 
 Some antibodies (CD24, NKA-α1, and sox2) label both ECs and CSFcCs at the 
central canal. 
 Galectin-3 and vimentin label only ependymal cells at the central canal. 
2. ECs express CXCR4 and galectin-3 which could be used for the manipulation of 
endogenous cells. 
Together, these data suggest that this transgenic line is suitable for studying the 
response of ECs to biomaterials. This transgenic line will therefore be used in chapter 5 
for culture method optimisation and together with the hydrogels developed in chapter 3, 




Chapter 5 -  Optimising Organotypic Spinal Cord Slice Cultures  
 
5.1 Introduction 
Organotypic slice culture models provide the opportunity to study cellular behaviour in 
a context more representative of the in vivo environment compared to approaches such 
as dissociated cell culture. Stoppini et al., 1991 first introduced the membrane-interface 
culture method whereby the tissue slices are maintained at the interface between 
culture medium and air. The retention of the native tissue cytoarchitecture ex vivo also 
enables cell-cell and cell-matrix interactions to be studied in response to experimental 
manipulation over several days or weeks. 
A number of organotypic spinal cord slice culture (OSCSC) models have been 
developed to study cellular response to mechanical insult. Spinal cord 
contusion/compression has been recapitulated using a weight-drop injury model 
(Krassioukov et al., 2002; Pandamooz et al., 2019). Stab and transection injury models 
have also been utilised within OSCSCs (Patar et al., 2019). 
OSCSCs enable multiple conditions to be tested from the same animal, therefore 
limiting the number of animals required for screening different hydrogels. Parameters 
investigated in response to hydrogels include: motorneuron survival, astrocyte 
morphology, microglial activation, and axonal growth (Bonnici and Kapfhammer, 2008; 
Schizas, Rojas, Kootala, Andersson, Pettersson, Hilborn and Nils P. Hailer, 2014). In 
particular, manipulation of OSCSC EC proliferation and migration using hydrogels 
and/or chemokines could provide insight into potential regeneration strategies, prior to 





5.1.1 Identifying proliferating cells 
A number of methods can be used to detect DNA synthesis and cell proliferation. 
Measuring the metabolic activity of cells using tetrazolium salts (e.g. 2-(4,5-Dimethyl-2-
thiazolyl)-3,5-diphenyl-2H-tetrazolium bromide (MTT), 2,3-Bis-(2-Methoxy-4-Nitro-5-
Sulfophenyl)-2H-Tetrazolium-5-Carboxanilide (XTT), and water-soluble tetrazolium 
salt-1 (WST-1)) can give an indication of the number of viable cells. Respiring cells 
convert these salts into dyes that can be quantified using a spectrophotometer, 
however, these metabolic assays may not accurately represent changes in cell 
proliferation. Immunohistochemical detection of antigens expressed in proliferating 
cells (e.g. proliferating cell nuclear antigen (PCNA), Ki67, and minichromosome 
maintenance (MCM) proteins) can also be used to study cell proliferation. Whilst these 
proliferation markers are commonly used as an indication of cell proliferation and 
therefore as diagnostic and prognostic factors for breast carcinoma, the scoring of the 
results is highly subjective and time consuming (Juríková et al., 2016).  
DNA synthesis can be monitored by incorporation and subsequent detection of a 
thymidine analogue in dividing cells. Two synthetic analogues used for this purpose 
include: bromodeoxyuridine (BrdU) and 5-ethynyl-2’deoxyuridine (EdU). These are 
incorporated into dividing cells during G1, S, and G2/M-phases (Buck et al., 2008) 
(Figure 5.1 A). BrdU detection requires DNA denaturation via hydrolysis using 
hydrochloric acid or heating (which can destroy antigens, hindering co-staining) (Zeng 
et al., 2010), whereas EdU can be detected using a click reaction without the need for 
such harsh staining conditions. Therefore, EdU incorporation was chosen for the 
detection of proliferating cells in experiments throughout this thesis. 
In the case of EdU detection, Cu(II) is first reduced to Cu(I) by ascorbic acid (Figure 5.1 
C) and Cu(I) then catalyses the azide-alkyne cycloaddition (CuAAC) of the biotinylated 
azide and the alkyne present on the EdU moiety (Figure 5.1 B). A streptavidin-




render the cell nucleus fluorescent (Figure 5.1 D). Fluorophores can also be directly 
conjugated to the azide (not shown). 
As Cu(II) is used for the catalysis of EdU detection, any fluorescence present in the 
tissue is quenched and requires detecting with antibodies against the fluorophore 
(Bálint et al., 2013). In the case of GFP-transgenic tissue, this quenching mechanism is 
thought to be a result of Förster resonance energy transfer (FRET) from GFP to Cu(II) 
(Hötzer et al., 2011). The fluorescence decay time (τ fl) of GFP is Cu(II)-concentration 
dependent, exhibiting “titration behaviour” and therefore by lowering the Cu(II) 
concentration, quenching should be reduced, enabling GFP fluorescence retention.  
Although the fluorophore can be re-detected using an antibody following EdU 
detection, this requires additional incubation washes and therefore increases the 
background fluorescence and tissue fragility. Furthermore, this also limits other 
antibody labelling and the order of tissue staining. As GFP expressing animal and cell 
lines are such a critical tool in the study of stem cells within the spinal cord, the 


















Figure 5.1 EdU detection method schematic.  
The thymidine analogue, 5-Ethynyl-2´-deoxyuridine (EdU) is administered to animals via  I.P. injection or into culture medium, and this is 
incorporated into the DNA of cells undergoing division (at the S-phase) (A). EdU is then detected using a copper catalysed azide-alkyne 
cycloaddition (CuAAC) (B). Cu(II) is reduced to Cu(I) by ascorbic acid (side reaction, C), and this is able to catalyse the cycloaddition of 
the biotinylated azide with the alkyne present on the EdU moiety. Streptavidin (SA)-conjugated Alexa Fluor is used to bind to biotin (black 




5.1.2 Aims  
The experiments in this chapter build on the characterisation work carried out in 
chapter 4; using the nestin transgenic line to optimise and develop methods for use in 
chapter 6 (Figure 5.2).  
 
Figure 5.2 Schematic depicting the aims of chapter 5 in relation to the rest of this 
thesis.  
In particular this chapter uses the transgenic line characterised in chapter 4 in order to 
optimise methods for use in chapter 6. 
 
 
1. To develop a method for detecting EdU-labelled cells in (nestin) GFP 
fluorescent tissue. 
Copper-chelating azides (e.g. picolyl azide) raise the effective concentration of Cu(I) by 




resulting in enhanced reaction kinetics of azide-alkyne cycloadditions (Uttamapinant et 
al., 2012). Therefore, this chapter aimed to use picolyl azide to develop an optimised 
method for the detection of EdU incorporated into cells, whilst maintaining GFP 
fluorescence in transgenic tissue. 
 
Figure 5.3 Chelation-assisted copper catalysed azide-alkyne cycloaddition for 
the improved detection of EdU.  
The reaction of biotin picolyl azide and the alkyne presented on EdU proceeds via an 
active complex around Cu(I) [A]. The chelating picolyl azide raises the effective 
concentration of the Cu(I) catalyst at the reaction site. In turn this allows for a reduction 
in the Cu(I) concentration. R1 = rest of the biotin picolyl azide structure. R2 = rest of the 




2. To determine optimal culture conditions. 
We plan to use the organotypic spinal cord slice culture model to assess the impact of 
hydrogels and SDF-1α delivery on EC behaviour. In order to do so, and to compare to 
a reliable control, the conditions for culture required optimising. This chapter aimed to 
determine the optimal EdU concentration and length of time in culture for monitoring 









5.2.1 Animals used 
All experiments were carried out under a UK Home Office Licence (P1D7A177), in 
accordance with the UK Animals (Scientific Procedures) Act 1986 and the ethical 
standards set out by the University of Leeds Ethical Review Committee. Every effort 
was made to minimise the number of animals used and their suffering.  
(Nestin) GFP transgenic mice were bred in-house as heterozygotes, housed in 
standard conditions with a 12 hour light-dark cycle, and given ad libitum access to food 
and water. Wild-type (WT) C56BL/6 animals were purchased from Central Biomedical 
Services (University of Leeds). 
5.2.2 Organotypic spinal cord slice culture 
The laminar flow hood, incubator, and surrounding surfaces were disinfected using 1% 
(w/v) Virkon followed by 70% (v/v) ethanol prior to use. All tools for in vitro and in vivo 
work were cleaned with boiling water, 70% (v/v) ethanol, then autoclaved at 121 °C for 
20 minutes under 103 kPa for sterilisation. Where possible, sterile, single use 
consumables were used and disinfected with 1% Virkon following their use, prior to 
disposal.  
5.2.2.1 Anaesthesia, perfusion, and dissection 
Animals were anaesthetised by intraperitoneal (I.P.) injection of sodium pentobarbital 
(60 mg/kg, See general methods, Table 2.6). Sufficient anaesthesia was identified with 
the abolishment of pedal and corneal reflexes. A transverse laparotomy was created 
using spring scissors, the diaphragm was perforated, and the ventral ribcage was 
removed.  The left atrium was cut and the animal was perfused transcardially through 
the left ventricle using 20 mL ice cold oxygenated (95% O2, 5% CO2) sucrose artificial 
cerebrospinal fluid (SaCSF, See general methods, Table 2.5). Death was confirmed via 




vertebrae, fine spring scissors were used to remove the dorsal lamina. The spinal cord 
was then carefully removed and placed in a petri dish containing oxygenated ice cold 
SaCSF. The meninges were then removed using fine forceps with the aid of a 
dissection microscope. Thoracic and lumbar spinal sections were used for sectioning.  
5.2.2.2 Slice preparation  
Tissue was embedded in 3% agar and glued to the chuck with an additional agar block 
behind for support. The chuck was secured in place in the water bath containing ice 
cold oxygenated SaCSF and tissue was sectioned at 300 μm in the transverse plane 
using a vibratome with a ceramic blade. A vibration frequency of 108 Hz was used with 
0.8 mm amplitude and 0.5 mm/s speed. Slices were transferred into ice cold dissection 
medium, Dulbecco’s modified eagles medium (DMEM, See general methods, Table 
2.7), using a spatula and paint brush. 
5.2.2.3 Maintenance of tissue slices 
All further work was carried out aseptically in a laminar flow hood. Culture medium was 
equilibrated at 37°C prior to slice addition. 1 mL culture medium containing serum was 
added below the insert. Slices within the dissection medium were transferred carefully 
into a sterile petri dish and 3 to 6 slices were transferred onto each filter insert or gel 
(placed on top of filter insert) using a P1000 Gilson pipette with the tip cut off to 
minimise damage to the slice. Excess medium was removed around each slice using a 
sterile P100 pipette. Plates were cultured in an incubator at 37 °C in a 5% CO2 
enriched environment. Following 1 day in vitro (DIV), the medium was exchanged for 
serum free medium (See general methods, Table 2.7) (Figure 5.4). Medium was then 







5.2.2.4 EdU addition 
Following 2 DIV (unless specified otherwise, Figure 5.4), EdU was added to the culture 
medium at a final concentration of 1 μM (unless specified otherwise) allowing for the 
visualisation of cells that have undergone proliferation with EdU present. 
 
Figure 5.4 Organotypic spinal cord slice culture method.  
(A) 300 µm transverse sections cut from agar-embedded spinal cord and (B) 
transferred onto hydrogels on porous culture inserts, or directly onto the inserts. (C) 
Culture medium with serum added below the insert and incubated at 37 °C for 24 h. (D) 
Schematic diagram depicting culture timeline: medium was changed to serum free 
following 1 day in vitro (DIV), and EdU was added to the medium after 2 DIV (*unless 
stated otherwise) prior to fixation and EdU detection.  
 
5.2.2.5 Fixation 
Spinal cord slices were fixed in situ on tissue culture inserts using 4% 
paraformaldehyde (PFA, See general methods, Table 2.7) for 1-2 hours at RT. 







5.2.3 EdU detection  
EdU detection reactions and incubation steps (control method detailed in Figure 5.5) 
were carried out at RT in the dark (See general methods, Table 2.4 for buffer solution 
compositions). Permeabilisation was carried out with either PBST or T20 depending on 
the requirements of any antibodies to be used (see antibody table). 
 
Figure 5.5 EdU detection protocol for fixed tissue slices & cultured slices 






5.2.3.1 Perfusion-fixed tissue 
In order to optimise the EdU detection method in perfusion-fixed tissue, firstly, three 
(nestin) GFP transgenic animals were given EdU in their drinking water at a final 
concentration of 0.793 mM (0.2 mg/mL), and their water bottle was protected from light 
using black tape. EdU was administered via the drinking water in order to minimise the 
distress caused to the animals by repeated injections. Drinking water (with EdU) was 
refreshed daily for three days prior to perfusion-fixation of the animal. As we couldn’t 
control or guarantee equal water consumption between each animal, slices from each 
animal were used for all reaction conditions detailed below. 
5.2.3.2 Fixation and tissue processing 
Mice were terminally anaesthetised with sodium pentobarbital (60 mg/kg) I.P. and 
perfused transcardially with 0.1 M PB to remove blood, then 4% PFA for fixation. The 
spinal cord and brain were removed and post fixed overnight at 4 °C in 4% PFA, before 
being stored in 0.1 M PB at 4 °C. The pia mater was removed using fine forceps and a 
dissection microscope. Sections of spinal cord were glued to the chuck and this was 
then screwed into place in the water bath containing 0.1 M PB and the blade was 
attached to the vibratome arm. The tissue was then sectioned serially at 40 µm in the 
transverse plane at an amplitude of 0.4 mm/s and vibrating frequency of 80 Hz. 
Sections were placed into wells containing PBS for EdU labelling. 
5.2.4 Optimising EdU detection reaction conditions  
5.2.4.1 Perfusion-fixed tissue 
A number of reaction conditions (Table 5.1) were trialled using picolyl azide in order to 
determine the optimal conditions for detecting EdU in tissue with fluorescence. The 
Cu(II)SO4 concentration was reduced from 1 to 0.01 mM (final concentration) and 
different reaction lengths were investigated. The original method using a non-




Table 5.1 Conditions used to optimise EdU detection method in fixed tissue 
  Time /minutes 
 [Cu(II)SO4] 
/mM 
5 10 30 60 90 120 





1 x x x    
0.5  x x x  x 
0.25  x x x  x 
0.1   x x x x 
0.01   x x x x 
x denotes conditions trialled. n=18 slices per condition, N=3. 
 
 
5.2.4.2 Cultured tissue 
Spinal cord slices were cultured for 2 DIV with EdU added for the final 24 h prior to 
fixation. Sections were then randomised, and EdU detection performed (Table 5.2). 
Table 5.2 Conditions used to optimise EdU detection method in fixed, cultured 
slices 
                 Time /minutes 
 [Cu(II)SO4] 
/mM 
5 10 20 30 45 




1 x   x  
0.5 x x x x  
0.1    x x 
x denotes conditions trialled. n=6 slices per condition, N=3. 
 
5.2.5 Immunofluorescence 
Immunofluorescence was carried out on fixed cultured slices using the method 
previously described (Chapter 4.3.4). Antibodies used to characterise (nestin) GFP 
cellular processes include: CD24, Gal-3, and neural/glial antigen2 (NG2 –also called 




processes included ependymal cells originating from the central canal and NG2 was 
used to identify pericytes (Table 5.3). 
 
Table 5.3 Antibodies used for the labelling of cultured spinal cord slices 
Target Raised in Dilution Labels  
Source  
& Cat. No 
CD24* Mouse 1:100 ECs (Pruszak et al., 2009; 
Pfenninger et al., 2011) 
Miltenyi Biotec 
130-110-686 
Gal-3* Goat 1:1000 
 
ECs (Comte et al., 2011; Yoo 
et al., 2017) 
R&D systems 
AF1197 




*detected using biotinylated secondary antibody and Streptavidin AlexaFluor555. 
 
5.2.6 Image capture and analysis 
Manual cell counts of EdU-labelled (EdU+ve) cells at the central canal were performed 
using a Nikon E600 microscope. Images of whole slices were taken using an EVOS 
fluorescent microscope at x4, x10, and x20 magnification for further quantification.  
5.2.6.1 EdU labelled cell quantification 
Using ImageJ, images were converted to binary 16 bit and cropped to remove scale 
bars where applicable. Background fluorescence was removed using the “remove 
background” tool, and a threshold was applied. The “watershed” tool was applied in 
order to split any overlapping cells that had been incorrectly identified as a single 
particle. The “analyse particles” tool was then used to create a total count of all 
EdU+ve cells (Figure 5.6). 
For analysis using quadrants, a line was drawn through the thresholded image along 
the mid-line, centring the line at the central canal. Five concentric circles were then 
drawn (centred at the central canal) and each was split into four quadrants using a 
macro written by Olivier Burri (Burri, 2016). The percentage area (% area of pixels 
highlighted using threshold limits) for each region of interest (ROI) was then calculated. 




area as a function of radial distance from the central canal (1= central canal region, 5 = 
periphery of slice, Figure 5.6).  
5.2.7 Data analysis 
Data were collated in Microsoft Excel and analysed using IBM SPSS statistics 21. 
Average EdU+ve cell counts were calculated and presented as mean ±SE unless 
stated otherwise. Shapiro-Wilk and Levine’s tests were applied for distribution and 
equality of variance analysis respectively. A decision tree was used to determine the 






Figure 5.6 Image analysis using ImageJ.   
(A) Representative EVOS image of whole cultured spinal cord slice with EdU labelling. 
(B) Fluorescent images were converted to 16-bit binary, the background was 
subtracted, the fluorescence was thresholded, and a macro was run to create 
quadrants and concentric circles, centred at the central canal. % area was calculated 
for each quadrant and averaged for regions 1 to 5. (C) EdU+ve cells were then counted 
































Table 5.4 Animals used in this chapter for method optimisation  




5.3.1 EdU detection optimisation (Nestin) GFP** 3 18 6-8 weeks 
5.3.2 EdU detection optimisation (Nestin) GFP 3 6 14 ±2 days 
5.3.3 Nestin-GFP expression (Nestin) GFP 9 >3 14 ±4 days 
5.3.4 Proliferation over time (Nestin) GFP 2 >3 12 days 
5.5.5 EdU availability - length of time in culture  
                          - uptake 
(Nestin) GFP 1 >3 18 days 
5.5.6 EdU concentration and length of time (Nestin) GFP 3 >3 15 days 
5.5.7 Delayed EdU addition (Nestin) GFP 1 >2 14 days 
5.5.8 Injury model - following 2 DIV, EdU 6 hours (Nestin) GFP 2 >3 14 days 
5.5.8 Injury model - 5 DIV, EdU 18 hours (Nestin) GFP 2 >3 14 days 
5.5.8 Injury model - 3 DIV, EdU 48 hours (Nestin) GFP 1 >2 13 days 




5.3 Results  
5.3.1 EdU can be detected in perfusion-fixed spinal cord tissue 
whilst maintaining GFP fluorescence  
Out of the 25 combinations of conditions trialled, an optimal reaction length and Cu(II) 
concentration was found when using biotin picolyl azide. Using 1 mM CuSO4 and 
reducing the reaction time to 5 minutes resulted in GFP retention and EdU detection 
comparable with control staining (1 mM, 30 mins) (Table 5.5, Figure 5.7). This protocol 
was therefore used for EdU detection in perfusion-fixed tissue. 
 
Table 5.5 Optimised EdU detection in fixed tissue 




5 10 30 60 90 120 
Biotin azide 1 1 1 1 1 0 3 0 3 0 3 0 0 
Biotin picolyl 
azide 
1 2 3 1 3 0 3       
0.5   0 2 0 3 0 3   0 3 
0.25   2 0 1 1 0 3   0  
0.1     1 0 1 1 0 0 0 1 
0.01     3 1 3 1 2 0 2 0 
Staining code: 0 = none, 1 = faint, 2 = good, 3 = best (comparable to control). Green = 





Figure 5.7 EdU detection in nestin-GFP perfusion-fixed tissue using picolyl azide.  
Representative confocal images showing EdU detected cells (red), nestin-GFP+ve 
cells (green), and a merged image with DAPI as a cell nuclei counter stain (blue). (A) 5 
minutes click reaction with 1 mM Cu(II) results in good EdU staining and GFP retention 
allowing for colocalisation counts to be made (white arrows). (B) 30 minutes reaction 
with 1 mM Cu(II) gives good EdU staining, however GFP fluorescence is quenched and 
appears faint (white arrows). (C) Control nestin-GFP (no EdU detection) for reference. 






5.3.2 EdU can be detected in cultured spinal cord slices whilst 
maintaining (nestin) GFP fluorescence  
Out of the 9 combinations of conditions trialled in cultured tissue, an optimal reaction 
length and Cu(II) concentration was found. Using a reduced copper concentration (0.5 
mM), and reducing the reaction time to 20 minutes resulted in (nestin) GFP retention, 
and EdU detection comparable with control staining (Table 5.6, image not shown). This 
protocol was used for subsequent EdU detection in cultured tissue slices. 
 





5 10 20 30 45 




1 2 3*     1 3*   
0.5 2 3 2 2 3 3 2 3   
0.1       2 2 1 2 
Staining code: 0 = none, 1 = faint, 2 = good, 3 = best (comparable to control). Green = 






5.3.3 (Nestin) GFP fluorescence expression and distribution ex-vivo 
(Nestin) GFP expression in the white and grey matter of cultured spinal cord slices 
reduced over 3 days in culture (Figure 5.8, radial segments 2 to 4). Whereas, central 
canal (nestin) GFP fluorescence remained clearly visible over this time-period, 
indicating viability of ependymal cells ex vivo (Figure 5.8 B).  
 
Figure 5.8 (Nestin) GFP expression in cultured spinal cord slices from 0 to 3 days 
in vitro. 
(A) (Nestin) GFP mean area % coverage as a function of radial distance from the 
central canal. Data presented as mean ±SE. N=9, n>3. (B) Representative EVOS 
images of half a cultured spinal cord slice at day 0 to day 3. Scale bar = 100 µm. 
 
  






5.3.4 Cell proliferation over time in OSCSCs 
1 µM EdU was added to the culture medium on either the day of plating (day 0) or day 
1 to day 4 and slices were left for 24 h (from EdU addition) prior to fixation and EdU 
detection (see Figure 5.9 A). 
A peak in the number of EdU+ve cells was observed at d4 for the central canal (11.12 
±1.197) and d3 for the total slice (2360 ±292.0), followed by a decline on day 5 (CC= 
3.333 ±1.856, total= 1625 ±289.3; Figure 5.9 B & C).  No significant differences were 
found between EdU+ve cell counts at the central canal, however, there were 
significantly fewer total EdU+ve cells in slices in which EdU had been added on day 0 
and fixed on day 1, compared to all other time points (d1= 318.3 ±41.53; P = 0.003 to 
0.047). The distribution of EdU+ve cells across the spinal cord slice remained similar 
for slices fixed on days 2 to 5, with the majority of EdU+ve cells in the white matter 
(WM) (Figure 5.9 D radial segment 4). Additionally, there were a number of slices with 






Figure 5.9 EdU+ve cell counts over time and EdU+ve cell distribution throughout 
the slice.  
(A) Schematic diagram depicting EdU addition. (B) Central canal and (C) total EdU+ve 
cell count per 300 µm slice. (D) EdU mean area % coverage as a function of radial 








5.3.5 EdU incorporation and availability in OSCSCs 
To further investigate EdU uptake by dividing cells, and to assess the availability (and 
remaining concentration) of EdU in the culture medium over time, EdU (1 µM) was 
added following 2 DIV (on day 2) and slices were fixed on days 3, 4, and 5 (Figure 5.10 
A). From the previous trend in EdU cell counts, we should expect a doubling of the 
number of EdU+ve cells for every 24 h in culture until day 5. No significant difference 
was found between the mean number of EdU+ve cells in slices cultured for 24 h (1053 
±155.0), 48 h (1166 ±98.51), or 72 h (1445 ±226.3) in the presence of EdU (Figure 






Figure 5.10 Effect of length of time EdU is in culture on EdU+ve cell count 
(A) Schematic diagram depicting EdU addition. (B) Total EdU+ve cell count after 24, 
48, and 72 hours in vivo in the presence of EdU. Data presented as mean total EdU+ve 





Subsequent experiments sought to determine if EdU remained intact in culture medium 
after 24 and 48 h. Culture medium (and any remaining EdU in solution) from the 24 and 
48 h conditions was then transferred to wells containing slices from the same animal 
(that had not yet had any EdU added), and cultured for a further 24 hours (“1 µM 
transferred”). This was to see if any EdU was present in the medium after these time 
points, and if so, how many cells incorporated this EdU compared to slices that had 
fresh 1 µM EdU added at the same time point (“1 µM control”) (Figure 5.10 C).  
The mean total number of EdU+ve cells in the 1 µM control and 1 µM transferred 
conditions were not significantly different when EdU was transferred/added on day 3 
(following 24 h in donor well) (Figure 5.11 A, control= 1656 ±219.3, transferred= 1469 
±190.3) indicating the concentration of EdU in culture medium was in excess (more 
EdU in culture medium than the number of dividing cells) and that EdU remained intact 
in culture conditions. 
As EdU was found to be in excess, the number of EdU+ve cells detected after 48 hours 
in vitro should equal the sum of the number of EdU+ve cells detected after the first 24 
hours in the donor condition, plus the number of EdU+ve cells in the transferred 
condition (when transferred on day 3) or the number of EdU+ve cells in the control 24 h 
condition. However, we found that the sum of these cell counts (1053 EdU+ve cells + 
1469 EdU+ve cells) was more than double the value found after 48 h (1166 EdU+ve 
cells). These data suggest that some of the cells that incorporated EdU in the first 24 
hours of incubation with EdU died or stopped proliferating further in the following 24 
hours before detection at 48 h.  
Following 48 h in a donor well, the mean total number of EdU+ve cells in the 1 µM 
transferred condition was significantly lower than in the control condition (Figure 5.11 
B, 1 µM control = 1805 ±217.7, 1 µM transferred= 599.4 ±122.5, P = 0.007). An 
additional control well of slices was cultured in the presence of 0.5 µM EdU (“0.5 µM 




into cells) in the transferred medium. The number of EdU+ve cells in the transferred 
condition was not significantly different to the 0.5 µM control, suggesting that the 
available concentration of EdU had indeed decreased after 48 h in culture (0.5 µM 
control= 1385 ±316.8, P = 0.06).  
These data indicate there is a significant reduction in the availability (concentration) of 
EdU following 48 hours in vitro, and suggests that death of proliferating cells or 
cessation of proliferation in cells that have incorporated EdU occurs. 
 
 
Figure 5.11 Uptake of EdU in cultured spinal cord slices.  
Amount of EdU in culture medium, as measured by total EdU+ve cell count following 
transferral into new well on (A) d3 – 24 h in donor well or (B) d4 – 48 h in donor well. 
Data presented as mean total EdU+ve cell count ±SE (N=1, n>4). ** P ≤ 0.01. (C) 
Schematic diagrams depicting EdU addition. Dashed bar corresponds to EdU being in 





5.3.6 Effect of EdU concentration and length in culture 
Spinal cord slices were cultured in the presence of 0.1, 0.5, or 1 µM EdU for 24 or 48 
hours in order to determine optimal culture conditions and investigate the behaviour of 
proliferating cells further (Figure 5.12 A). Reduced EdU concentrations were used to 
determine if the potential toxicity of EdU was causing cell death over this time period. 
No significant differences were found between the mean EdU+ve cell counts at the two 
time points when counted at the central canal or total slice, for any of the EdU 
concentrations investigated (Figure 5.12 B). However, the average number of EdU+ve 
cells detected in slices cultured in the presence of 1 µM EdU for 24 or 48 hours was 
significantly greater than in the 0.1 µM condition (24 h: 0.1 µM= 179 ±38.41, 1 µM= 
407.1 ±48.09, P = 0.0140; 48 h: 0.1 µM= 181.7 ±31.04, 1 µM= 412.1 ±55.34, P = 
0.0261), indicating EdU concentration is an important and limiting factor.  
This finding supports the previous data, indicating death of proliferating cells over this 
time period as the number of detected proliferating cells remained constant over 24 
and 48 hours as previously seen. Additionally, there was no change in the number of 
EdU+ve cells detected when using 0.5 µM compared to 1 µM control, and so the 
concentration of EdU over this time period isn’t thought to be toxic. Therefore, 1 µM 
EdU was chosen for experiments assessing the impact of hydrogels on proliferation. 
The distribution of proliferating cells also appeared similar over these time points 
(Figure 5.12 D). In all conditions, proliferating cells were detected at the central canal 
and within the white matter, whereas the grey matter was seen to be largely devoid of 
EdU+ve cells. This distribution pattern was more pronounced at greater EdU 
concentrations. EdU+ve cell chains were also found to extend radially into the grey 
matter at 24 h (not shown) and 48 h post EdU addition in slices with 0.5 and 1 µM EdU 










Figure 5.12 Effect of EdU concentration and length in culture on total and central 
canal EdU+ cell count and EdU distribution.  
(A) Schematic diagram depicting EdU addition. (B) Central canal and (C) total EdU+ 
cell count per 300 µm slice. (D) EdU mean area % coverage as a function of radial 
distance from the central canal. Data presented as mean ±SE. N=3 n>3, * P ≤ 0.05. (E) 
Representative EVOS image of spinal cord slice with EdU-labelled cells following 48 h 
incubation with 1 µM EdU and (Ei) enlarged image of central canal EdU+ve cell chains. 




5.3.7 Effect of delaying EdU addition 
To investigate the potential benefits of delaying EdU addition until after the initial peak 
in proliferation (injury response, day 3 to 4), slices were cultured in the presence of 
EdU over a number of time periods following addition on day 2 (control) or day 4 
(delayed) (Figure 5.13 A). 
No statistically significant differences were found between any of the conditions 
investigated, however a trend towards reduced EdU+ve cell counts for increased 
lengths of time in culture was observed for both control and delayed conditions.  There 
was also a trend towards reduced central canal EdU+ve cell counts in slices where 
EdU addition was delayed, compared to control (Figure 5.13 B).  
The distribution of EdU+ve cells appeared similar in delayed conditions over the three 
time points investigated (Figure 5.13, blue), whereas the distribution of EdU+ve cells 
for the control condition appeared to alter over time (Figure 5.13, green). 24 h post-
EdU addition, a greater mean area percent of EdU+ve cells was detected in the white 
and grey matter of the control slices (radial segments 3 and 4). At 120 h post-EdU 
addition, the central canal region (radial segment 1) exhibited an increased mean area 







Figure 5.13 Effect of delaying EdU addition on mean total EdU+ cell count and 
distribution.  
(A) Schematic diagram depicting EdU addition. (B) Central canal and (C) total EdU+ve 
cell count per 300 µm slice for control (green) and delayed (blue) conditions. (D) EdU 
mean area % coverage as a function of radial distance from the central canal. Data 




5.3.8 Creating an injury model in OSCSCs 
In an attempt to create an injury model in OSCSCs, slices were cultured for 2, 3, or 5 
days in vitro (DIV) then scratched using a sterile needle. The scratch was made to the 
grey and white matter, with care taken to not damage the insert. EdU was added to the 
culture medium immediately following injury, at a final concentration of 0.1, 0.5, or 1 
µM, and cultured slices were fixed following 6, 18, or 48 hours in culture in the 
presence of EdU.  
 
Injury following 2 DIV, EdU in culture for 6 hours 
There was no significant difference between the control and injured EdU+ve cell counts 
of the central canal or total slice when injured following 2 DIV (Figure 5.14 B & C). The 
distribution of EdU+ve cells throughout the slice was also similar for both conditions 
(Figure 5.14 D). The areas with the greatest percentage of fluorescence were shown to 
be the central canal (radial segment 1) and in the white matter, towards the slice 







Figure 5.14 Development of a scratch injury model in OSCSCs: Injury following 2 
DIV, EdU in culture for 6 hours  
(A) Schematic diagram depicting EdU addition following 2 days in vitro for 6 hours. (B) 
Central canal and (C) total EdU+ve cell count per 300 µm for control (blue) and 
scratched (green) slices. (D) EdU mean area % coverage as a function of radial 




Injury following 5 DIV, EdU in culture for 18 hours 
There was also no significant difference between the control and injured EdU+ve cell 
counts at the central canal or total slice when injured following 5 DIV (Figure 5.15 B & 
C). The distribution of EdU+ve cells throughout the slice also appeared similar for the 
control and injured conditions (Figure 5.15 D). 
   
Figure 5.15 Development of a scratch injury model in OSCSCs: Injury following 5 
DIV, EdU in culture for 18 hours 
(A) Schematic diagram depicting EdU addition following 5 DIV for 18 hours. (B) Central 
canal and (C) total EdU+ve cell count per 300 µm for control (blue) and scratched 
(green) slices. (C) EdU mean area % coverage as a function of radial distance from the 





Injury following 3 DIV, EdU in culture for 48 hours 
When slices were injured following 3 DIV and incubated in the presence of EdU for 48 
hours, there were significantly more EdU+ve cells at the injured slice central canal 
compared to control when detected using 1 µM EdU (Figure 5.16 B; 1 µM control: 
11.17 ±2.372, scratch: 29.00 ±2.449,  P = 0.001). These data suggest that by creating 
an injury to the spinal cord, we can trigger an increase in central canal cell proliferation 
(and survival) over 48 hours compared to control.  
Whilst there was also a trend towards increased EdU+ve cell counts at the central 
canal of scratched slices when detected using lower concentrations of EdU, this 








Figure 5.16 Development of a scratch injury model in OSCSCs: Injury following 3 
DIV, EdU in culture for 48 hours 
(A) Schematic diagram depicting EdU addition following 3 DIV for 48 hours. (B) Central 
canal and (C) total EdU+ cell count per 300 µm for control (blue) and scratched (green) 
slices. (C) EdU mean area % coverage as a function of radial distance from the central 





5.3.9 Characterisation of Cultured Central Canal GFP Projections 
(Nestin) GFP processes extending radially away from the central canal were observed 
in a number of cultured transgenic spinal cord slices (Figure 5.17). These were found 





Figure 5.17 Characterisation of (nestin) GFP processes 
Representative confocal images of the central canal of cultured (nestin) GFP spinal 
cord slices stained with antibodies against (A) CD24, (B) Galectin-3, and (C) NG2. 
Proliferating cells detected using (D) EdU. White arrows indicate a number of 





In this chapter a number of culture variables were investigated including: EdU 
concentration, length in culture, delaying EdU addition, and creating an injury.  
Important findings: 
1. EdU can be detected in perfusion-fixed and cultured spinal cord tissue whilst 
maintaining GFP fluorescence. By using a copper chelating azide (picolyl azide) 
and reducing the reaction time and copper concentration for cultured slices, EdU 
was successfully detected without quenching the GFP fluorescence needed for 
identifying ECs. 
2. (Nestin) GFP expression in the central canal remains clearly visible over 3 DIV – 
indicating survival of ECs. 
3. (Nestin) GFP expression in the white and grey matter reduces over 3 DIV – 
indicating death or differentiation of pericytes. 
4. There is a peak in the number of proliferating cells on the third/fourth DIV. 
5. There is no significant difference in the number of proliferating cells when detected 
over 24 to 72 hours in vitro. 
6. The concentration of EdU in culture medium reduces significantly (from 1 µM) 
following 48 hours in vitro. 
7. 1 µM EdU is the optimal concentration for our culture experiments. 
8. Delaying EdU addition until after the initial peak in proliferation reduces the number 
of proliferating cells detected at the central canal (but not significantly). 
9. Creating an injury to the white and grey matter only results in significantly more 
proliferating central canal cells when scratched on d3 and monitored over 48 hours, 
and 1 µM EdU is required to detect this change. 
10. Proliferating (Nestin) GFP cells extend radially from the central canal, express 





5.4.1 EdU detection in fluorescent tissue 
This chapter reveals how to localise EdU in GFP tissue. Considering how widespread 
GFP use is in studies employing transgenic animals, this is an extremely valuable 
protocol. High copper concentrations have been shown to inactivate enzymes and 
quench the fluorescence of GFP and other fluorescent proteins (DsRed, (Rahimi et al., 
2008)), and so the findings from this chapter could also be applied to transgenic tissue 
with other fluorophores. Whilst there are commercial EdU detection kits available 
(Click-iT Plus kit, Invitrogen) these are costly and still require method optimisation for 
use in different tissues. This also highlights the importance of the order in which 
immunofluorescence and EdU labelling is carried out as the fluorophores on secondary 
antibodies are also quenched using the original EdU protocol.  
5.4.2 Nestin GFP expression and distribution ex vivo 
(Nestin) GFP expression in pericytes in the white and grey matter of spinal cord slices 
reduced over 3 days in culture, whereas the central canal (nestin) GFP fluorescence 
remained bright over this time-period. This indicates viability of ependymal cells and 
maintenance of GFP expression in these cells over time. 
It isn’t clear however, whether pericyte death, or the loss of pericyte (nestin) GFP 
expression due to cell differentiation, gives rise to the reduced (nestin) GFP 
fluorescence over time. Pericyte death could be occurring due to the damage caused 
to vasculature and lack of blood flow ex vivo (Mayo and Bearden, 2015) however, 
blood vessels have been detected (using the endothelial cell marker RECA-1) in slice 
cultures of the rat brain (10 days old) up to 14 DIV, indicating the survival of 
vasculature ex vivo (Schmidt-Kastner and Humpel, 2002). Pericytes have also been 
shown to behave as stem cells (reviewed in (Andreotti et al., 2019)) and could 
therefore be differentiating and losing GFP expression.  
To investigate this further, FG could be administered to animals prior to culturing slices 




old) has been shown to diminish at 48 h post I.P. injection, indicating methodological 
challenges to this approach (Edwards et al., 2013). Additionally, labelling of neurons 
typically occurs 3 days post FG I.P. injection and so it is unclear what conditions would 
be required for the optimal and selective visualisation of pericytes in pre-weaner mice 
(~14 days) and whether the tracer fluorescence would be retained when cultured in 
vitro. An alternative to this could be the use of a transgenic mouse line in which 
pericytes display DSRed, even following pericyte differentiation.  
5.4.3 EdU availability  
To accurately quantify the number of proliferating cells in vitro, it was firstly assessed 
whether the EdU concentration and length in culture was appropriate for our spinal 
cord slice culture model. When 1 µM EdU was added, the amount of EdU was found to 
be in excess for the first 24 hours. The concentration of EdU in culture medium then 
reduced significantly (from 1 µM) following 48 hours in vitro. This could be due to the 
uptake of EdU by cells during this time, leading to a significant reduction in the 
concentration of EdU remaining in the culture medium. Alternatively, this could be due 
to the degradation of EdU under these conditions. An ELISA assay or mass 
spectrometry (for EdU concentration quantification) could be used in order to determine 
which scenario is occurring. In either case, studies investigating the long-term 
proliferation of cells will require re-addition of EdU to replenish the EdU taken up or 
degraded.  
5.4.4 Proliferation in spinal cord slice cultures 
In pre-weaner mice (under 21 days old), the injury response caused by the sectioning 
of the spinal cord was found to elicit an increase in the proliferation of cells, peaking at 
3/4 days after sectioning, followed by a decline in the number of EdU+ve cells. Other 
groups (Mothe and Tator, 2005b; Lacroix et al., 2014) also found a peak in EC 
proliferation at 3 days post injury in vivo in adult rodents, followed by a decline in 




We also found a reduced variance in central canal EdU+ve counts for cultures where 
EdU addition was delayed, suggesting that detecting proliferation a later time point 
when the injury response has subsided could produce more repeatable data.  
5.4.5 Cell death vs cell birth  
There was no observed cumulative increase in the total number of dividing cells over 
the time period investigated, therefore indicating that the proliferating cells were dying 
before detection. EC proliferation within the intact adult spinal cord has been shown to 
be limited to self-renewal for the maintenance of cell populations (Meletis et al., 2008). 
Even following an increase in proliferation induced by an injury, EC turnover eventually 
reduces to baseline levels, indicating that ECs are no longer required for SCI repair 
and so these cells die as they are surplus to requirement (Lacroix et al., 2014). 
Additionally, EdU incorporation into dividing ECs may also impact their survival. 
Sensitivity to thymidine analogues, including EdU, has been shown to be cell type 
specific and dependent on concentration and incubation time. In a number of cell types, 
EdU addition results in reduced cell viability caused by DNA damage and disruption to 
cell cycle progression via G2/M cell cycle arrest, ultimately leading to cell death 
(Diermeier-Daucher et al., 2009; Ross et al., 2011; Kohlmeier et al., 2013).  
Alternatively, this EdU toxicity could be halting further cell division of daughter cells, 
thereby reducing the number of EdU+ve cells detected over time rather than causing 
cell death. This could be investigated using BrdU to label subsequent proliferation. EdU 
could be administered for the first 24 hours, followed by BrdU for the second 24 hours; 
double labelled cells would therefore show that cells are capable of proliferating 
following EdU incorporation.  
5.4.6 Cell migration from the central canal 
Cell chains extending from the central canal were observed in a number of spinal cord 




reactive against CD24 and galectin-3; thus identifying them as ependymal cells. In the 
absence of a pericyte-specific antibody (NG2 also labels oligodendrocyte progenitor 
cells), NG2 was used to determine if these cells were migrating along vascular 
structures. We found that NG2 labelling colocalised with (nestin) GFP+ve cells, 
suggesting a potential guidance mechanism.  
Could the EC processes be guided by basement membranes?  
Vasculature has been shown to play an important role in the maintenance and 
regulation of the neurogenic niches within the brain. Within the adult SGZ and SVZ, 
neurogenesis and the vasculature are interconnected, with clusters of proliferating cells 
typically found in close proximity to growing capillaries and blood vessels (Palmer et 
al., 2000; Shen et al., 2008). Neuroblasts have also been shown to migrate along blood 
vessels in a chain formation; suggesting the vasculature plays a role in the guidance of 
cell migration (Shen et al., 2008). 
In the CNS, two basement membrane (BM) structures have been identified: vascular 
BMs that ensheath blood vessels, and fractones comprising of bulbs and stems. These 
BMs are specialised cell-adherent ECMs comprising of laminins, collagen subunits, 
heparin sulphate proteoglycans (HSPGs), and nidogens (amongst others) and these 
cell adhesion molecules are critical elements of the neurogenic niches in which they’re 
found (Mercier et al., 2002; Kerever et al., 2007) .  
BM HSPGs are thought to play a role in controlling neurogenesis and NPC proliferation 
via the binding of Bone morphogenic protein-4 and -7 (Douet et al., 2012; Mercier and 
Douet, 2014), and the neurogenic growth factor FGF-2 (Kerever et al., 2014). 
Additionally, fractones within the SVZ are enriched in laminin-α5, and have been 
shown to maintain embryonic stem cells in a non-differentiated state and regulate cell 
proliferation (Nascimento et al., 2018). Interestingly, ependymal cells adjacent to the 
SVZ produce the BMP antagonist Noggin, thereby blocking endogenous BMP 




In addition to the concentration and activation of numerous trophic/growth factors, BMs 
also provide structural guidance for migrating cells via cell-ECM binding. NSCs adhere 
to the laminin subtypes (α3/α5) found on BMs via integrin binding; further directing the 
movement and behaviour of stem cells within the niche (Jacques et al., 1998; Sato et 
al., 2019).  
In the rostral migratory stream (RMS) of the brain, migrating neuroblasts also form 
chains to migrate through “glial tubes” formed by specialised astrocytes (Sun et al., 
2010). Aligned blood vessels provide additional physical guidance as well as molecular 
signals (PSA-NCAM, etc.) to aid migration along the RMS towards the OB (Whitman 
and Greer, 2009; Snapyan et al., 2009). Therefore it is reasonable to presume a similar 
phenomenon could be occurring within the spinal cord; with ependymal cell migration 
occurring along vascular structures and pericytes.  
In a focal photothrombotic cortical stroke model, ECs of the adult mouse forebrain 
exhibited elongated processes projecting towards the stroke site, however this wasn’t 
seen in mice with a cortical stab injury (Muthusamy et al., 2018). Further studies are 
required in order to unpick the mechanisms controlling and directing EC process 
extension, and investigate whether cell migration could be manipulated for 
regeneration following injury. As part of this, the vasculature and influence of BMs 
requires careful consideration.   
5.4.7 Creating an injury model 
A number of in vitro models have been developed to investigate and replicate the 
cellular response to spinal cord injury (Pandamooz et al., 2019). In this chapter a 
scratch injury was used as a simple method of damaging the white and grey matter. A 
significant increase in the number of proliferating central canal cells was found when 
the slice was injured on day 3, measured over 48 h post injury, and this was detectable 




It is unclear whether this enhanced proliferation was due to the injury itself, or because 
the scratch increased the retention and survival of cells proliferating due to the initial 
injury response (e.g. by giving them a purpose), or a combination of the two. 
Elsewhere in this chapter a peak in central canal cell proliferation was shown to occur 
at day 3 to 4 (Figure 5.9). It is therefore hypothesised that by creating an injury when 
central canal cell division is at its greatest, an enhanced injury response can be 
triggered. Scratching the slice before or after this critical peak in central canal cell 
proliferation was shown not to elicit an injury response. No significant differences were 
found between the injured and control cell counts when the slice was scratched on day 
2 and measured over 6 hours or when the slice was scratched on day 5 and 
proliferation was measured over 18 hours. At these time points in un-injured controls, 
there is minimal central canal proliferation (see Figure 5.9), and therefore, when the 
white and grey matter were scratched, this caused no increase in central canal 
proliferation. 
Future studies investigating the response of cells to hydrogels in an injury model will 
benefit from the insight gained in this chapter. In particular this optimised injury protocol 
(scratching on day 3 and measuring proliferation over 48 hours) will provide a simple 
method by which to assess the impact of hydrogels on ependymal cell behaviour in 
vitro. These data also support the rationale for using 1 µM EdU in future studies, for the 
















The experiments in this chapter built on the characterisation work developed in chapter 
4 in order to develop and optimise methods for use in chapter 6, for the investigation 
into the potential manipulation of ependymal cells. 
In this chapter it was concluded that: 
1. Picolyl azide raises the effective concentration of Cu(II) in the EdU reaction and 
therefore enables the detection of EdU incorporated into cellular DNA, whilst 
retaining fluorescence in transgenic tissue. 
2. Cell proliferation in OSCSCs was found to peak at day 3 to 4 at the central canal, 
and day 2 to 3 when the whole slice was counted. 
3. Optimal cell culture conditions were determined: 
 1 µM EdU allows the detection of proliferating cells within spinal cord slices for up 
to 48 hours in vitro. 
 After 48 hours in vitro the concentration of EdU requires replacing for long-term 
proliferation detection. 
 1 µM EdU was determined to be optimal for these experiments – enabling changes 
in central canal proliferation levels to be detected following a scratch injury in vitro. 
4. An optimised injury model protocol was identified: 
 Scratching the white/grey matter on day 3 results in a significant increase in central 
canal cell proliferation when measured over 48 hours. 
5. Ependymal cells may migrate radially from the central canal in OSCSCs, potentially 
guided by vascular structures. 
 Proliferating (Nestin) GFP cells extend radially from the central canal, express 
CD24 and galectin-3, and colocalise with NG2. 
Overall, this chapter identifies the conditions required for organotypic spinal cord slices 
to be used to study EC behaviour in chapter 6. In addition, results suggest that ECs do 




Chapter 6 -  Manipulating Ependymal Cells in Organotypic 
Spinal Cord Slice Cultures and In Vivo 
 
6.1 Introduction 
SDF-1α/CXCR4 – directing migration and proliferation 
The chemokine CXCL12, also known as stromal cell-derived factor-1 (SDF-1), and its 
signalling receptor C-X-C chemokine receptor type 4 (CXCR4) are reported to have 
multiple roles within the CNS. CXCR4 is a G protein-coupled receptor, and binding of 
SDF-1 is thought to lead to downstream effects via modulation of G nucleotide-binding 
proteins (Wescott et al., 2016). CXCR4 has been implicated in neuronal migration and 
morphogenesis during development (Lu et al., 2002; Stumm et al., 2003) and adult 
neurogenesis (Tran et al., 2007). SDF-1/CXCR4 signalling is also thought to function 
as an axon guidance cue for mammalian motor neurons, dorsal root ganglion (DRG) 
sensory and sympathetic axons, and retinal ganglion cells of the zebrafish (Chalasani 
et al., 2003; Lieberam et al., 2005; Chalasani et al., 2007). 
Following focal cerebral ischemia in adult rodents, an increase in endogenous neural 
progenitor cell (NPC) proliferation in the SVZ is seen, followed by SDF-1/CXCR4 
mediated neuroblast migration (Robin et al., 2006; Ohab et al., 2006; Wang et al., 
2012). Directed migration of new neurons was also shown to be regulated by SDF-
1/CXCR4 up to 4 months following stroke-induced neurogenesis in rats (Thored et al., 
2006). 
Migration of oligodendrocyte progenitor cells (OPCs) is also thought to occur via 
CXCR4-mediated signalling, with neurospheres formed from CXCR4-defective mice 




(Dziembowska et al., 2005). Cell migration within a viral-induced immune-mediated 
demyelination model of multiple sclerosis was investigated by (Carbajal et al., 2010; 
Carbajal et al., 2011). In these animals, NSCs (expressing CXCR4 and CXCR7) were 
injected into the spinal cord and these were found to migrate to the demyelinated white 
matter tracts, proliferate extensively, and differentiate into mature oligodendrocytes 
(~7%) and oligodendrocyte progenitor cells (~29%); ultimately aiding remyelination of 
axons. SDF-1 immunoreactivity was found in the white matter tracts and astrocytes of 
infected mice, and blocking studies (using the antagonists: AMD3100 and CCX771) 
indicated that CXCR4 signalling, rather than CXCR7, was important for NSC migration 
and proliferation.  
In the uninjured spinal cord, SDF-1 is expressed within the meninges and dorsal 
corticospinal tract, and CXCR4 is expressed in ependymal cells at the central canal 
(Tysseling et al., 2011). Following a compression injury in adult mice, CXCR4+ve cells 
appeared to migrate towards the periphery of the spinal cord, towards SDF-1-
expressing meningeal cells and the SDF-1-containing dorsal corticospinal tract rostral 
to the lesion. Fewer CXCR4+ve ependymal cells were found to reside in the central 
canal following injury, however it was unclear whether the migrating CXCR4+ve cells 
were ECs or macrophages (Tysseling et al., 2011). 
Delivery of SDF-1α using a number of scaffolds has been achieved for various tissue-
repair applications (reviewed in (Zhao et al., 2017)). In the brain, the retention of 
transplanted neural stem/progenitor cells (NSPCs) was significantly increased when 
cells were incorporated into a hyaluronic acid (HA)-laminin hydrogel compared to bolus 
delivery. Migration of these cells towards SDF-1α (injected close to the transplantation 
site) was also significantly increased compared to bolus controls (Addington et al., 
2017). This chapter aims to determine whether delivering SDF-1α in a hydrogel 
promotes endogenous ependymal cell proliferation and/or migration within the spinal 





Previous studies have shown that stem cells can be manipulated using tissue 
engineering strategies involving chemokines and materials with modified mechanical 
properties. The hypothesis here is that hydrogels and/or SDF-1α can be used for the 
modulation of ependymal cells within the spinal cord. 
The experiments in this chapter build on the work carried out in chapters 3 to 5 and use 
the methods and transgenic line optimised earlier in this thesis (Figure 6.1). 
6.1.2 Aims  
1. To investigate the impact of culturing spinal cord slices on hydrogels with regards 
to cell proliferation and distribution. 
2. To assess the effect of SDF-1α on ependymal cell proliferation and migration in 
vitro and in vivo. 
 
Figure 6.1 Schematic depicting the aims of chapter 6 in reference to the rest of 
this thesis 
The work carried out within this chapter builds-on the methods developed in chapters 3 





6.2.1 Animals used 
All experiments were carried out under a UK Home Office Licence (P1D7A177), in 
accordance with the UK Animals (Scientific Procedures) Act 1986 and the ethical 
standards set out by the University of Leeds Ethical Review Committee. Every effort 
was made to minimise the number of animals used and their suffering.  
(Nestin) GFP transgenic mice (characterised in chapter 4) were bred in-house as 
heterozygotes, housed in standard conditions with a 12 hour light-dark cycle, and given 
ad libitum access to food and water.  
6.2.2 Sterilisation and disinfection 
The laminar flow hood, incubator, and surrounding surfaces were disinfected using 1% 
Virkon followed by 70% ethanol prior to use. All tools for in vitro and in vivo work were 
cleaned with boiling water, 70% ethanol, and then autoclaved at 121 °C for 20 minutes 
under 103 kPa for sterilisation. Where possible, sterile, single use consumables were 
used and disinfected with 1% Virkon following their use, prior to disposal. Collagen 
hydrogels were disinfected using 70% ethanol washes, all other hydrogels were 
created aseptically in a laminar flow hood.  
6.2.3 Hydrogel synthesis 
As we were unable to reliably manipulate the stiffness of collagen hydrogels developed 
in-house, we compared 4Ph-crosslinked collagen hydrogels to two commercial 
hydrogels (Table 6.1).  
6.2.3.1 Collagen  
4Ph crosslinked collagen hydrogels were synthesised as previously described (Chapter 
3.3.2). Briefly, rat tail collagen (extracted in-house, 1.2 wt.% in acetic acid) was 




groups: collagen lysine groups) to form hydrogels. Prior to tissue culture, collagen 
hydrogels were washed in diH2O and 70% ethanol to remove any unreacted species 
and disinfect the gels. 
6.2.3.2 Commercial hydrogels: 
VitroGel 
According to the manufacturer (TheWell BioScience), VitroGel is “an animal origin-free 
hydrogel system mimicking the natural ECM” and is “unmodified polysaccharide-
based”. This hydrogel is shear-thinning and recoverable, and therefore injectable. 
VitroGel hydrogels were created by mixing VitroGel with sterile VitroGel dilution 
solution (ratio of 1:1 VitroGel: dilution solution) and culture medium (no serum) was 
then added (ratio of 4:1 VitroGel: medium), mixed, and immediately transferred to 
sterile culture inserts to initiate gelation in situ.  
HyStem  
HyStem hydrogels comprise of a thiol modified HA (Glycosil) and a thiol reactive 
crosslinker (Extralink), with or without thiol-modified denatured collagen fibrils (Gelin-S) 
for cellular attachment sites (referred to as HyStemC). HyStem hydrogels were formed 
according to the manufacturer’s protocol. Each gel component (Glycosil, Extralink, and 
Gelin-S) was reconstituted under aseptic conditions using degassed sterile water. 
Glycosil and Gelin-S bottles were placed onto a plate shaker for 1 hr at RT to fully 
dissolve. Extralink did not require shaking and was prepared immediately prior to 
hydrogel formation. Extralink and HyStem solutions were mixed at a ratio of 1:4 
(Extralink: HyStem) to initiate gelation. For HyStemC hydrogels, HyStem was first 
mixed with Gelin-S at a ratio of 1:1. Extralink was then added at a ratio of 1:4 




Table 6.1 Hydrogels used in this chapter and their composition and mechanical 
properties 
Hydrogel Composition G’ (Pa) Testing method Reference 
Collagen  
4Ph crosslinked 
rat tail collagen  
~ 100 to 
650* 
Rheology (Kinexus Pro, 
frequency sweep) 
































*taken from all rheology data, **Incubated at 37°C for 24 hrs before the rheological test 
 
6.2.4 Organotypic spinal cord slice culture 
Hydrogels were washed twice (30 minutes) with culture medium, incubated in culture 
medium containing serum (Chapter 2, Table 2.7) and equilibrated to 37 °C for 2 hours 
prior to spinal cord slice addition and organotypic spinal cord slice cultures (OSCSCs) 
were carried out as described in Chapter 5.2.2.  Following 1 day in vitro (DIV), the 
medium was exchanged for serum free medium (Chapter 2, Table 2.7) (see Chapter 5, 
Figure 5.4). EdU was added to the culture medium following 3 DIV at a final 
concentration of 1 μM, allowing for the visualisation of cells that have undergone 
proliferation with EdU present. 
6.2.4.1 SDF-1α and AMD3100 addition 
In this chapter the response of cells to SDF-1α was investigated. Here, collagen 
hydrogels were used to deliver SDF-1α or AMD3100 in order to determine if cell 




For uniform SDF-1α concentration, hydrogels were pre-saturated in SDF-1α (referred 
to as collagen & SDF; 1 µL of SDF-1α added to the medium used to hydrate the 
hydrogels; 7.9 kDa, 126.6 nM,) 24 hours prior to culturing. To create a gradient, SDF-
1α was also added to the culture medium in the well (referred to as collagen & SDF x2; 
2 µL of SDF-1α, 253.2 nM) thereby creating a concentration gradient through the 
hydrogel due to SDF-1α diffusion (see Addington et al., 2015) (see table 6.2 for more 
details).  
To investigate whether CXCR4 was involved in SDF signalling, the CXCR4 antagonist 
AMD3100 was used. In this condition, hydrogels were pre-saturated in medium 
containing 1 µL of AMD3100 (referred to as AMD3100; 794.48 g/mol, 1.259 nM) 24 
hours prior to culturing.  These experimental conditions were compared to slices from 
control wells where slices were cultured directly onto the tissue culture insert (no 
hydrogel) with/without SDF referred to as control and SDF respectively) and those 
cultured on hydrogels in the absence of exogenous SDF-1α (referred to as collagen: 
Table 6.2).  
Table 6.2 Conditions investigated in this chapter 
Condition Hydrogel SDF in gel 
SDF in 
medium (1 µM) 
SDF in 
medium (2 µM) 
AMD3100 
Control ✗ ✗ ✗ ✗ ✗ 
SDF ✗ ✗ ✓ ✗ ✗ 
Collagen ✓ ✗ ✗ ✗ ✗ 
Collagen & SDF ✓ ✓ ✗ ✗ ✗ 
Collagen & SDF x2 ✓ ✓ ✗ ✓ ✗ 
AMD3100 ✓ ✗ ✗ ✓ ✓ 
See Supplementary Figure 8.2 for more detail regarding the culture set up. 
6.2.4.2 Fixation 
Spinal cord slices were fixed in situ on tissue culture inserts using 4% 
paraformaldehyde (PFA, Chapter 2, Table 2.5) for 1-2 hours at RT. Following fixation, 




6.2.5 In vivo methods 
Glass electrodes were used for the delivery of hydrogels to the spinal cord and were 
pulled using a Sutter P27 micropipette puller. VitroGel was used as it is sterile, shear-
thinning and recoverable, and therefore suitable for injecting in vivo. Hydrogels were 
prepared by mixing VitroGel with sterile PBS (±SDF, 12.66 µM) and left to stabilise in a 
sterile syringe for 18 h at 4 °C prior to injection. Adult (Nestin) GFP mice (6-8 weeks) of 
either sex were used for in vivo experiments. Mice were weighed prior to surgery and 
anaesthetised with an I.P. injection of ketamine (75 mg/kg, Chapter 2, Table 2.6) and 
medetomidine (1.0 mg/kg, Chapter 2, Table 2.6) to maintain anaesthesia for 
approximately 1 hour. Absence of pedal reflexes determined adequate anaesthesia. 
Fur around the surgery site was removed using electric clippers and ethanol wipes 
were used to clean the skin. A lubricant was applied to the eyes to prevent drying 
during surgery and the animal was kept on a heated table at 37 °C.  
6.2.5.1 Intraspinal injection 
Using a surgical microscope and a sterile blade, a small incision was made through the 
dorsal skin and muscle, rostral to the rib cage. Blunt forceps were used to resect 
muscle caudal to the spinal column and retractors were used to hold the site open. The 
dura and pia mater were then removed using fine forceps. 
A stereotactic frame was used to secure the animal in place, and 5 µL hydrogel 
(VitroGel ± SDF-1α) was drawn up the electrode in preparation using a syringe pump. 
The electrode was then moved in place above the spinal cord and the frame height 
was zeroed. The electrode was then lowered to a depth of 300 µm and a syringe pump 
was used to deliver 1 µL of hydrogel (Figure 6.2). Following surgery the muscle was 
sutured using absorbable sutures, the skin was closed using non-dissolvable sutures 






Figure 6.2 Injection of a hydrogel ± SDF-1α into the grey matter of lumbar spinal 
cord.  
A glass electrode was lowered through the intervertebral space into the spinal cord, 
and a syringe pump was used to deliver 1 µl of hydrogel ± SDF-1α at a depth of 300 
µm. 
 
6.2.5.2 Postoperative care and EdU injections 
Atipamezole (1 mg/kg, Chapter 2, Table 2.6) was administered I.P. to reverse the 
effects of medetomidine. Buprenorphine (0.1 mg/kg, Chapter 2, Table 2.6) was given 
subcutaneously to alleviate post-operative pain, and the animal was transferred to a 
cage on a heated pad for recovery. Soaked diet was made available and each animal 
was observed and weighed daily to monitor recovery. 24 hours post-surgery 0.5 mL 
sterile saline was given I.P. in order to ensure animals were not dehydrated and 
buprenorphine (0.1 mg/kg, Chapter 2, Table 2.6) was given subcutaneously to ensure 
pain prevention. EdU (10 mM, 0.1 mL in sterile saline) was delivered via I.P. injection at 
24 and 48 h post-surgery (day 1 and 2) to enable detection of proliferating cells. 
6.2.5.3 Perfusion-fixation and tissue processing 
Mice were terminally anaesthetised 62 h post-surgery with sodium pentobarbital (60 
mg/kg) I.P. and perfused transcardially with 0.1 M PB to remove blood, then 4% PFA 
for fixation. The spinal cord and brain were removed and post fixed overnight at 4 °C in 




fine forceps and a dissection microscope, and the injection site and the spinal cord 
tissue rostral and caudal to it were embedded in gelatin. 
6.2.5.4 Gelatin-embedding of tissue and vibratome sectioning 
A 1cm block of tissue was cut using a flat blade, and a solution of 10% gelatin (Chapter 
2, Table 2.5) was prepared and left to cool slightly. The tissue section was then 
orientated on the bottom of a glass petri dish placed onto a frozen metal block. The 
cooled gelatin solution was then carefully pipetted around the tissue until the gelatin 
was ~1 inch above the tissue section. The block and petri dish containing the 
embedded section were then transferred into a fridge to set for 2 h. The gelatin was 
then cut leaving ~2 cm around the tissue section and this was placed into 4% PFA with 
0.25% glutaraldehyde overnight at 4 °C. Embedded sections were then washed twice 
in 0.1 M PB (10 minutes). 
Sections of embedded spinal cord were glued to the chuck with the exposed end of 
tissue facing up. The chuck was then screwed into place in the water bath containing 
0.1 M PB and the blade was attached to the vibratome arm. The tissue was then 
sectioned serially at 40 µm in the transverse plane at an amplitude of 0.4 mm/s and 
vibrating frequency of 80 Hz. Serial sections were placed into wells containing PBS for 
EdU labelling. 
6.2.6 EdU detection  
EdU detection reactions and incubation steps were carried out at RT in the dark as in 
the optimised method detailed in Chapter 5.2.3, Figure 5.4. Briefly, spinal cord slices 
were permeabilised using 0.2% PBST, washed twice in 0.1 M Tris buffer (10 minutes 
each), then incubated in the optimised click reaction mixture (with picolyl azide) for 20 
minutes (0.5 mM Cu(II)SO4 for cultured slices) or 5 minutes (1 mM Cu(II)SO4 for in vivo 
slices). Slices were then washed twice in 0.1 M Tris buffer (10 minutes each), followed 
by 10 minutes in PBS, then incubated in Streptavadin Alexa Fluor555 for 2 hours. 




mounted on microscope slides, air-dried, covered in Fluoroshield with DAPI and 
coverslipped.  
6.2.7 Image capture and analysis 
6.2.7.1 OSCSC EdU-labelled cell counts 
Manual cell counts of EdU-labelled (EdU+ve) cells at the central canal were performed 
using a Nikon E600 microscope. Images of whole slices were taken using an EVOS 
fluorescence microscope at x4, x10, and x20 magnification for further quantification. As 
previously described in Chapter 5.2.6, EdU labelled cells were then quantified using 
ImageJ to get total counts of all EdU+ve cells, and their radial distribution throughout 
the slice (see Figure 5.6).  
6.2.7.2 (Nestin) GFP process quantification 
ImageJ Simple Neurite Tracer was used to create a skeleton of the processes 
extending from the central canal (Figure 6.3). Processes were manually traced using 
the plugin, with paths starting from the edge of the central canal region. Branches were 
mapped and logged (Longair et al., 2011). Outputs included: number and length of 




Figure 6.3 ImageJ skeleton creation for analysis of (Nestin) GFP processes.  
Representative EVOS image of (Nestin) GFP central canal processes. (B) Manual 






6.2.7.3 In vivo EdU-labelled cell counts 
Manual cell counts were performed using a Nikon E600 microscope. EdU labelled cells 
were counted at the central canal, white, and grey matter regions to allow for 
comparison between experimental groups. Representative images were taken using a 
Zeiss LSM880 laser scanning confocal microscope equipped with argon (λex = 488 nm) 
and He‐Ne (λex = 543 nm) lasers. Images were acquired using Carl Zeiss SEN 
software (Zeiss Microscopy) and CorelDRAW 2017 was used for image processing. 
6.2.8 Data analysis 
Data were collated in Microsoft Excel and analysed using IBM SPSS statistics 21. 
Average EdU-positive (EdU+ve) cell counts were calculated and presented as mean ± 
standard error of the mean (SE) unless stated otherwise. Shapiro-Wilk and Levine’s 
tests were applied for distribution and equality of variance analysis respectively. A 
decision tree was used to determine the appropriate statistical test (Chapter 2, Figure 
2.6). 
 
Table 6.3 Animals used in this chapter to investigate the response of ECs to 
hydrogels and the chemokine SDF-1α 
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6.3 Results  
6.3.1 Effect of Hydrogels on the Proliferation of Cells  
Spinal cord slices were cultured on hydrogels in the presence of EdU for 6 hours on d3 
(Figure 6.4 A) in order to determine if these materials affected the proliferation of cells. 
The number of EdU+ve cells was lower in hydrogel conditions compared to control 
when the central canal or whole slice was counted (Figure 6.4 B & C). There was a 
statistically significant reduction in the number of EdU+ve cells at the central canal of 
slices cultured on HyStemC hydrogels compared to control (mean rank difference:        
-22.33; p=0.0027). The number of EdU+ve cells in the whole slice for those cultured on 
HyStem and HyStemC hydrogels was also significantly less than control (mean 
difference ±SE of difference: HyStem= -602.5 ± 162.2, P= 0.0018; HyStemC= -538.6 
±204.1, P = 0.0321). 
There were no statistically significant differences between the central canal EdU+ve 
cell counts of each hydrogel condition, however there were significantly fewer EdU+ve 
cells when the whole slice was counted, in slices cultured on HyStem gels compared to 
collagen gels (mean difference ±SE of difference= -494.0 ±146.9; P = 0.0198).  
The distribution of EdU+ve cells appeared similar in the control and collagen 
conditions, with fluorescence throughout the slice and a peak in the area % in the white 
matter (Figure 6.4 D, radial segment 4 & E). Similarly in the HyStem conditions, the 
fluorescence was distributed throughout the slice, with a total reduction in area percent 










Figure 6.4 Effect of hydrogels on the number and distribution of EdU labelled 
cells.  
Schematic diagram depicting EdU addition following 3 DIV for 6 hours. EdU count as a 
% of control slices for (B) central canal area and (C) total slices. (D) EdU mean area % 
coverage as a function of radial distance from the central canal. Data presented as 
mean ±SE. Individual data points represent mean values from each repeat. N=3, n>3, * 
P≤0.05, **P≤ 0.01. (E) Representative EVOS images of half a cultured spinal cord slice 




Spinal cord slices were then cultured on hydrogels in the presence of EdU for 18 hours, 
this time with an additional commercial hydrogel: VitroGel (Figure 6.5 A). Whilst not 
statistically significant, the number of EdU+ve cells detected at the central canal of 
slices cultured on VitroGel hydrogels was 37% greater than that of the control. This 
was however, significantly greater than the corresponding value found for slices 
cultured on collagen hydrogels (Figure 6.5 B, mean difference ±SE of difference: 12.75 
±4.384; P = 0.0434). 
As previously found, there was a reduced number of EdU+ve cells for all slices cultured 
on collagen and HyStem hydrogels compared to control, with significantly fewer total 
EdU+ve cell counts compared to control (Figure 6.5 C, mean difference ±SE of 
difference: collagen= -1158 ±318.5, p= 0.0043; HyStem= -1074 ±296.5; P = 0.0045). 
The mean total number of EdU+ve cells in slices cultured on VitroGel hydrogels was 
similar to that of control and as found previously, the distribution of EdU+ve cells 
remained similar in control and hydrogel conditions (Figure 6.5 D and E).  
 
6.3.2 Effect of SDF-1α on spinal cord slice cultures 
6.3.2.1 SDF-1α does not affect the number or distribution of EdU-labelled 
cells in vitro 
Slices were cultured on collagen hydrogels ±SDF-1α for 4 DIV and EdU was added to 
the culture medium for the final 18 hours to detect proliferating cells (Figure 6.6 A). 
Collagen was selected as this previously resulted in the greatest change to proliferating 
cell numbers (Figure 6.5). SDF-1α did not affect the number of EdU+ve cells or their 
distribution within the cultured slice compared to collagen hydrogels alone (Figure 6.6 
B-E). There was a trend towards reduced EdU+ve cell counts at the central canal and 
in the total slice compared to control slices for collagen hydrogels with/without SDF-1α 







Figure 6.5 Effect of hydrogels on OSCSC EdU labelled cells. 
(A) Schematic diagram depicting EdU addition following 3 DIV for 18 hours. EdU count 
as a % of control slices for (B) central canal area and (C) total slices. (D) EdU mean 
area % coverage as a function of radial distance from the central canal. Data presented 
as mean ±SE. Individual data points represent mean values from each repeat. N=2, 
n>3, * P ≤ 0.05, ** P ≤ 0.01. (E) Representative images of half a cultured spinal cord 






Figure 6.6 Effect of SDF-1α on EdU labelled cell distribution in OSCSCs.  
Schematic diagram depicting EdU addition following 3 DIV for 18 hours. EdU count as 
a % of control slices for (B) central canal area and (C) total slices. (D) EdU mean area 
% coverage as a function of radial distance from the central canal. Data presented as 
mean ±SE. N=1, n>3. (E) Representative images of half a cultured spinal cord slice for 




6.3.2.2 SDF-1α does not affect the GFP projections from central canal 
Following the addition of SDF-1α into the culture medium for either 1 or 2 days in vitro, 
the central canal (nestin) GFP projections were assessed by measuring the number of 
primary projections, the number of branches, the branch length, and the number of 
secondary branches compared to control slices (Figure 6.7).  
 
 
Figure 6.7 Effect of SDF-1α on cultured spinal cord slice central canal (Nestin) 
GFP projections and branching characteristics.  
EVOS images of the central canal region for (A) control and (B & C) SDF treated slices. 
(D) Mean number of primary projections, (E) branches, (F) length of branches, and (ɢ) 
number of secondary branches. Data presented as mean ±SE. N=1, n=5. Scale bars = 
275 µm. Slices were cultured for 4 days in vitro with 1 µM SDF-1α added into the 




Whilst not statistically significant, the number of primary projections, branch length, and 
the number of secondary branches appeared to increase with increasing SDF addition 
(Figure 6.7 D, F, and G) indicating SDF may influence (nestin) GFP processes at the 
central canal. An increased number of repeats would be required in order to investigate 
this trend further.   
 
6.3.2.3 SDF-1α does not affect the radial distribution of (Nestin) GFP+ve 
cells in vitro, but may influence cell migration 
The effect of a concentration gradient of SDF-1α was then investigated using a method 
developed by (Addington et al., 2015). The radial distribution of (nestin) GFP remained 
similar for slices cultured on collagen hydrogels with SDF-1α and/or AMD3100 (CXCR4 
antagonist), compared to control slices, with the majority of GFP % fluorescence 
remaining at the central canal (Figure 6.8 A). Interestingly, in slices with a gradient of 
SDF-1α (SDF x2), there was an increase in (Nestin) GFP fluorescence in the grey 
matter (Figure 6.8 A, radial segments 2 and 3), however it isn’t clear whether this is 
due to cell migration. When cultured with SDF-1α, GFP+ve cells were also found to 
migrate through the collagen hydrogels (towards the higher SDF-1α concentration in 
the culture medium) and attach to the culture insert, similar to when the slice was 
cultured directly onto the insert (Figure 6.8 B). This was not seen for slices cultured on 









Figure 6.8 Effect of SDF-1α and AMD3100 on (nestin) GFP distribution and 
migration  
(Nestin) GFP mean area % coverage as a function of radial distance from the central 
canal for slices cultured on collagen hydrogels either (i) alone, (ii) with uniform SDF 
(blue) or an SDF gradient (SDF x2 - red), or (iii) with SDF & AMD3100. Data presented 
as mean ±SE. (B) EVOS images of (Nestin) GFP+ve cells on culture inserts (DAPI co-
stain) where control= no hydrogel or SDF, and SDF= no hydrogel. N=1, n>3. Scale 
bars = 20 µm.  
 
6.3.3 Effect of Injecting SDF-1α Intra-Spinally Within a Hydrogel in 
Vivo 
The effect of SDF-1α was then assessed in vivo. VitroGel was used as it is sterile, 
shear-thinning and recoverable, and therefore suitable for injecting in vivo. VitroGel 
was injected ±SDF-1α intra-spinally and proliferating cells were labelled via EdU 
injection at 24 and 48 h post-surgery. A number of EdU+ve cells were detected at the 
central canal (Figure 6.9 a i) and grey matter surrounding the injection site (Figure 6.9 
a ii), presumably due to the injury caused by the needle. (Nestin) GFP+ve cells were 




dorsoventrally from the central canal (Figure 6.9 b i). (Nestin) GFP+ve cells were also 
found surrounding the injection sites (Figure 6.9 bii). 
The number of proliferating cells was then quantified. When the whole slice was 
counted, there were significantly more EdU+ve cells at the level of injection (Figure 
6.10 A, level 0) in animals injected with hydrogels with SDF-1α (N=2, n=6; 715.83 
±116.7) compared to those injected with hydrogel alone (N=2, n=8, 347.50 ±56.88; P = 
0.024). At levels rostral to the injection site (levels -2 to -4), the number of EdU+ve cells 
in the entire slice was significantly lower in the tissue from the SDF-1α loaded 
hydrogels, compared to the hydrogel control (P = 0.012 to <0.0001) indicating potential 
migration of proliferating cells to the injury site.  
The same trend in EdU+ve counts was seen in the white and grey matter (WM and GM 
respectively), when counted separately. There were significantly more EdU+ve cells in 
the WM at the level of injection (Figure 6.10 B, level 0) in animals injected with 
hydrogel with SDF-1α (n=8, 191.50 ±13.43) compared to those injected with hydrogel 
alone (n=6, 82.63 ±4.953; P = 0.0002). Whilst there were more EdU+ve cells at the 
level of injection in the grey matter of animals injected with hydrogels with SDF-1α 
compared to the hydrogel control, this was not significantly different (Figure 6.10 C, 
level 0; P = 0.08). 
At the central canal, there was no significant difference in EdU+ve cell counts at the 
level of injection (Figure 6.10 D, level 0). At levels rostral to the injection site (levels -4 
to -2), the number of central canal EdU+ve cells was slightly lower in the hydrogel with 









Figure 6.9 Effect of delivering SDF-1α intra-spinally within a hydrogel in vivo. 
Representative confocal images taken at the level of injection showing EdU labelled 
cells (red) and DAPI labelled cell nuclei (blue) (b) and (nestin)GFP (green) and DAPI 
labelled cell nuclei (blue) (c) at the central canal region (i) and injection site (ii). Scale 
bars: a, b & bi = 100 µm, ai & bi/ii = 20 µm 
 
 






Figure 6.10 Effect of delivering SDF-1α intra-spinally within a hydrogel in vivo on 
EdU counts. 
Mean count of EdU+ve cells at the site of injection (0) and levels rostral (negative) and 
caudal (positive) for control hydrogel-injected animals (blue) and hydrogel & SDF-1α-
injected animals (green). Total (A), white matter (WM), grey matter (GM), and central 
canal (CC) counts. Each level incorporates data from N=2 per condition, n<6 sections, 
covering a length of ~480 µm spinal cord (a). Data presented as mean ±SE. * P ≤ 0.05, 





This chapter aimed to investigate manipulating ependymal cells using hydrogels and 
the chemokine, SDF-1α. The response of spinal cord cells varied depending on the 
hydrogel. 
Important findings: 
 Culturing spinal cord slices on collagen hydrogels leads to a ~50% reduction in 
central canal cell proliferation compared to control 
 Culturing spinal cord slices on collagen hydrogels also leads to an overall reduction 
of cell proliferation throughout the spinal cord slice, compared to control 
 Spinal cord slices cultured on Hystem hydrogels had slightly less proliferation at the 
central canal and a significant reduction in the proliferation in the whole slice 
 Slices cultured on VitroGel hydrogels had significantly more central canal 
proliferation compared to collagen hydrogels 
 The total cell proliferation throughout the spinal cord slice was similar in slices 
cultured on VitroGel hydrogels and control slices  
In OSCSCs, SDF-1α didn’t appear to impact: 
- Proliferation levels 
- EdU+ve cell distribution 
- (Nestin) GFP central canal radial processes 
- (Nestin) GFP cell distribution 
 However, an SDF-1α concentration gradient may influence ependymal cell 
migration as (nestin) GFP cells migrated through hydrogels along the concentration 
gradient 
 Injecting SDF-1α within a hydrogel intra-spinally results in significantly more 
EdU+ve cells at the level of injection in: (a) the whole slice, (b) the white matter (c) 




6.4.1 Effect of hydrogels on ependymal cell behaviour 
There was a reduced number of proliferating cells when slices were cultured on 
hydrogels (with the exception of VitroGel). It is unclear whether this was due to the 
migration of proliferating cells into the hydrogel that were subsequently not detected; 
due to a reduction in proliferating cell survival (or overall cell viability); or indeed a true 
reduction in proliferation, potentially as a result of minimised or alleviated injury 
response.  
We attempted to unpick this trend by labelling and imaging cells within the hydrogels to 
determine if any migration had occurred, however had minimal success. This was due 
to the auto fluorescence of collagen fibrils hindering imaging of cells within some 
hydrogels, along with the processing and re-sectioning of hydrogels and tissue slices 
leading to tissue fragility and loss. Alternatively, DAB (3,3′-diaminobenzidine) could be 
used to visualise (using light microscopy) horseradish peroxidase-conjugated 
secondary antibodies; potentially allowing for the quantification of cells within 
hydrogels.  
In addition to these methodological challenges, it is also unclear what a “good” 
proliferative response would be. As previously discussed, we observed what we 
believe to be an injury response in control cultures (see Chapter 5). As such, a 
reduction in the proliferation of cells when cultured on softer hydrogels may be 
indicative of the hydrogel having a protective effect on the cells, thus reducing their 
response to injury. Changes in inflammatory cytokine release (using RNase protection 
assay and/or enzyme-linked immunosorbent assay) would help confirm this hypothesis. 
Additionally, immunofluorescence to determine the reactivity state of astrocytes and the 
cell lineage of differentiated ECs would further determine the protective nature of 
hydrogels on OSCSCs. 
A significant increase in cell proliferation at the central canal of slices cultured on 




reported elastic modulus of around 1000 Pa (when diluted at 1:1 with VitroGel dilution 
solution, created using DMEM, and incubated at 37 °C for 24 hours prior to testing), 
and is therefore the stiffest hydrogel trialled (compared to: collagen ~100-650 Pa, 
HyStem ~110 Pa, HyStemC ~159 Pa). This difference in hydrogel stiffness could be 
causing the change in cell proliferation at the central canal, and leading to a total cell 
proliferation count similar to control slices cultured directly on culture inserts. However, 
discrepancies between the hydrogel composition reported in literature and that used in 
this thesis could mean the stiffness reported may not be truly representative of the 
VitroGel hydrogel used in this experiment. Furthermore, the rheological testing 
methodologies used to characterise the VitroGel and HyStem hydrogels were not the 
same as that used to characterise the collagen hydrogels developed in-house (see 
Table 6.0), and therefore these values may not be directly comparable. Further 
experiments are required in order to determine a relationship between cell proliferation 
trends and the mechanical properties of the hydrogel substrate. 
6.4.2 Effect of SDF-1α on ependymal cell behaviour 
The results in this chapter show the delivery of SDF-1α had no measurable effect on 
the central canal (nestin) GFP processes extending radially in vitro, however, these 
were difficult to characterise and varied highly between cultured slices. Migration to a 
chemotactic gradient of SDF-1α is thought to be concentration-dependent. In this 
chapter a concentration of 1000 ng/mL (126.6 nM) SDF-1α was selected for in vitro 
studies, as this concentration has been shown to result in increased proliferation and 
migration of human neural stem cells in vitro (Imitola et al., 2004), however, this 
concentration may not be optimal for directing EC migration and proliferation and 
further optimisation may be required. Interestingly, a gradient of SDF-1α resulted in an 
increase in a mean area % for the (nestin) GFP fluorescence within the white and grey 




chemotaxis experiments are required to confirm this observation (e.g. Boyden chamber 
assay).  
We also show potential cell migration in vivo from the area rostral to the injection site, 
towards SDF-1α. These preliminary data indicate the injection of SDF-1α within a 
hydrogel could be a potential method for recruiting endogenous ECs to the site of 
injury. Research in our lab has shown that EC proliferation can be increased in vivo 
using the nicotinic acetylcholine receptor modulator PNU-120596 (Corns et al., 2015). 
Therefore a combinatorial approach, delivering SDF-1α and PNU, post-injury may give 
rise to increased migration and proliferation of ECs for spinal cord repair.  
Future experiments utilising immunofluorescence for fate mapping would determine if 
ECs can also be manipulated in vitro and in vivo into forming oligodendrocytes and/or 
neurons. Additional in vivo experiments are required in order to investigate the potential 
benefits of directed migration following injury. This could be achieved by creating an 
injury to the spinal cord followed by delayed injection of a hydrogel with SDF-1α. This 
study may recreate the injury response seen in human patients and determine if 
directed migration occurs in an inflamed spinal cord. 
The complex balance between stem cell retention and chemotaxis via SDF-1/CXCR4 
binding may further complicate regenerative strategies. Functional repair wasn’t 
improved in rats when treated with SDF-1 following spinal cord injury (Pakulska et al., 
2017). The CXCR4 antagonist AMD3100 has been shown to mobilise progenitor cells 
from the bone marrow (Dar et al., 2011) and a similar approach may be required within 
the CNS for endogenous stem cell recruitment and tissue repair. Whether manipulating 
ECs in vivo using SDF-1α leads to an improvement in the physiological recovery 







1. The proliferation of cells within the spinal cord can be manipulated using a number 
of hydrogels 
2. Delivering a concentration gradient of SDF-1α in vitro may trigger ependymal cell 
migration 
3. Delivering SDF-1α in vivo within a hydrogel leads to an increase in the number of 
proliferating cells at the level of injection – potentially via recruitment of dividing 
cells rostral to the injection site 
Overall, this results in this suggest that cell proliferation within the spinal cord can be 
manipulated using hydrogels; and delivering a gradient of the chemoattractant SDF-1α 





Chapter 7 – General Discussion 
 
7.1 Summary 
This study has highlighted the complex nature of spinal cord repair. Injuries to the CNS 
cause a myriad of cell behaviour changes; all influenced by a number of intrinsic and 
extrinsic processes and cellular cascades. 
Novel developments made include: 
 Characterisation of (nestin)GFP expression in the spinal cord of transgenic mice 
 Development protocols for the detection of proliferating cells in vitro and in vivo, 
reducing the detrimental effect of Cu(II) on GFP fluorescence  
 Investigation into the behaviour of ependymal cells in organotypic spinal cord slice 
culture 
 Optimisation of culture conditions for the detection of proliferative changes at the 
central canal following injury 
 Potential manipulation of ependymal cells using hydrogels and SDF-1α 
 
7.1.1 Investigating the potential manipulation of hydrogel 
mechanical properties 
A number of collagen hydrogel variants were synthesised with the aim of manipulating 
mechanical properties independently of the physical structure of the resulting gel 
matrix. Altering the collagen concentration was shown not only to impact the 
mechanical properties of the hydrogel, but also the porosity. Additionally, modulating 
the crosslinker molar ratio was investigated, however this wasn’t shown to impact the 
mechanical or physical properties of the hydrogels formed. Finally, the crosslinker was 





mechanical properties as a result. In contrast to previous research (Head et al., 2016), 
the storage modulus of hydrogels was not shown to reliably change as a result of 
crosslinker structural changes. As a result, I was not able to determine the effect of 
collagen hydrogel stiffness on ependymal cell behaviour as initially planned.  
7.1.2 Characterisation of (nestin) GFP expression  
Characterisation of (nestin) GFP expression in transgenic mice was carried out within 
this thesis; identifying the spinal cord ependymal cells as GFP+ve and expressing a 
number of stem cell markers. ECs were colocalised with antibodies against: CD24, 
Galectin-3, NKA-α1, Sox2, vimentin, CD63, CXCR4, foxJ1, and calbindin-D28k. I also 
demonstrate that (nestin) GFP expression within the SC of these transgenic mice is 
limited to ECs and pericytes, and at the central canal, (nestin) GFP is specific to ECs 
and does not label CSFcCs. Additionally, I have shown that ECs express the exosomal 
marker CD63 and therefore may sense changes in the CSF following injury and 
modulate the neurogenic niche via released exosomes. Immunofluorescence labelling 
also highlighted that ECs express CXCR4 and galectin-3, targeting of which may prove 
useful for the manipulation of endogenous cells.  
7.1.3 Optimised culture methods 
Experiments within chapter 5 enabled the detection of proliferating cells within 
fluorescent transgenic tissue. Picolyl azide was used to raise the effective 
concentration of the Cu(II) catalyst for the detection of EdU incorporated within the 
DNA of dividing cells. Additionally, spinal cord slice culture conditions were investigated 
and optimised; enabling the detection of injury-induced proliferation changes in pre-
weaner mice. 
Pre-weaner mice were used in this chapter as our group previously determined optimal 
cell survival in cultured slices from animals of this age, compared to older animals 
(unpublished observation). Pre-weaner animals were also used in order to minimise the 





animals may have been more appropriate (Pandamooz et al., 2019). Organotypic 
spinal cord slice cultures, as with other in vitro methods, are a simplified system lacking 
blood supply and therefore exclude the inflammatory response and any blood-borne 
substances that may be critical in manipulating EC behaviour in vivo. However, they do 
present a method by which cell-cell and cell-ECM interactions may be investigated, and 
so offer an insight into tissue engineering opportunities. 
 
7.1.4 Manipulation of ependymal cells using hydrogels and the 
chemokine SDF-1α 
The response of cells within spinal cord slices was shown to vary depending on the 
hydrogel substrate used. Collagen hydrogels were shown to reduce the central canal 
cell proliferation by around 50%, and an overall reduction in cell proliferation compared 
to control culture inserts. Additionally, culturing spinal cord slices on VitroGel hydrogels 
resulted in significantly more cells proliferating at the central canal compared to control. 
The trends observed using commercial hydrogels and those developed in-house show 
promise with regards to cell manipulation. The collagen and HyStem hydrogels used in 
this thesis have elastic moduli of ~100 to 650 Pa whereas VitroGel hydrogels are 
reported to have a gel strength of around 1000 Pa. The reduction in cell proliferation 
when cultured on softer hydrogels (collagen and HyStem) could be due to the 
mechanical properties of the substrate, however further research is required in order to 
determine the factors directing this response (e.g. matrix material, porosity, stiffness). 
Interestingly, uniform delivery of SDF-1α in vitro wasn’t shown to significantly affect the 
number or distribution of proliferating cells within the spinal cord. A concentration 
gradient of SDF-1α however, was shown to influence ependymal cell migration and 
injecting SDF-1α (within a hydrogel) into the spinal cord of adult mice resulted in the 
detection of significantly more proliferating cells at the level of injection in both the 





preliminary data therefore shows the promise of ependymal cell migration towards the 
chemokine SDF-1α.  
 
7.2 Applicability of these results to humans  
It was long believed that the postnatal central nervous system of mammals was devoid 
of newly born neurons. However, following advances in the labelling of proliferating 
cells; autoradiographic and histological data provided evidence to the contrary (Altman 
and Das, 1965). The evidence of adult hippocampal neurogenesis in rats propelled 
postnatal neurogenesis into the forefront of neuroscience research and since then, 
numerous investigations have also debated the existence of neurogenesis within the 
spinal cord.  
Recent work has shown that the cells around the central canal are capable of 
proliferating and differentiation into multiple lineages in response to injury (Takahashi et 
al., 2003; Hugnot, 2011). As such, manipulating the behaviour of the endogenous 
ependymal cells of the central canal presents an alternative to stem cell therapies for 
spinal cord repair following injury or disease (Barreiro-Iglesias, 2010). 
Proliferation of ependymal cells in response to other neurodegenerative diseases has 
been investigated. Ependymal cells isolated from symptomatic G93A-SOD1 mice 
presenting motoneuron degeneration as a model of amyotrophic lateral sclerosis (ALS) 
showed increased proliferation and migration compared to asymptomatic and wild type 
(WT) mice (Guan et al., 2007). Additionally, neurosphere-forming ECs from these mice 
preferentially differentiated into neurons over astrocytes; opposite to the trend seen in 
WT controls where astrocyte differentiation prevailed.  
Ependymal cells are not thought to proliferate in response to demyelination induced by  





regenerative strategies aimed at the manipulation of these cells for increased 
remyelination are required. 
Whether humans have ependymal cells that respond in a similar way to animal models 
is greatly debated (Garcia-Ovejero et al., 2015; Paniagua-Torija et al., 2018). Similar to 
the spinal cord stem cell niche of mice, some of the ependymal cells of the human 
central canal express the stem cell markers: nestin, sox2, and CD15 (a marker of SVZ 
neural stem cells) (Dromard et al., 2008). Recent RNA profiling of ependymal cells also 
indicated a number of transcription factors and genes are conserved between adult 
humans and rodents (Ghazale et al., 2019). In vitro studies have also evidenced the 
multipotent nature of human stem cells; with nestin and sox2 expression seen in 
neurospheres formed when cultured in growth factor (EGF and FGF) supplemented 
medium (Mothe et al., 2011). 
 
7.3 Future experiments  
The experiments in this thesis have set the foundations for future elucidation of the 
factors influencing ependymal cell behaviour. The data presented indicate that 
ependymal cells may be manipulated using biomaterials and chemokines however, the 
fate of such cells is yet to be determined and a number of questions remain: 
 What is the origin and ultimate fate of the proliferating cells detected in vitro and in 
vivo? 
Future studies using transgenic fate mapping in combination with immunofluorescence 
would further determine the regenerative potential of ependymal cells following SCI 
and address this question. Additionally, inducible transgenic reporter lines (e.g. under 
the control of the foxJ1 reporter) whereby ependymal cell progeny are labelled would 





would also enable further distinction between migratory proliferating ependymal cells 
and other cells proliferating in the white and grey matter of the spinal cord.  
 Which cell response would be desirable following injury (i.e. would an increase or 
decrease in proliferation be beneficial for repair), and do these cell responses 
correlate with functional repair and physiological recovery? 
Whether manipulating ECs in vivo following injury leads to an improvement in the 
physiological recovery following spinal cord injury is unclear and so behavioural studies 
in rats would be critical.  
Additional studies investigating the response of ependymal cells in vitro and in vivo are 
required in order to increase sample sizes, and thus the statistical power of our 
conclusions. Furthermore, assessment of the hydrogel properties directing ependymal 
cell behaviour would enable regenerative strategies to be designed according to the 
cell-response desired. Therefore, the correlation of functional repair with cell behaviour 
in organotypic slice models would enable the screening of a library of regenerative 
strategies and minimise the use of animals in future experiments 
 What delivery paradigm/injury model would best recapitulate the spinal cord injuries 
experienced by humans (i.e. when should SDF-1α be delivered following injury)? 
Additional factors to consider when translating research to human spinal cord injury 
regeneration strategies include the delivery paradigm for patients, and how this may 
impact the potential manipulation of endogenous repair. Patients presenting to A&E 
with traumatic spinal cord injury often also have life-threatening comorbidities requiring 
immediate stabilisation and treatment. Referral of these patients to a specialised SCI 
centre once fit-for-transfer typically occurs within the first 24 hours in the UK, however 
spinal surgery may not be available immediately; further limiting standardised SCI 
treatment and restricting the opportunity for delivering regenerative interventions 





Additionally, non-traumatic spinal cord injury, including spinal cord tumours and 
prolapsed intervertebral disks impact the spinal cord over longer periods of time; 
leading to further challenges with regards to repair. Further work is required to 
establish the optimal time point at which SCI repair strategies should be delivered, in 
addition to determining the effects deviating from this would cause. 
7.4 Conclusions 
The studies carried out in this thesis have provided evidence that the ependymal cells 
of the murine spinal cord possess stem cell markers and can be manipulated using 
hydrogels and chemokines. Promising preliminary data showed ependymal cell 
migration may be directed via the delivery of exogenous SDF-1α; indicating the 
potential for targeting this pool of quiescent stem cells for injury repair. These results 
also provide an insight into ependymal cell behaviour within organotypic spinal cord 
slice cultures and the methods developed will be crucial for the assessment of 
regenerative strategies. As a result, this thesis has provided a platform from which 
future experiments will be able to assess cell mechanosensory behaviour in response 





Chapter 8 Supplementary data 
Table 8.1 Rheology frequency sweep data for each hydrogel repeat.  
0.5, 1, and 1.5 denote the molar ratio of crosslinker: collagen lys groups. 0.6 and 0.4 
refer to the collagen concentration (wt.%). Average G’ values are quoted at 0.9976 Hz 
in this thesis. 
4Ph 0.5 1 2 3 Average 
Frequency 
(Hz) G' (Pa) 
G'' 
(Pa) G' (Pa) 
G'' 
(Pa) G' (Pa) 
G'' 
(Pa) G' (Pa) 
G'' 
(Pa) 
0.5000 353.00 39.20 378.00 40.41 433.70 47.48 388.23 42.36 
0.6295 358.80 39.51 383.60 40.55 438.60 46.76 393.67 42.27 
0.7924 364.20 38.04 388.70 40.08 443.80 46.66 398.90 41.59 
0.9976 370.50 38.32 395.80 39.19 447.80 47.52 404.70 41.68 
1.2560 376.60 37.38 401.70 39.25 455.40 47.49 411.23 41.37 
1.5810 385.40 32.48 402.80 38.69 465.60 49.62 417.93 40.26 
1.9910 385.50 37.64 415.20 40.05 467.70 46.63 422.80 41.44 
2.5060 392.20 36.54 421.30 39.58 470.70 47.74 428.07 41.29 
3.1550 405.80 42.44 433.70 41.16 481.50 52.49 440.33 45.36 
3.9720 415.60 41.07 445.30 40.21 496.40 52.25 452.43 44.51 
5.0000 429.30 50.93 460.30 42.07 508.90 54.43 466.17 49.14 
         
4Ph 1 1 2 3 Average 
Frequency 
(Hz) G' (Pa) 
G'' 
(Pa) G' (Pa) 
G'' 
(Pa) G' (Pa) 
G'' 
(Pa) G' (Pa) 
G'' 
(Pa) 
0.5000 309.30 42.86 392.70 46.53 305.30 36.04 335.77 41.81 
0.6295 312.70 42.83 399.30 44.46 310.50 35.58 340.83 40.96 
0.7924 317.50 41.71 404.70 44.72 316.50 35.78 346.23 40.74 
0.9976 321.60 42.82 411.10 44.93 322.50 33.89 351.73 40.55 
1.2560 325.80 43.26 417.40 44.68 327.30 34.60 356.83 40.85 
1.5810 335.90 46.43 423.30 50.41 335.00 32.08 364.73 42.97 
1.9910 332.60 43.66 431.00 44.95 336.80 35.02 366.80 41.21 
2.5060 339.30 43.80 436.80 44.67 343.50 35.55 373.20 41.34 
3.1550 347.30 46.22 447.60 45.95 358.20 33.19 384.37 41.79 
3.9720 357.70 46.45 462.70 50.25 366.00 36.69 395.47 44.46 


















4Ph 1.5 1 2 3 Average 
Frequency 
(Hz) G' (Pa) 
G'' 
(Pa) G' (Pa) 
G'' 
(Pa) G' (Pa) 
G'' 
(Pa) G' (Pa) 
G'' 
(Pa) 
0.5000 375.80 46.45 393.00 46.79 350.00 41.39 372.93 44.88 
0.6295 382.90 44.89 399.00 46.17 356.10 39.89 379.33 43.65 
0.7924 388.90 44.94 404.80 45.48 361.00 38.16 384.90 42.86 
0.9976 395.20 44.67 410.20 45.06 367.70 40.52 391.03 43.42 
1.2560 401.50 44.49 417.80 45.73 372.90 40.39 397.40 43.54 
1.5810 413.60 44.97 419.40 46.83 387.40 39.62 406.80 43.81 
1.9910 415.30 43.95 430.30 45.07 383.90 40.22 409.83 43.08 
2.5060 422.10 44.26 435.30 46.20 388.10 41.19 415.17 43.88 
3.1550 434.70 43.39 445.30 45.22 399.90 44.50 426.63 44.37 
3.9720 447.00 49.84 459.90 46.75 413.40 44.21 440.10 46.93 
5.0000 462.60 51.28 477.20 48.98 430.90 50.60 456.90 50.29 
         
4Ph 0.4 1 2 3 Average 
Frequency 
(Hz) G' (Pa) 
G'' 
(Pa) G' (Pa) 
G'' 
(Pa) G' (Pa) 
G'' 
(Pa) G' (Pa) 
G'' 
(Pa) 
0.5000 80.65 10.01 70.42 8.09 85.90 10.40 78.99 9.50 
0.6295 81.18 9.81 72.72 8.36 87.40 9.17 80.43 9.11 
0.7924 82.25 10.52 74.72 8.18 86.63 9.02 81.20 9.24 
0.9976 83.63 9.15 77.88 7.63 82.85 8.99 81.45 8.59 
1.2560 86.20 9.13 79.10 8.35 81.07 11.34 82.12 9.61 
1.5810 92.25 10.32 76.49 8.43 76.59 4.75 81.78 7.83 
1.9910 90.35 8.72 83.16 7.78 83.95 10.06 85.82 8.85 
2.5060 96.16 10.35 88.78 10.28 92.62 9.94 92.52 10.19 
3.1550 104.50 12.00 97.52 11.32 104.20 7.57 102.07 10.30 
3.9720 109.40 11.90 102.60 10.88 108.00 12.23 106.67 11.67 
5.0000 120.10 14.95 114.90 15.01 118.60 9.55 117.87 13.17 
         
4Ph 0.6 1 2 3 Average 
Frequency 
(Hz) G' (Pa) 
G'' 
(Pa) G' (Pa) 
G'' 
(Pa) G' (Pa) 
G'' 
(Pa) G' (Pa) 
G'' 
(Pa) 
0.5000 196.90 23.82 232.30 25.89 177.00 20.44 202.07 23.38 
0.6295 200.70 25.41 236.40 24.91 180.10 20.47 205.73 23.60 
0.7924 204.40 22.87 238.90 25.76 183.30 20.28 208.87 22.97 
0.9976 206.50 23.38 243.60 25.72 185.30 19.62 211.80 22.91 
1.2560 211.80 21.98 246.60 23.84 187.20 19.76 215.20 21.86 
1.5810 207.40 23.29 242.40 24.61 182.30 22.55 210.70 23.48 
1.9910 214.50 22.58 247.30 24.24 190.60 18.53 217.47 21.78 
2.5060 222.80 22.91 254.90 25.31 198.80 20.26 225.50 22.83 
3.1550 232.80 25.48 260.30 25.25 204.60 18.30 232.57 23.01 
3.9720 241.80 26.09 275.40 29.79 216.30 21.46 244.50 25.78 









13Ph 1 2 3 Average 
Frequency 
(Hz) G' (Pa) 
G'' 
(Pa) G' (Pa) 
G'' 
(Pa) G' (Pa) 
G'' 
(Pa) G' (Pa) 
G'' 
(Pa) 
0.5000 296.60 38.09 451.50 48.48 382.20 44.42 376.77 43.66 
0.6295 302.00 36.88 459.80 49.01 388.00 43.63 383.27 43.17 
0.7924 307.10 36.57 467.00 48.16 393.30 42.90 389.13 42.54 
0.9976 312.90 36.08 474.50 47.91 399.50 42.30 395.63 42.10 
1.2560 317.40 36.20 482.30 47.76 406.20 43.59 401.97 42.52 
1.5810 323.50 29.69 485.90 48.50 417.30 39.76 408.90 39.32 
1.9910 326.90 35.10 499.50 46.02 418.90 42.11 415.10 41.08 
2.5060 333.60 36.48 507.10 46.99 423.70 43.10 421.47 42.19 
3.1550 346.00 35.15 518.50 52.17 439.30 44.84 434.60 44.05 
3.9720 355.90 39.64 532.80 52.75 448.10 46.60 445.60 46.33 
5.0000 368.40 42.97 550.30 56.41 462.00 56.41 460.23 51.93 
         
Ad 1 2 3 Average 
Frequency 
(Hz) G' (Pa) 
G'' 
(Pa) G' (Pa) 
G'' 
(Pa) G' (Pa) 
G'' 
(Pa) G' (Pa) 
G'' 
(Pa) 
0.5000 274.90 35.21 320.30 38.32 346.10 41.40 313.77 38.31 
0.6295 280.20 35.47 326.60 37.83 351.90 40.70 319.57 38.00 
0.7924 285.50 34.62 333.20 36.92 358.00 40.54 325.57 37.36 
0.9976 291.40 34.67 339.70 36.29 365.00 40.26 332.03 37.07 
1.2560 296.90 34.06 346.10 37.10 371.70 39.99 338.23 37.05 
1.5810 300.50 39.09 347.20 41.75 382.90 40.41 343.53 40.42 
1.9910 310.40 34.10 355.80 38.19 383.50 40.15 349.90 37.48 
2.5060 317.50 33.26 362.90 38.70 389.00 39.39 356.47 37.12 
3.1550 325.00 35.21 374.60 41.50 400.60 36.32 366.73 37.68 
3.9720 338.50 38.43 387.60 44.62 413.70 43.47 379.93 42.17 











Figure 8.1 Mean storage moduli of hydrogels varies between repeats 
Storage modulus determined by rheology frequency sweeps, quoted at 1 Hz. Dashed 
lines denote separate experiments (i.e. different batches of collagen solution, 
crosslinker solution batches, and testing dates). Data presented as mean +SD. N=3 for 
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